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Abstract
Membrane transport proteins take a pivotal role in all forms of life as they
are responsible for organising traffic of ions and small molecules across the
hydrophobic barrier of biological membranes. Mutations in membrane trans-
porters can often lead to severe diseases and they often consitute drug tar-
gets. Hence, assaying function of membrane transporters is of great impor-
tance.
In this project the method used for this task was mainly a relatively un-
common technique called solid-supported membrane based electrophysiol-
ogy. The goal was to test this technique on targets that are challenging to
investigate by more conventional methods. A first target was the TRPM2
ion channel. TRP channels are difficult to investigate because they often
show a very complex activation pattern. A second target was the bacterial
transition metal transporter MntH2 from Enterococcus faecalis, belonging
to the SLC11 family. Transition metal transporters are generally difficult
to investigate, because of the nature of their substrates. Some transition
metals are redox-active and in solution they act as complexing agents.
Application of solid supported membrane based electrophysiology was not
successful for TRPM2, but the method was used to perform basic biophysi-
II
cal characterisation of MntH2. It was found that MntH2 transports a range
of substrates including Mn2+, Cd2+,Co2+ and Zn2+. Ni2+ and Cu2+ were
not transported and in fact inhibited manganese uptake. Interestingly, in
the presence of the protonophore carbonyl cyanide m-chlorophenyl hydra-
zone (CCCP) electrophysiological currents were not affected. This, together
with the observation from a complementary assay, that reconstituted MntH2
did not acidify the interior of vesicles loaded with pH-sensitive fluorescence
probes, led to the hypothesis that MntH2, contrary to common belief, is not
a H+ symporter.
MntH2 was attempted to crystallise and in initial screens some conditions
were identified which could be a basis for optimisation in future trials.
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Chapter 1
Introduction
1.1 Introduction to membrane transport and re-
lated terminology
In biological organisms, phospholipid bilayer membranes separate cells from
their environment and in eukaryotes they make the border between the in-
terior of organelles and the surrounding cytoplasm [1]. The large hydropho-
bicity of these membranes provides an effective barrier for ions and polar
molecules, which cannot diffuse from one side to the other due to the large
energy ”penalty” when passing the membranes hydrophobic core. The func-
tion of facilitating or promoting the traffic of ions and small compounds with
low membrane permeability is taken by transmembrane transport proteins.
The term ”transmembrane transport” has been used to describe different
processes. In this thesis the term ”(trans)-membrane transport protein” in-
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Figure 1.1: Functional classification of membrane transport proteins. Transport
directionality of substrates and cosubstrates are depicted by arrows, where dashed
arrows are used to indicate cotransport. Channels and uniporters operate both in a
passive mode, but there are other features to distinguish the two classes (see text).
*ABC stands for ATP-binding cassette transporters which, as ATPases, use the
energy from ATP hydrolosis to drive transport.
cludes all classes of proteins involved in membrane traffic as shown in fig.
1.1. Fig. 1.1 indicates that there are three fundamentally different ways
how transport of substrates is driven in these proteins. Ion channels and
uniporters do not use any external energy source to drive transport. Hence,
they equilibrate the concentration of their substrate on both sides of the
membrane to a thermodynamic minimum. Substrate transport is said to
be ”passive” [2]. Other membrane transporters are powered by an external
energy source and are able to transport their substrate against a concen-
tration gradient. Some transporters use ATP, which is a primary energy
source. Hence they are referred to as ”primary active” transporters and
include the family of the ATPases and the ABC-transporters. Finally, a
large class of proteins couple the unfavourable process of substrate trans-
port to a thermodynamically favourable transport of a co-substrate [3]. The
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co-substrate is usually a small cation like H+ or Na+. These are secondary
energy sources, because in order to maintain a gradient of the co-substrate,
ATPases are needed, that use the primary energy source ATP. Transporters
using a cosubstrate are therefore referred to as ”secondary active” trans-
porters. It should be mentioned that in some textbooks the uniporters are
also referred to as secondary active transporters. This is inconsitent, how-
ever, because the term ”active” suggests that substrate can be transported
uphill, which is not the case for uniporters. From a thermodynamic view
point, the uniporters are in fact much more similar to ion channels [2]. Still,
it can be useful to have a general term for uni-, sym and antiporters, as these
protein classes have several properties in common. A possible choice would
be to use simply the term ”transporter”. The problem with this term is
that it is not very well defined and depending on the context it may include
primary-active transporters and even ion channels. To avoid ambiguities it
would therefore be better to use a different term, but the problem is, that
alternatives are lacking. The approach used in this thesis, is that, whenever
possible, the term SoLute Carrier (family) transporters (SLC-transporters)
is used. SLC-transporters form a large family of membrane transporters
that has enlisted all human uni-, sym- and antiporters. They will be intro-
duced in section 1.5.
Of the two proteins investigated in this thesis one (TRPM2) is an ion chan-
nel and the other one (MntH2) is an SLC-transporter homologue. TRPM2
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will be introduced first, starting with a general introduction section about
ion channels (1.2) followed by more specific sections about TRP-channels
(1.3) and TRPM2 (1.3.2). The same structure will be applied to introduce
MntH2, starting with a general section about transporters (1.4), then SLC-
transporters (1.5), followed by sections introducing the SLC11 family (1.6)
and bacterial SLC11 homologues to which MntH2 belongs (1.7).
1.2 Ion channels
1.2.1 Thermodynamics of ion transport
Before ion channels are discussed in detail some basic thermodynamics con-
cepts will be introduced. Transport in ion channels is passive, meaning no
external energy source is required to drive ions through the channel [1]. The
channel provides a pore through which ions diffuse freely, but selectively.
Diffusion of ions is directed by two factors. The first one is the concentra-
tion difference of an ionic species between the two sides of the membrane.
Diffusion drives ion flow from higher to lower concentration until concentra-
tions are equal on both sides. The free energy released in that process is
described by eq. (1.1):
∆G = RTln
(
[Ain]
[Aout]
)
(1.1)
In this equation, ∆G is the difference in Gibbs free energy, R is the universal
gas constant, T the temperature and Ain and Aout are the concentrations of
4
1.2 Ion channels
the solute on the cytoplasmic and on the extracellular side of the membrane
respectively. A look at the physiological ion concentrations in biological
systems will show that ion distribution can be highly asymmetrical. In
mammals, for instance, the concentrations of Na+ and K+ are highly im-
balanced between in- and outside of cells. Concentrations are ca. 150 mM
Na+ and 4 mM K+ in the extracellular fluid and ca. 140 mM K+ and 12
mM Na+ in the cytoplasm. Apart from the concentration gradient, the di-
rection of ion flow is influenced by a second factor, which is the membrane
potential. The membrane potential is a reflection of the difference in the
sum of electrical charges between the two sides of the membrane. In case of
the cell membrane, there is an excess of negative charges on the cytoplasmic
side, whereas the extracellular side is positively charged. Ions are attracted
to the side that has a total charge opposite their own charge. To account
for the membrane potential the eq. 1.1 is modified by an additional term:
∆G = RTln
(
[Ain]
[Aout]
)
+ zF∆Ψ (1.2)
In eq. 1.2 F is the Faraday constant, z is the ionic charge of A and ∆Ψ is
the membrane potential.
The membrane potential results from a combination of passive and active
transport of certain ion species across biological membranes. In typical ani-
mal cells, for instance, the largest contribution to the membrane potential is
5
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made by passive transport of permanently open potassium channels. These
channels allow potassium ions, that have a high concentration in the cyto-
plasm to diffuse out. In doing so, the cytoplasmic side becomes negatively
charged, which stops potassium concentrations from equilibrating. Sodium
ions, that are present in excess on the extracellular side, are very much
attracted to he cytoplasmic side, but they have a low membrane permeabil-
ity. As a consequence the system cannot reach its thermodynamic minimum
and a membrane potential is constantly maintained. The Na+/K+-ATPase
assists this process by electrogenic transport of K+ into- and Na+ out of
the cell. The magnitude of the membrane potential can be calculated by
using the Goldman-Hodgin-Katz equation for monovalent ions (1.3). This
equation takes into account the in- and outside concentrations of the three
most abundant ions in biological systems (K+, Na+ and Cl−) as well as the
respective permeability of these ions.
∆Ψ =
RT
F
ln
(∑n
i PM+i
[M+i ]out +
∑m
j PA−i
[A−i ]in∑n
i PM+i
[M+i ]in +
∑m
j PA−i
[A−i ]out
)
(1.3)
For obvious reasons anions and cation show opposite behaviour with respect
to their position in the fraction and therefore a letter M is used for cationic
species and A for anionic species. P is assigned for ion permeability coeffi-
cients. To calculate physiological membrane potentials, generally only Na+,
K+ and Cl− ions are considered. Evaluating equation 1.3 will typically re-
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sult in values for membrane potentials between -40 and -80 mV, depending
on cell types.
1.2.2 Structural architecture of ion channels
Ion channels are designed to enable a rapid passage of ions such as Na+,
K+, Ca2+ and Cl− across biological membranes. They form essentially a
hydrophilic pore through which selected ions diffuse freely from one side to
the other. Ion channels have in common two main features that are impor-
tant for their function: A selectivity filter, that allows only certain species of
ions to pass, and a gate, that can be opened and closed depending on exter-
nal stimuli. The nature of the stimulus determines whether an ion channel is
classified as a ligand-gated, signal-gated, voltage-gated or mechano-sensitive
channels (fig. 1.2). Some channels, like for instance several members of the
Figure 1.2: Different classes of ion channels. (A): Voltage-gated channels respond
to changes in membrane potential. (B) and (C): Ligand-gated and signal-gated
channels respond to binding of a molecule to the extra-/intracellular side. Often
these two classes are not distinguished and are both referred to as ligand-gated
channels. (D): Stress-activated channels may be gated by different mechanisms.
The depicted mechanism could occur in channels that are abundant in auditory
hair cells in the ear basilar membrane. Figure adapted from [4].
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TRP family, show a more complex activation pattern and their state of
transport depends on a combination of stimuli.
To give a general introduction on the molecular basis of ion channel pores,
KcsA will be discussed as a model channel. KcsA is one of the best charac-
terised and most intensively investigated channels. The structure of (trun-
cated) KcsA was solved in 1998 by Doyle et al. [5]. KcsA is a bacterial
Figure 1.3: Structural representation of the bacterial potassium ion channel KcsA.
A: Pore with selectivity filter viewed from the membrane plane. From this perspec-
tive one can see the inverted tipee arrangement where the top of the tipee forms the
gate at the intracellular side. The potassium ions in the selectivity filter (purple)
and the coordinating oxygen ligands (red) are shown in a space filling representa-
tion. For better view the two subunits in the front and the back of the pore have been
omitted. B: Top view from the extracellular side. This view shows the tetrameric
architecture of the core that is found to be similar in most ion channels. One can
also guess the 8-fold coordination of the hydration shell of the potassium ion in the
selectivity filter. Figure made with PyMOL [6].
potassium channel from Streptomyces lividans and it is activated at low
pH [7]. There are several reasons why KcsA is such a good model system.
First of all its structure is very simple: Like other potassium channels, it is
tetrameric, but its monomer contains only two transmembrane helices. It
is much more common for ion channels to have six transmembrane helices
instead. Also KcsA’s primary sequence is very homologous to the pore re-
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gion of eukaryotic voltage-gated potassium channels. The structure of KcsA
contributed to a large extent to solve one of the most puzzling questions
at the time: It was hard to understand how ion channels could transport
their substrate with such great speed, close to the diffusion limit, and at
the same time provide such a high selectivity: KcsA has a greater than
10000-fold selectivity of potassium over sodium. The problem was that high
substrate selectivity is usually associated with a high specificity of the bind-
ing site. High specificity, at the same time, implies a strong affinity for the
substrate. But a strong affinity would slow down transport, because the
rate of substrate release would become a limiting factor. The structure of
KcsA answered this conundrum, in particular because the crystals included
potassium ions in the selectivity filter (fig. 1.3)
As mentioned, KcsA is a tetramer, where each monomer contributes two
transmembrane helices, named M1 and M2. The M2 segments form the
pore in what has been called an ”inverted teepee” arrangement, where the
pinnacle of the teepee is on the cytoplasmic side and the base faces the
extracellular side. This provides a large cavity within the membrane with
a maximal diameter of ca. 10 A˚, that enables K+ ions to reside there in
hydrated form (fig. 1.3). The selectivity filter, which lies adjacent to the
cavity, is much narrower with a width of ca. 3 A˚, that forces ions to strip
off their hydration shell. This process requires energy, which slows down ion
translocation. However, the filter is lined with oxygen-ligands from backbone
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carbonyl-oxygens that arrange in a way that closely resembles the geometry
of the water-oxygen atoms in the potassium hydration shell. This minimizes
the energy required for dehydration and rehydration of K+ ions and so they
can pass through the filter still with a very high turnover. Na+ ions, on the
other hand, are too small to coordinate well with the backbone oxygens of
the selectivity filter, which considerably hampers their passage. This expla-
nation answers the question about high selectivity with simultaneous high
speed K+-conduction on a basic level. For the same reason this section will
spare a detailed discourse about the gating mechanism. What has to be
mentioned in this regard is that there is a conserved glycine residue in M2
that acts as a hinge between open and closed state. In related channels the
hinge residue may also be a proline.
The last issue topic that will be illustrated by the example of KcsA is channel
inactivation. So far it has been assumed that there are only two states that
a channel can adopt: An open and a closed state. However, in some chan-
nels a third state can occur, which is the inactivated state. The inactivated
state describes a configuration of the protein that is not ion-conducting, re-
gardless of whether the gate is open or closed. In K+ channels two types of
inactivation can occur: N-type and C-type inactivation. N-type inactivation
describes the autoinhibitory blocking of the pore by a ball-shaped domain
located on the N-terminus. C-type inactivation is often a slow inhibitory
process that deforms the cavity of the selectivity filter and thereby stops ion
10
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translocation. Structural details of this process are known from a study on
KcsA where several structures in transition to an inactivated state of this
channel have been solved showing a stepwise deformation of the backbone
of the selectivity filter [8]. This work will not be discussed in detail here,
but it is worth noting that C-type inactivation has been reported to occur
in the TRPM2 channel [9].
Structures from different types of potassium channels, including the volt-
age sensitive K+-channels KvAP [10] and Kv 1.2 [11], the bacterial inward
rectifier K+-channel KirBac 1.1 [12] and the calcium activated K+-channel
MthK [13] gave insights into voltage and ligand-gating mechanisms. These
structures revealed that all the channels were tetrameric and that in general
the architecture of the pore shows great similarity to KcsA. Most of these
channels, with the exception of KirBac 1.1, differ from KcsA in that they
have six TM helices instead of two. The transmembrane helices are generally
labelled S1 to S6, where S5 and S6 are homologous to the M1 and M2 helices
of KcsA. The first four helices may be involved in the gating mechanism, but
the exact function may vary depending on the type of channel activation.
In voltage sensitive channels, for instance, the S4 helix is rich in positively
charged amino acids and thereby acts as a voltage sensor. Continuing with
the example of voltage gated channels, the arrangement of the transmem-
brane part of the protein is very similar when comparing K+ channels to
channels conducting Na+ or Ca2+ [14–16]. The main topological difference
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of Na+ and Ca2+ channels compared to K+ channels is that rather than
forming a tetramer, these channels consist of a single chain that adopts a
pseudotetrameric fold [17]. Regarding the selectivity filter, it is noteworthy
that it is wider for Na+ and Ca2+ channels, which implies that these ions are
transported at least partially hydrated, as their ionic radii are smaller com-
pared to K+ [14]. Another difference is that in the selectivity filter of Na+
and Ca2+ channels the ion coordination sites are partly formed by amino
acid side chains, whereas in K+ channels K+ is coordinated solely by back-
bone oxygens. By having side chains as part of the coordination sites, amino
acid substitutions can modify the charge density inside the filter cavity, e.
g. by varying the number of positively and negatively charged amino acids.
As a consequence, a channel can be made more selective for either Na+ or
Ca2+ ions and studies have shown that by making appropriate mutations of
amino acids in a conserved sequence, the selectivity of a Na+ channel can
be shifted towards Ca2+ selectivity [16].
Anion channels constitute a very intricate and interesting category of pro-
teins. Some anion channels actually are classified as SLC26 transporters [18]
and therefore are covered in section 1.5. Even the ClC channels, of which
the structure of two bacterial homologues has been solved [19], have been
found in many cases to be in fact Cl−/H+-exchangers [20]. For this reason,
and the fact that anion channels have not been the subject of this thesis,
they will not be further introduced here.
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1.3 TRP channels
Transient receptor potential (TRP) channels form a large family of non-
selective cation-channels [21–24]. The first TRP channel was discovered in
Drosophila melanogaster where a spontaneous mutant led to an unusual re-
sponse to steady light which appeared to be transient in contrast to the
sustained response in wild-type flies [25] (Hence the name of these chan-
nels). Homologous channels found in eukaryotes have been classified into six
subfamilies based on their protein sequence homology: TRPC (canonical)
[26, 27], TRPV (vanilloid) [28], TRPA (ankyrin) [29], TRPP (polycystin)
[30], TRPML (mucolipin) [31–33] and TRPM (melastatin) [34]. To a large
extent TRP channels are involved in the molecular mechanisms of sensory
perception in humans [23]. This includes touch, taste and smell, but also in
hearing and vision TRP channels may play a crucial role. Because of their
function as primary sensors, TRP channels naturally respond to a great va-
riety of physical and chemical stimuli. A prototype TRP channel is TRPV1
that responds to a wide range of structurally unrelated vanilloid ligands
[35, 36]. These include capsaicin (the pungent compound of hot peppers),
resiniferatoxin (a chemical found in the cactus Euphorbia resinifera), piper-
ine (the pungent extract of black pepper) and camphor (a strongly smelling
compound extracted from Cinnamomum camphora, commonly known as the
camphor tree). In addition, the channel is activated by some spider-toxins,
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including the double-knot toxin DkTx, which is a short peptide of 75 amino
acids [37]. Apart from ligand binding, TRP channel activity may depend on
other factors including temperature [35, 38–44], membrane voltage [45–48],
post-translational modifications such as phosphorylation [49] and ubiquiti-
nation [50], as well as the presence of certain membrane lipids, especially
phophatidylinositol(4,5)biphosphate (PIP2) [51–53]. Because of the large
variety of functions and activation mechanisms even among TRP subfami-
lies it is impossible to give a concise overview of this aspects of the family.
Detailed lists of all human TRP channels together with their proposed acti-
vation mechanism and physiological functions have been published elsewhere
[22].
Structural research on TRP channels has been challenging in the past, as
it is for all eukaryotic membrane proteins. However, relatively recently,
structures of several TRP channels have been published using cryo-EM,
which gave some exciting new insights. The first published high-resolution
structure appeared in 2013 and was of TRPV1 [54]. Subsequently, also
high-resolution structures of TRPA1 [55], TRPV2 [56, 57] and TRPV6 [58]
were published. From these structures it was found that the transmembrane
core of TRP channels is structurally similar to voltage gated potassium (Kv)
channels. Like Kv-channels, TRP channels are tetrameric and one monomer
consists of six transmembrane helices, where S5 and S6 of each subunit form
the pore. Helices S1-S4 are equivalent to the voltage sensing domain, even
14
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Figure 1.4: Structural representation of the TRPV1 ion channel based on data
from cryo-EM. The structure revealed a core architecture that is similar to the one
of KcsA and other voltage gated ion channels (figure with permission from [54]).
Figure 1.5: a: Linear diagram of structural domains of TRPV1. Typical features
for TRP channels are the ankyrin repeat and the TRP domain. Dashed lines in-
dicate lack in electron density of that part b: Cartoon representation of TRPV1
monomer. The coloring matches with the diagram in a. From this view the po-
sitioning of the TRP domain can be identified which is parallel to the membrane
plane close to the cytoplasmic side (figure with permission from [54]).
though in voltage insensitive TRP channels, like TRPV1, helix S4 is not
rich in charged residues. Of the published structures of TRP channels so
15
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far, the one of TRPV1 is particularly insightful, because it has not been
only solved in its apo-state (without ligand) but also with different ligands
[59]. An interesting observation was that binding of activating vanilloid lig-
Figure 1.6: Cryo-EM structure of TRPV1 core domain bound to two of its acti-
vators: capsaicin (red electron density) and Dktx (purple electron density). The
structure reveals that these ligands bind to sides that are very far apart from each
other. This illustrates the complexity of the activation mechanism in TRP channels
(figure with permission from [59]).
ands (capsaicin/resiniferatoxin) takes place in a very different location than
binding of the spider toxin. Intriguingly, the channel appeared to be in a
different state of activation depending on the nature of the ligand. Only the
spider toxin, which binds to the outer pore region of TRPV1, causes the
channel to adopt a fully open state. The vanilloid activators, which bind in
a membrane buried region between the S4 and S5 helix, cause only a par-
tial opening of the channel. This illustrates the complexity of TRP channel
regulation and the challenges involved in getting a detailed understanding
of the gating mechanisms.
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1.3.1 The TRPM subfamily
The TRPM sub-family has been named after its first member, melastatin
(TRPM1), which is predicted to be a tumour suppressor [34, 60]. So far
eight members of this family have been described, for which a large vari-
ety of physiological functions have been proposed. Some of them (TRPM1,
TRPM5, TRPM7 and TRPM8) appear to have a role in sensing, where
the function of TRPM8 as a cold sensor is presumably the best established
[43, 44, 61]. TRPM5 is expressed in taste bud cells and is supposed to be
involved in the sensing of bitter, sweet and umami taste [62]. TRPM7 has
been proposed as a shear stress sensor, but this hypothesis has not yet been
proven [63, 64]. Finally, the tumor repressor TRPM1 also is involved in
the light response in ON bipolar retinal ganglia cells [65]. For the majority
of the TRPM channels, increasing evidence suggests that they are not in-
volved in perception, but take on different functions, including contributing
to maintaining homeostasis and organ function [66]. TRPM2, the channel
under examination in this thesis, has been identified as a sensor for oxida-
tive stress, which appears to be one of its key roles [67–71]. Potentially,
TRPM4 and TRPM7 are also involved in oxidative stress sensing [72–79],
but their contribution is less significant. The high diversity of functions
among TRPM members is also reflected by the varying cation selectivity
between the different channels. TRPM4 and TRPM5 are non permeable
to Ca2+ [80], whereas the remaining members of the family show varying
17
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selectivities between mono- and divalent cations. A peculiar feature of three
TRPM family members (TRPM2, TRPM6 and TRPM7) is that their C-
termini form a domain that carries out enzymatic activity. TRPM6 and
TRPM7 exhibit α-kinase activity [81, 82] and TRPM2 catalyzes hydrolysa-
tion of ADP-ribose [83, 84]. A summary of TRPM family cation selectivity,
physiological functions and cellular expression is given in table 1.1.
1.3.2 TRPM2
TRPM2 (formerly also called TRPC7 or LTRPC2) was the first target for
biophysical characterisation in this thesis. Compared to other channels of
the TRP family, it is fairly large with a monomer molecular weight of 173
kDa. It is expressed in a variety of tissues or cell types including the brain,
bone marrow, neutrophils [85–87], lung, spleen, eye, heart and liver [84].
Whereas generally TRPM2 has been found located in the cell membrane,
in pancreatic β-cells TRPM2 was found to be expressed as well in the lyso-
somes [88]. It is possible that TRPM2 is located elsewhere as well, because
in a stable overexpressing HEK293 cell line, TRPM2 is also found in mito-
chondria [89]. TRPM2 is widely considered to be an oxidative stress sensor
after it was found that Ca2+ influx via TRPM2 regulates H2O2-induced
cell death [90, 91]. Additional functions have been proposed for TRPM2
involving maturation of dendritic cells and chemotaxis, as well as insulin
secretion [66]. Furthermore, TRPM2 has been associated with a number of
18
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Figure 1.7: Schematic representation of TRPM2 sequence. The protein consists of
three main domains: A large N-terminal which includes a calmodulin binding site,
a transmembrane domain, presumably strongly resembling that of Kv-channels, and
a C-terminal domain that includes the TRP domain, a coiled coil domain and an
ADPR-hydrolosis (NUDT9-H) domain. Figure adapted from [92].
serious diseases. Its activation by H2O2 in vivo suggests a role in pathogenic
processes which are characterised by an increased oxidative environment, in-
cluding carcinogenesis, inflammation, neurodegenerative disorders, diabetes
and others [90].
The modulatory mechanisms of TRPM2, like of most TRP channels, are
very complex as has been shown in previous studies. The primary gating
molecule is adenosine-diphosphate-ribose (ADPR; [90]), which binds with
high specificity to the TRPM2 specific Nudix-like domain at the C-terminus
(fig. 1.7). Considerable amount of work has been done to characterise
TRPM2 in numerous patch clamping studies of different cell types [93–98].
Despite this large body of work there are still some issues that have not
yet been fully resolved. For instance, the role of Ca2+ in gating is still not
fully understood. Although it is widely agreed that in addition to ADPR,
intracellular calcium ions ([Ca2+]i) are needed as co-activators to open the
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channel [66], it is not quite clear whether Ca2+ ions bind independently or
whether they mediate channel opening via calmodulin. Tong et al. claim ev-
idence that activation occurs via calmodulin binding [99]. The authors used
a calmodulin mutant that was made insensitive to Ca2+. When TRPM2
was coexpressed with the calmodulin mutant, Ca2+ influx was suppressed
which led to the conclusion that the mutant competes with the endogeneous
calmodulin and stops it from activating TRPM2. In a further experiment it
was shown with immunoblotting that calmodulin associates with TRPM2 in
a region at the N-terminus (fig. 1.7). Later, Csana´dy et al. postulated that
in addition to calmodulin binding, the channels has four Ca2+ binding sites
that regulate channel opening [100]. Although it seems likely that bound
and unbound Ca2+ affect the channel, results from biophysical studies could
give a definitive answer to that question. Apart from ADPR and Ca2+, a
large number of other compounds also appear to have regulatory effects
on TRPM2. These include ADPR related compounds such as cyclic ADPR
(cADPR) [101, 102], nicotinamide adenine dinucleotide (NAD+) [68, 84] and
nicotinic acid adenine dinucleotide phosphate (NAADP) [102, 103], but also
unrelated compounds such as reactive oxygen species (ROS), most notably
H2O2 [68, 101]. The activation mechanism of these compounds, especially
of H2O2, has been highly controversial in the past, as the debate has been
on whether they are direct or indirect activators of TRPM2. From exper-
iments, taking advantage of the inside-out patch-clamp technique, Toth et
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al. claim that most of the compounds are indirect modulators [104], but it
would be worth confirming this with a different technique.
Most studies on TRPM2 have focussed on the channel in the plasma mem-
brane. Little work has been done yet on the characterisation of the lysosomal
channel. The sensitivity of the channel towards changes in intra- and extra-
cellular pH has been investigated by Starkus et al. [105] and they found a
decrease in activity at lower pH. It remained unclear, whether the channel
is able to conduct protons or not, or whether cotransport of protons with
cations takes place. At least of equal importance is the question whether the
channel is permeable to other cations such as Zn2+. This is of significance in
the context of the channel’s potential role in cell death of pankreatic β-cells.
It has been shown that activity of the lysosomal TRPM2 channel alone can
lead to oxidative-stress induced cell death in mouse β-cells, but the path-
way of apoptosis remains unknown. There is evidence that TRPM2 releases
Zn2+ from the lysosomes, which would explain the occurence of cell death,
as free Zn2+ is toxic [106]. But cell death is not the only process in which
TRPM2 has potentially a detrimental role. Experimental evidence suggests
that TRPM2 is directly linked to type II diabetes. A study using TRPM2
KO mice showed that mice not expressing the channel were protected from
diet-induced obesity and insulin resistance [107]. Inhibiting TRPM2 there-
fore should help to prevent type II diabetes. Besides biophysical character-
isation of TRPM2, a declared goal of this project was to establish a stable
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assay for screening compounds inhibiting TRPM2. A chemical library for
this purpose has been designed in preceeding work. Here it was attempted
to screen this library to identify the direct inhibitors to be used for iterative
screening.
1.4 Transporters
For reasons outlined in section 1.1 the term ”transporter” used as a title of
this section refers to secondary active- and passive transporters only. Sec-
ondary active transporters include a co-substrate, like Na+ or H+, in the
transport mechanism, that moves down its electrochemical potential gradi-
ent. The free energy of this downhill movement is then coupled to uphill
transport of the substrate. Depending on the directionality of co-transport,
the transporter is referred to as a sym- or antiporter (fig. 1.1). Uniporters
do not use a cosubstrate and are initiated only by a transmembrane gra-
dient of their own substrate. What all transporters have in common, and
distinguishes them from ion channels, is that they operate in an ”alterna-
tive access” mechanism. This means that the protein alternates between
two conformations: An outward facing conformation, that allows access of
substrate only from the extracellular side and an inward facing conformation
that can only take up substrate from the cytoplasmic side. It is nowadays
assumed in general that some occluded states are involved in the transport
cycle as well, where the substrate is shielded completely from either bulk
solution ([109], fig.1.8). Membrane transport following this mechanism can
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Figure 1.8: Illustration of a transport cycle following an alternating access mecha-
nism. A symporter mechanism is shown for this example. Apart from outward open
and inward open states the cycle contains as many as four occluded states (figure
adapted from [108]).
be written as a chemical equation. For a transporter molecule P exporting
a substrate S out of the cell this would look as follows:
Sin + P PS
ktransport
P + Sout (1.4)
Thereby PS represents the substrate bound transporter, ktransport is the
rate constant of substrate transport and Sin and Sout is the substrate in- and
outside of the cell respectively. It turns out that this equation is equivalent
to an enzyme catalysed reaction where Michaelis Menten kinetics applies.
Therefore, a Michaelis constant can be defined analogously:
v0 = ktransport[PS] =
vmax[S]
KM + [S]
(1.5)
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Where KM is the Michaelis constant and v0 is the initial velocity of trans-
port. This implies that at high substrate concentrations, transport velocity
is limited by the number of proteins available. Based on kinetic data it is
therefore possible to distinguish whether a protein has an alternating access
transport mechanism or whether it behaves like an ion channel.
1.5 The solute carrier family
The solute carrier (SLC) nomenclature system has been introduced only
in the 1990s. Essentially, the idea of that system was to assign all human
genes of membrane transporters, that do not belong to any of the remain-
ing classes (ion channels, aquaporins and primary active transporters) to a
large superfamily [110]. Consequently, the SLC family is very diverse and its
members are responsible for transport of a large variety of substrates. Most
of these are small organic molecules such as amino acids, sugars or neu-
rotransmitters, but some also transport ions or larger molecules, including
oligopeptides. Up to date there have been 52 subfamilies identified which
account for more than 400 human genes [110].
Structural information about SLC-transporters is available mostly from crys-
tal structures of bacterial homologues. Up to 2017 only three human SLC
structures have been published [111–113]. From a structural point of view,
SLC-transporters are very different from the classical ion channels, that have
been introduced in the previous sections. Perhaps surprisingly, despite hav-
ing highly diverse function and substrates, there have only been identified
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a few different folds of SLC transporters that are shared among the many
different members of the SLC family. One of the most predominantly oc-
curring folds is the LeuT-fold, named after the protein where this fold has
been first discovered [114]. Another common fold is the major facilitator
superfamily fold (MFS-fold). This fold is named after the protein family for
which the structures of two members were released in 2003 (the glycerol-3-
phosphate/phosphate antiporter GlpT and the proton-coupled lactose sym-
porter LacY) [115, 116]. Finally, a group of transporters shows distinct
folds that are not widely shared among other members. Examples include
the glutamate transporter GltPh [117], the Na+/H+-antiporter NhaA [118]
and the concentrative nucleoside transporter VcCNT [119]. For a complete
list see ref. [2]. Progress has also been made in elucidating the transport
mechanism of these proteins. As expected, they all display an alternative
access mechanism, but the way it is implemented varies between proteins
of different folds. Although not conclusive, it is thought that all proteins
adopting a similar fold share the same principal mechanism. Two of these
mechanisms, the so called rocker-switch and the rocking-bundle mechanism,
are conceptually related and are based on the principle of a moving-barrier.
What this means is illustrated in fig. 1.9. The barrier is formed at the
interface of two domains that interact in close proximity. This interaction
is formed close to one of the membrane surfaces so that from that side the
barrier completely blocks access to the substrate binding pocket, which is
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Figure 1.9: The three general transport mechanisms in SLC transporters. a: The
Rocker switch mechanism is found in MFS-folded transporters and features two
domains which at their interface form a barrier which keeps the substrate from
passing. During the transport cycle the two domains move around the substrate
binding pocket. Thereby the barrier is being taken apart but if will reform at the side
which previously was accessible to the substrate.From the principle this mechanism
works very much like a water lock, where of the two doors, only one is open at a time
b: The Rocking bundle mechanism is very similar to the Rocker switch mechanism
and also follows the concept of the water lock (”moving barrier”). c: The elevator
mechanism is different from the other two, because it has a fixed barrier (figure from
[2]).
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located about in the middle of the membrane. Towards the other end, the
binding pocket is shielded only by a thin gate. During substrate transloca-
tion the domains move apart and the barrier is broken. At the same time
the domains approach each other on the other side of the membrane and
eventually they will close up to reform the barrier. The barrier has now
moved so that the accessibility of the substrate binding pocket has changed
sides.
Mechanisms involving a moving barrier are the ones that have been most
commonly found in transport proteins. Crystal structures so far showed that
proteins adopting the LeuT-fold are displaying the rocking-bundle mecha-
nism and MFS-fold proteins are operating on the basis of a rocker-switch
mechanism. The difference between the two mechanisms, as based on fig.
1.9, may appear rather subtle. Indeed, the main distinction is that in a
rocker-switch mechanism the barrier is formed by two structurally sim-
ilar domains, which both undergo movement during substrate transport,
whereas in the rocking-bundle mechanism the two domains share no anal-
ogy and only one domain is moving.
In contrast to the above, the third mechanism shown in fig. 1.9 is very dif-
ferent from the first two in that there is a fixed barrier between two domains.
One of these domains is a moving domain that binds to the substrate on one
side and then translocates it all the way to the other side before releasing
it again. Remarkably, it has been found that this elevator type mechanism
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is shared by proteins which do not have a common fold. Among these are
GltPh [120], NhaA [121] and VcCNT [119] and there are more proteins dis-
playing a rare or unique fold predicted to work according to an elevator-type
mechanism [2].
1.5.1 The LeuT fold and mechanism
To examine substrate transport more closely, one of the mechanisms will
be explained in more detail by taking aid of a model protein for which in-
depth research on that matter has been done. Several model proteins could
be considered for this introduction, but LeuT seems to be the most obvious
choice. This is not only because the LeuT fold and its corresponding rocking
bundle mechanism are very common and well studied. Even more important
is the fact that homologues of the SLC11 family, the same family to which
belongs MntH2, have been crystallised in this fold [122, 123]. The first LeuT
structure was solved from the bacterium Aquifex aeolicus and appeared in
2005 [114]. It reveiled a fold that was unique at that time and therefore it
was named after this protein. To understand what defines the LeuT-fold, it
is best to have a look at its membrane topology (fig. 1.10). There are two
main characteristics of the LeuT fold. The first is a two-fold pseudosym-
metry axis in the plane of the membrane that relates five transmembrane
helices to the consecutive five. In LeuT these are TM1-TM5 that are sym-
metric to TM6-TM10, but in other LeuT fold transporters these numbers
may be different. This feature may be called a ’5+5’ inverted structural
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Figure 1.10: Illustration of the LeuT fold. a: Representation of the LeuT structural
arrangement in the membrane. Helices that are part of the scaffold domain (TM3-
TM5,TM8-TM10) are depicted as rods and helices belonging to the core domain
(TM1,TM2,TM6,TM7) are shown in a stick representation. Not shown are TM11
and TM12 that don’t contribute to the signature LeuT fold. The two-fold axis
parallel to the membrane plane is indicated and coincides with the substrate binding
pocket. b: Same as a but with view from top of the membrane. The bound substrate
(carbon, grey; oxygen, red; nitrogen,blue) and sodium ions (yellow) are shown. c:
Topology diagram of LeuT. The helices are represented in the same color as in
a. The diagram reveals the architecture with the substrate (depicted as a yellow
triangle) bound in the center. The pseudosymmetric fold of the 5+5 helices around
the substrate is emphasized by the two orange and blue colored triangles [124].
symmetry motif. The second common signature is that the first two helices
of the inverted repeat (TM1 and TM6 in LeuT) are not continuous, but
are interrupted in the middle by a few residues (including e.g. a proline
and glycine), which do not adopt an α-helical fold. These non-helical parts
of TM1 and TM6 together form the substrate binding site, which is in the
center of the membrane and coincides with the symmetry axis. It is worth
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Figure 1.11: The implementation of the ”rocking bundle” mechanism in LeuT as
a cartoon representation. The figure illustrates the movement of the core domain
helices in a transport cycle [2, 133].
noting that the themes of a two-fold symmetry axis and partially unwound
helices is also found in transporters of different folds; It is the specific ar-
rangement of these motifs that defines the LeuT fold. The 2005 structure
of LeuT captured the transporter in an occluded state, which alone is not
sufficient to define a mechanism for substrate transport. Before the struc-
ture of LeuT was solved in different conformations, a number of related
protein structures appeared that showed transporters adopting the LeuT
fold in different conformational states [125–131]. All these structures helped
to shape the understanding of substrate translocation. Still, it was crucial
that for LeuT a new set of structures was published in 2012 that contained
the important inward and outward facing states, required to get a complete
transport cycle [132]. Fig. 1.11 shows the three states in the LeuT rocking-
bundle transport cycle in a cartoon representation. Of the two structurally
distinct domains that are found in proteins with the rocking-bundle mech-
anism, the fix domain, which is called the scaffold-domain is depicted as a
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single entity. The helices of the flexible domain, which is called the core do-
main, are represented as tubes. Of course, this cartoon depicts only a very
schematic representation of the mechanism, but it illustrates the common
underlying principle of transport following the rocking bundle mechanism.
It should be noted that, even though LeuT fold transporters share simi-
larities in their overall mechanism, there is considerable variation in how
they work in detail. This is not surprising considering the high variability
of substrates (and also co-substrates) that is found among proteins sharing
the LeuT fold.
1.6 The SLC11 family of proton coupled metal ion
transporters
1.6.1 The human transporters SLC11A1 and SLC11A2
The SLC11 family has two human representatives: SLC11A1 and SLC11A2.
Before the SLC nomenclature took over, SLC11 was better known as the
Natural Resistance Associated Macrophage Protein (NRAMP) family, be-
cause its original member (NRAMP1/SLC11A1) is expressed in macrophages
and has an important role in defending against microbial invasions. The
second member (NRAMP2/SLC11A2) is expressed in the duodenum and
is responsible for the uptake of Fe2+ and other divalent metal ions. Hence
this protein is often referred to as DMT1 or DCT1, which is short for Di-
valent Metal/Cation Transporter 1. Both proteins are recognised to be pro-
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ton coupled transporters but whereas it is undisputed that SLC11A2 is a
proton/Me2+-symporter it is still not fully clear whether SLC11A1 is a sym-
or antiporter [134]. Determining the directionality of the proton flow is im-
portant to answer the question about the strategy involved to kill bacteria.
In macrophages SLC11A1 is expressed in the phagosomal membranes, that
Figure 1.12: Illustration of the two hypothesises concerning the working mechanism
of NRAMP1. A: NRAMP1 acts as a symporter. Metal ions are transported out
of the phagosome to prohibit pathogens to use them in their defense system (SOD)
against ROS. B: NRAMP1 acts as an antiporter. Metals are transported into the
phagosome where they catalyse the generation of ROS by Fenton-like chemistry
(figure adapted from [135]).
have an acidic lumen inside. Researchers in favour for SLC11A1 as a sym-
porter argue that the function of the transporter is to transport metal ions
out of the phagosome to starve bacteria from essential transition metal ions
[136–138]. In particular this would make the bacteria susceptible to reactive
oxygen species (ROS) because enzymes like superoxide dismutase (SOD)
that protect the bacteria against ROS, use transition metal ions in their
active centre. Some scientists, however, would argue that SLC11A1 is an
antiporter, transporting transition metal ions into the phagosome [139, 140].
In that case the metal ions could catalyse reactions of Fenton-like chemistry
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(eq. 1.6) that yields the particularly reactive and damaging hydroxyl radical.
Fe2+ + H2O2 Fe
3+ + OH· + OH− (1.6)
Compared to SLC11A1, characterisation is further advanced for the duode-
nal transporter SLC11A2. It has been identified that Fe2+ is the preferred
physiological substrate, although selectivity has been ranked even higher for
the toxic Cd2+ ions [141]. Co2+ and Mn2+ compete with Fe2+ uptake and
are reasonably good substrates whereas Zn2+, Ni2+ and VO2+ are consid-
ered to be weak substrates. No transport activity has been shown for earth
alkali metal- or other ions including Cr2+, Cr3+, Cu+, Cu2+, Fe3+, Ga3+,
Hg2+ and VO+ [141].
The situation gets more complicated when it comes to co-transport in
SLC11A2. The unusual part of symport in the duodenal transporter is
that the ratio of metal ion to proton transported is not fix, but varies de-
pending on external conditions. This was already established in the first
publication on SLC11A2, where it was found that at low pH a higher num-
ber of protons per turnover was transported than at high pH [142]. In a
later publication [143] the findings of the first paper was confirmed and the
authors proposed a model according to which SLC11A2 can adopt at least
eight different states and although it acts primarily as a H+/Me2+ sym-
porter, under certain conditions it will operate as a H+- or Me2+ uniporter
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(fig. 1.13). Proton co-transport will be discussed in chapter 6.
Figure 1.13: Proposed states of DMT1 related to substrate transport. Each reaction
step x→y is described by its rate constant kxy. According to this DMT1 acts mainly
as a H+ coupled Fe2+ transporter (step 3 → 4), but under some conditions may
work as well as a H+ leak (step 2 → 5) or Fe2+ uniporter (step 2a → 5a) [143].
1.6.2 Structural aspects of SLC11 transporters
This paragraph will focus on the two structures of bacterial SLC11 homo-
logues that have been solved recently by X-ray crystallography. The first
structure was of Staphylococcus capitis DMT (ScaDMT) [122]. The struc-
ture revealed a LeuT fold which is likely to be shared among SLC11 family
members (fig. 1.14A). Of particular interest are the residues of the bind-
ing pocket which were identified to be an alanine (backbone oxygen), an
asparagine, an aspartate and a methionine (fig.1.14B). As expected for the
LeuT fold, these residues are located in the unwound part of TM1 and TM6
and are highly conserved among the family. Maybe the most unusual contri-
bution comes from the methionine that coordinates the metal via its sulfur
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Figure 1.14: A: Structure of ScaDMT in a cartoon representation. The colours of
the helices are equivalent to fig. 1.10. The bound Mn2+ is represented as a sphere
(mangenta). B: Residues involved in the substrate binding pocket of ScaDMT. The
four residues identified in the crystal structure are shown in yellow. Grey residues
have been suggested to contribute as well to substrate binding in computer simu-
lation. Atoms of oxygen (red), nitrogen (blue) and sulfur (dark-yellow) have their
separate colour. Figure made with PyMOL [6]
atom. It was later demonstrated that the methionine plays a key role for
the protein to distinguish between transition metal and earth alkali metal
ions [144]. The thiol-ligand is not a good binding partner for the hard earth
alkali metal ions. In MntH from Deinococcus radiodurans substituting me-
thionine by an alanine led to a mutant which remained fully functional, but
in addition to transition metals, the mutant would transport calcium and
magnesium ions.
Crystals of ScaDMT have been obtained in the apo-form as well as bound
to a series of different transition metal ions. These structures showed that
Mn2+, Fe2+, Co2+, Ni2+, Cd2+ and Pb2+ occupy the same binding site.
Cu2+ does so too but in a slightly shifted position. Of the transition metal
ions, only Zn2+ prefers to occupy a different location, coordinating to a con-
36
1.6 The SLC11 family of proton coupled metal ion transporters
served histidine that may have a role in proton cotransport [123, 143, 145].
Some earth-alkali metals did bind to the protein as well, but in different
locations and with low affinity. Binding of these ions did not interfere with
protein activity. In terms of activity, substrate transport in ScaDMT could
be confirmed for Mn2+, Cd2+, Co2+ and Ni2+ in transport assays using the
metal sensitive dye calcein. With this assay it could not be unambiguously
determined whether Zn2+, which does not occupy the main binding pocket,
is a substrate or an inhibitor of the transporter. The assay was also incom-
patible for the ions Fe2+ and Cu2+.
The second structure of a SLC11 transporter homologue, was from the Er-
emococcus coleocola protein EcoDMT and appeared very recently in 2017
[123]. Whereas ScaDMT was crystallised in an inward-facing conformation,
EcoDMT showed an outward facing conformation. This second publica-
tion contained considerable work on functional studies showing proton co-
transport. This will be discussed more closely when compared to functional
data from MntH2 obtained in this thesis. The authors also tried to establish
a transport mechanism based on their two structures and using analogies
with LeuT. Nevertheless many details remain obscure. As the authors ad-
mit, for instance, it is unclear, if the mechanism is proton coupled, how
proton binding to the outward open state would help substrate binding or
vice versa.
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1.7 The MntH-family and Enterococcus faecalis
MntH2
Bacterial homologues of the SLC11 family are generally named MntH which
is to suggest that these proteins are H+-coupled manganese transporters
[146]. Evidently, the nomenclature is not fully consistent, which is why the
SLC11 homologues of which the structure has been solved, are named differ-
ently. MntH proteins form one of the two major protein families responsible
for Mn2+ uptake in bacteria. The other one consists of the Mn2+ specific
ABC-transporters named MntABC(D) [147, 148]. Manganese is an essential
transition metal and required for a number of important enzymes. These in-
clude most famously superoxide dismutase (SOD), but there are many more
processes where Mn2+ plays a key role, including glycolysis [149]. There-
fore, bacteria have to rely a great deal on their Mn2+ import machinery.
This is especially the case when bacteria are invading host tissue, because
Mn2+ concentrations are very low in this environment due to the cellular
defense of the host, that includes scavenging of Mn2+ and other ions by a
histidine rich protein called calprotectin [150]. To be able to compete with
calprotectin, bacterial uptake proteins have to be very efficient and operate
with a KM in the order between 100 nM and a few µM [149]. A single strain
of bacteria may express more than one SLC11 homologue. In Enterococcus
faecalis there are three SLC11 homologues expressed, which after an elabo-
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rate nomenclature are labelled EfcmCβ, EfaCβ1 and EfaCβ2 [151]. EfaCβ1
is the protein investigated in this thesis, but instead it will be referred to
as MntH2, following the nomenclature of a different publication [152]. The
mentioned publications on MntH2 included some in vivo characterisation
of the protein: Richer et al. [151], in an assay measuring metal-induced
growth inhibition, found that MntH2 overexpression in E. coli leads to en-
hanced sensitivity towards Cd2+, Co2+ and Fe2+. No change in the growth
was found when the bacteria were subjected to excess Mn2+. A number of
studies have performed expression analyses in response to metal replete or
deplete conditions. From this work it is known that MntH2 expression in
Enterococcus faecalis is downregulated in the presence of Mn2+ and Cu2+
and upregulated by excess Zn2+ or Fe2+ [152]. A further study reported
downregulation in the presence of Fe3+ [153].
An overexpressing construct of MntH2, as well as a purification protocol
has been established in a thesis precedent to this one [108] and been subject
to a publication [154]. The construct is shown in fig. 1.15 as a topology
diagram. It includes the full length protein bearing a His8-tag at the C-
terminus that is precluded by a HRV cleavage side. To predict the topology
of the residues, the crystal structure of ScaDMT has been used as a tem-
plate. Besides an overexpressing construct, the aforementioned publication
included as well some functional data from in vitro experiments using the
stopped flow fluorescence technique, which show Zn2+ transport in MntH2.
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1.7 The MntH-family and Enterococcus faecalis MntH2
However, Mn2+ transport was failed to be detected in similar experiments
[108]. In this project MntH2 served as a model protein to test the applicabil-
ity of solid supported membrane based electrophysiology towards transition
metal transport. Details about why this technique was chosen and its ad-
vantages over fluorescence based and other membrane transport measuring
techniques are discussed in the following chapter.
In summary this project consisted of two parts, for which the main research
question was addressed with solid supported membrane based electrophysi-
ology. In case of TRPM2 a major goal was to provide direct evidence that
TRPM2 is able to conduct Zn2+ to confirm its proposed role in apoptosis
[106]. Another goal was to identify direct and indirect activators among
natural and synthetic ligands.
The main question connected to MntH2, initially was to confirm that the
protein is a Mn2+ transporter. Later it was attempted to obtain a com-
plete biophysical characterisation of MntH2. This included determining all
substrates/inhibitors and co-substrates.
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Chapter 2
Methods for measuring
membrane transport
This chapter will introduce the most important techniques to assay mem-
brane transport. The largest part of this chapter will be dedicated to
solid supported membrane based electrophysiology, which is the technique
that has been predominantly used in this thesis. For comparison, an in-
troduction of the patch-clamp method is given, even though this tech-
nique has not been applied in this thesis. At the end of this chapter some
non-electrophysiological methods to measure substrate uptake of membrane
transporters are briefly discussed as well.
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Figure 2.1: Schematic representations of selected circuit elements and components.
2.1 Electrical circuits
An electrical circuit is a closed loop of a conducting element which allows
current to circulate when driven by a power source [155]. A very simple
electrical circuit consists only of a voltage source and a resistor in a circular
connection. Electrical circuits are an abstract way to describe the flow of
currents in a real system. They are built by a combination of basic circuit
elements with well defined electrophysical properties. Three basic circuit
elements are, for instance, resistor, capacitor and inductor, whereby only
the first two of these elements will be introduced here. Fig.2.1 gives an
overview of all the circuit elements and other circuit components that occur
in this thesis. The simplest circuit element is the resistor. Its characteristics
are described by eq. 2.1.
U = R ∗ I (2.1)
Equation 2.1 is called Ohm’s law. Ohm’s law states that the current, I, pass-
ing a resistor is proportional to the applied voltage, U. The proportionality
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constant R is called the resistance and has the unit ohm (Ω). It is defined
by a resistor’s ability to oppose a current to pass through it. The resis-
tance depends on the material the resistor is made of and on its geometrical
properties (eq. 2.2).
R = ρ
l
A
(2.2)
In eq. 2.2 ρ is the electrical resistivity that is a material specific constant.
The variables l and A stand for the length and the area respectively. The
inverse of the resistance 1/R is called the conductance. It is usually assigned
with the symbol ”G” and it is measured in siemens (S).
Another important circuit building block is the capacitor. It consists of
two conducting surfaces in close proximity, separated by a non-conducting
medium. Its most common form is the plate capacitor where two parallel
plates of a conductor enclose a non-conducting medium. Other geometrical
forms of capacitors exist as well but will not be discussed here. When a
voltage is applied to a capacitor charges of opposite sign are built up on
the capacitors surfaces. The amount of charge in the capacitor is linearly
related to the applied voltage:
Q = C ∗ V (2.3)
The constant C is called the capacitance. It has the unit Farad (F) where
one Farad is equal to one coulomb per volt. A capacitor’s capacitance is
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dependent on the material/substance and the thickness of the medium layer
in between the two conductors. It is given by the following equation
C =
0rA
d
(2.4)
where A is the area of the capacitor, d is the distance in between, 0 is the
permittivity of free space and r is the relative permittivity of the medium.
r is also named dielectricity constant. This constant describes the mediums
ability to polarize in response to an electric field. Molecules with a perma-
nent dipole, like water, are highly polarisable because the dipoles will align
with an applied electric field, in antiparallel fashion, such that the electric
field of the dipole points into the opposite direction of the original field.
This means that in a capacitor with a polarisable medium the influence of
the charges from one plate to the other is diminished which allows the ca-
pacitor to accumulate more charge. Consequently, if the medium is apolar
less charge will be built up.
The remaining circuit elements depicted in fig. 2.1 shall be explained briefly.
A power source is an element that provides either a voltage or a current to
energize the circuit. A typical would be a battery, for instance.
A pump is in principal similar to a power source. The difference is that
the power source has a constant output that is not affected by the circuit,
whereas the performance of the pump is dependent on the electrical pro-
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Figure 2.2: A capacitor and resistor connected in series (left) and in parallel (right).
cesses that happen in the circuit. In this thesis, the pump will be used to
represent a membrane protein.
The switch provides control over the electrical energy flow of the circuit. A
closed switch allows the energy flow to continue and an open switch breaks
it. Finally, the galvanometer is a device to measure current.
2.1.1 Series and parallel circuits
In an electrical circuit, elements can be either connected to each other in
series or in parallel (fig. 2.2). The following relations can easily be derived
when considering that a given circuit element can be conceptually split up
into two halves. Depending on how the element is split, the two halves
can then be recombined in parallel or in series to yield back the original
element. For instance, splitting a resistor perpendicular to its axis will yield
two elements that in series must have the same resistance as the original
element according to eq. 2.2. Likewise, when the same resistor is cut along
its axis, the resulting elements in parallel are equivalent to the resistor as a
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whole. Analogous considerations can be made for capacitors.
It will be found that for resistors in series the following relation holds:
Rtot = R1 +R2 + ... (2.5)
and in parallel:
1
Rtot
=
1
R1
+
1
R2
+ ... (2.6)
For capacitors the relationships are analogous but are switched around for
in series and parallel circuits. The total capacitance of multiple capacitors
in parallel is the sum of the individual capacitances:
Ctot = C1 + C2 + ... (2.7)
and the relationship for capacitors in series is reciprocal:
1
Ctot
=
1
C1
+
1
C2
+ ... (2.8)
2.1.2 Equivalent circuits
In practice the relations from section 2.1.1 can be used to simplify electrical
circuits representing a complex system. This includes essentially any system
in the real world that is not made entirely of electrical components. As an
example could serve for instance a cell membrane. The electrical properties
of a cell membrane are generally represented by a capacitor and a resistor
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in parallel. An exact representation would be much more complex: The
capacitance of the membrane will vary slightly with the exact spot on the
cell surface due to inhomogeneities in lipid composition and the presence
of membrane proteins. In a completely accurate description this would be
accounted for by a huge number of capacitors and resistors in parallel. Such a
representation would obviously be very impractical and therefore a simplified
circuit is used that reflects the systems properties sufficiently accurate. Such
circuit is then referred to as an equivalent circuit.
2.1.3 Kirchhoff’s circuit laws
When dealing with electrical circuits it is very useful to know two basic laws
that are valid in any given circuit. They are called Kirchhoff’s laws after
the German physicist Gustav Kirchhoff who described them first in 1845.
Kirchhoff’s first law is also called Kirchhoff’s current law (KCL). It states
that at any node or junction in an electrical circuit the sum of currents
flowing in and out of that node is zero (eq. 2.9).
n∑
k=1
Ik = 0 (2.9)
In eq. 2.9, n is the total number of branches with currents flowing in or out
of a node and currents flowing out are signed negatively. This law intuitively
makes sense because the sum of currents flowing into the node has to be the
same as the sum of currents flowing out.
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Kirchhoff’s second law is referred to as Kirchhoff’s voltage law (KVL). It
states that the (directed) sum of any electrical potential differences around
any closed loop is zero (eq. 2.10).
n∑
k=1
Vk = 0 (2.10)
In this case n is the number of circuit elements in the loop across which a
potential difference is measured. This rule also is very intuitive. When mak-
ing a full turn around a loop one has to arrive at the same potential as one
has started with. Otherwise it would violate the law of energy conservation.
2.1.4 Capacitive coupling
Capacitive coupling is a term that will be of importance when discussing
the SURFE2R technique and is introduced here, because it is a phenomenon
that can be easily explained by using the basic electrophysics from previous
sections. First, it has to be clarified, that the term ”capacitive coupling”,
when used in a different context from this thesis, can have a slightly differ-
ent meaning. More commonly, capacitive coupling describes the interaction
between two electrical circuits, mediated by a capacitor. This is often un-
wanted as it can be a source of noise. For instance when two conducting
wires come close to each other, they form a capacitor, which can then lead
to communication between the wires, distracting their signals.
Here, ”capacitive coupling” is used to describe the behaviour of an electrical
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circuit with two capacitors in series. It merely states that in such a cir-
cuit, if the first capacitor experiences a change in voltage, the voltage across
the second capacitor has to alter simultaneously, for the circuit to obey the
KVL. An illustration of this is given in fig. 2.3 , which shows the process
in four panels (A-D). For ideal capacitive coupling the circuit consists of
basically two capacitors in series (fig. 2.3A). The first capacitor has a pump
in parallel, that can transport charges against a potential gradient, when
it is switched on. For simplicity it is assumed that both capacitors have
the same capacitance (C1=C2). In the initial state, the pump is switched
off, no charges are moving and there is no potential difference across the
capacitors (V1=V2=0). At some point the pump will be switched on for a
short time, ∆t, during which it will transport the charge ∆Q (fig. 2.3B).
This creates a charge imbalance on the first capacitor. It can be noted that
fig. 2.3B represents a physically impossible state as Kirchhoff’s voltage law
is violated. In reality, when the first capacitor is charged, the second capac-
itor will charge in an immediate response so that V1 is equal to -V2 at all
times. This is illustrated in fig. 2.3C: Half of the charge transported by the
pump (∆Q/2) is passed on to the second capacitor which equivalently passes
∆Q/2 through the external circuit. In this way both capacitors will end up
carrying the same charge (fig. 2.3D). Note that this is only true because
in this example the capacitances are equal. The distribution of the charges
depends on how the capacitances of the two capacitors relate to each other.
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Figure 2.3: Schematic illustration of charge movements in the event of ideal ca-
pacitive coupling. A: A requirement for ideal capacitive coupling is a circuit with
two ideal capacitors in series. One of the capacitors can be charged by a pump that
is connected in parallel to the capacitor. B: When the pump is switched on for a
time ∆t it will transport a charge ∆Q which leads to charging of the first capacitor.
C: This will lead to an immediate response in the second capacitor because accord-
ing to Kirchhoff’s voltage law both capacitors must experience the same potential
difference at all times. For this reason, given that in this example C1 = C2, a
total charge ∆Q/2 is passed through the external circuit, that will recombine with
the negative charge on the first capacitor. The resulting current is registered by the
galvanometer. C: The pump has switched off and both capacitors end up carrying
the same charge.
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A mathematical expression for this is given in eq. 2.15 (section 2.4) where
the signal detection with the SURFE2R technique will be discussed.
2.2 Electrophysiology
Electrophysiology is a field in biology that studies the processes in living sys-
tems that in some way cause a charge imbalance in the system and therefore
can be recorded as a current. The field dates back to as early as the late
18th century when Luigi Aloisio Galvani observed that frog muscles contract
when he applied an electric shock to one of its nerves [156]. From this dis-
covery researchers began to understand that nerve signals are of electrical
nature. One and a half centuries later, during which techniques and experi-
ments have steadily developed, the American biophysicists Cole and Curtis
could already measure a complete action potential of a giant squid [157].
But although this was a milestone, to understand signal transmission on a
molecular level further technological advance had to be made: At this time
there was no technique available that was sensitive enough to measure the
currents of single ion channels that promote the progression of the action
potential and hence at this point there was no evidence even that these ion
channels even existed. The breakthrough was made in the late 1970’s with
the development of the ”patch clamp” technique by Erwin Neher and Bert
Sakman that enabled the recording of single ion channel currents [158]. For
their achievement Neher and Sakman got awarded the Nobel Prize in 1991.
After it was understood how electrical signals are transmitted in neurons,
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the field of electrophysiology advanced to investigate function and mecha-
nism of electrophysiologically active ion channels and transporters in detail.
”Patch clamp” is by far the most common technique to address these ques-
tions and the basics of the technique will be introduced in the following
paragraph. The technique applied in this project, solid-supported mem-
brane based electrophysiology, is less commonly used but it is very useful
for certain purpose. A thorough introduction of this technique will be given
in section 2.4 that, along with explaining the working principle of this tech-
nique, will discuss some aspects of its development and highlight the key
aspects where it performs better than ”patch clamp”.
2.3 Patch clamp technique
In the patch clamp technique a micropipette is pressed against a single cell
and by applying suction a very tight junction is formed between cell mem-
brane and pipette that has a gigaohm resistance (fig. 2.4). In patch clamp
terminology this is called a gigaseal. The high resistivity of the gigaseal
allows for the detection of single ion channel currents across the membrane
patch spanning the pipette. The measured current is the sum of two compo-
nents: The ions flowing through the ion channels and the capacitive current.
The capacitive current results from ions of one kind adsorbing to one side
of the membrane, attracting ions of the opposite charge to the other side of
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Figure 2.4: Illustration of the patch-clamp technique. In a first step suction is
applied with a micropipette to the membrane of a single cell to yield the initial
configuration (A). In this step the gigaseal is formed. From the initial configuration
different configurations can be reached including (B): Whole-cell configuration and
(C): Inside-out configuration.
the membrane. This can be summed up in the following equation [159]:
Im = Iionic + CmdV/dt (2.11)
Im is assigned for the total current, Iionic for the current gated through the
ion channel and Cm is the membrane capacitance. To diminish the contri-
bution of the second term of equation 2.11, voltage clamp experiments are
usually performed where the membrane voltage is fixed [159]. In voltage
clamp experiments the current is then recorded as a function of the mem-
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brane potential. Other experimental parameters that need to be varied in
patch clamp experiments include the concentration of extra- and intracel-
lular ion concentrations. However, in the conformation described above,
this is not possible because the solutions on neither side of the patch (cyto-
plasm and pipette solution) can be easily exchanged. Therefore the initial
conformation is of limited practical use in terms of conducting experiments.
There are several ways to adapt the experiment to enable exchange of extra-
and intracellular solutions. Two conformations will be described here: The
”whole cell” and the ”inside-out” conformation. Details about other patch
clamp conformations have been excellently reviewed elsewhere [159, 160].
Whole cell configuration
The whole cell configuration is the most common set up for patch clamp
experiments. It can be achieved from the initial configuration by briefly
applying a higher suction that will remove the membrane patch at the end
of the pipette so that the interior of pipette and cell are connected (fig. 2.4).
In this configuration transport from all ion channels in the cell membrane is
observed and the extracellular buffer can be altered by exchanging the bath
solution. An advantage of the whole-cell configuration is that cytosolic com-
ponents are retained, which can be essential for activation of the channel.
At the same time the presence of cytosolic components can be a drawback
when the experimental goal is to determine direct activators of the channel.
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Compounds that are added to the extracellular buffer might start a signal
cascade that can set free effectors of the target protein contained within
the cell. In this way a molecule might be identified as a modulator of a
protein even though it affects its state of transport only indirectly. This
can make an accurate biophysical characterisation very challenging and this
is especially a problem for drug discovery. Another drawback of the whole
cell configuration is that modulators that bind intracellularly will not be
identified in experiments if they are not membrane permeable. A different
patch-clamp configuration, that is applied to avoid these downsides, is the
inside-out configuration. It will be introduced here shortly because it has
been applied in relevant research studies on the TRPM2 channel [100, 104].
Inside-out configuration
The inside-out configuration can be reached from the initial configuration
by abruptly pulling the pipette away from the cell to which the pipette is
attached (fig. 2.4). As a result the membrane patch will rupture from the
cell and the cytoplasmic side of the patch will face the bath solution. In
this configuration, the cytosolic components are removed from the system
so they do not contribute to the experiment. The disadvantage of this con-
figuration is that it is further away from a native like environment than the
whole cell configuration as intracellular components might be required to
assist modulation of the protein.
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To conclude the introduction of the patch clamp technique some practical
aspects should be discussed: The patch clamp technique is very challenging
to perform and it requires a researcher several months of training to learn.
To achieve the formation of a gigaseal, exact protocols for the preparation
of the cells and the pipettes have to be followed. For this reason traditional
patch clamp is a very low throughput technique. A lot of research effort has
been undertaken to increase the throughput of the patch clamp technique.
Nowadays there are different systems of patch clamp robots available that
can automate some of the tasks. But even though these systems are very
useful for drug screens, automated patch clamp is still less flexible compared
to manual patch clamp in terms of experimental design, quality of data and
types of cells investigated [161]. A detailed discussion of the possibilities
and limitations of automatic patch clamp would go beyond the scope of this
section. However, with respect of the work performed in this thesis, it is
noteworthy that among other families, TRP channels turned out to be chal-
lenging to investigate by automated patch clamp [161, 162].
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2.4 Solid supported membrane based electrophys-
iology
2.4.1 Introduction
Solid supported membrane based electrophysiology is a technique that has
been developed in the 1990’s by Fendler and co-workers [163, 164]. It has
been commercialised and is currently marketed by NaNion technologies as an
instrument called SURFE2R (SURFace Electrogenic Event Reader). It was
designed with the main purpose to study membrane transport proteins and
measure their activity with a high time resolution (>5 ms). A high time
resolution is needed to measure pre-steady state currents of transporters,
that contain information about different steps in their reaction cycle [163].
Fig. 2.5 shows a schematic representation of the chip’s surface that forms
the basic of the technique: Preparations are adsorbed onto a modified gold
surface in a sensor chip. These preparations can either be proteoliposomes
or membrane extracts from overexpressing cells/bacteria. The modification
on the gold surface consists of a layer of 1-octadecantethiol (1-ODT) com-
pleted with a layer of a specific lipid (DPhPC) to form a so called ”hybrid
bilayer”. This hybrid bilayer provides a surface with a very low capacitance,
which is a requirement to keep noise levels low during experiments. The
sensor is mounted in a fluidic system that allows for a rapid exchange of
the external buffer. At the beginning of the experiment this buffer will be
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Figure 2.5: Experimental setup of the SURFE2R technique. Protein is added in
membrane fragments (proteoliposomes, membrane extracts), which are adsorbed to
a chemically modified gold sensor. The sensor is mounted in a fluidic system and
when substrate is added by exchanging the external buffer, the protein is activated.
Currents resulting from protein activity will be registered in the external circuit by
capacitive coupling. In the left part of the figure the equivalent circuit of the system
is illustrated.
neutral towards the target protein (typically a transporter; see next para-
graph in case the protein is an ion channel) and is called ”non-activating
buffer”. This means that the protein will be inactive. When the external
buffer is exchanged by a buffer containing a substrate (”activating buffer”),
the protein will be activated because the substrate gradient between the
internal and the external buffer will drive uptake of the substrate. In case
transport is electrogenic this will lead to a response in the external circuit
due to the effect of capacitive coupling as described in section 2.1.4. It is
worth noting that not only transport of a charged substrate, but any process
that is electrogenic, will be recorded. This includes binding of a substrate
to its binding pocket [165] or a conformational change in the protein that
leads to rearrangement of some charged domains [166].
The protocol described above includes only one solution exchange and works
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only if the target protein is a transporter. SSM-based electrophysiology
works also for (ligand/signal gated) ion channels [167] but the workflow
has to be adjusted. Instead of one solution exchange, the protocol for ion
channel includes two solution exchanges and a third buffer, which is called
the ”resting buffer”. In the first solution exchange an ion gradient is es-
tablished by exchanging the ”resting-buffer” with ”non-activating” buffer,
which has a different ion composition. This ion gradient is needed to drive
ion flow through an open channel. The channel is then activated by ex-
changing ”non-activating buffer” with ”activating buffer” as described for
transporters above.
2.4.2 Development and theory of SSM-based electrophysiol-
ogy
To get a better understanding of SSM based electrophysiology and its ben-
efits, an outline of the context in which the technique was developed will be
given.
Before solid supported membrane based electrophysiology was developed,
studies were performed with free standing bilayers called black lipid mem-
branes (BLMs). A BLM is a lipid bilayer membrane is ”painted” over a
small aperture (< 200 µm diameter) in a teflon membrane that separates
two aqueous chambers (fig. 2.6). In each of the chambers an electrode is
placed so that by linking the electrodes over an external circuit, potential
changes and charge flow between the two chambers can be detected. The
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Figure 2.6: Setup for a BLM experiment. The BLM separates two aqueous cham-
bers that are connected by an external circuit. For investigation of transport pro-
teins, membrane fragments containing the target protein are added on either side of
the membrane. It has to be noted that in the BLM technique ion channels are incor-
porated directly into the BLM. Only when transporters are investigated on a BLM
the sample is adsorbed in membrane fragments as in SSM-based electrophysiology
[164].
protocol for Membrane fragments containing the target protein are added
on either side of the membrane (if the target protein is a transporter, see
legend to fig. 2.6). Conceptually, transport studies on BLMs are similar
as on a SSM with the only differences being of practical nature. The most
definite advantage of using a SSM as opposed to a BLM is that SSMs have
a much higher mechanical stability compared to BLMs which enables one to
rapidly exchange the solution in the aqueous chamber by applying a rapid
flow. This is of great importance in order to measure currents under the
limits of ideal capacitive coupling, as will be discussed later.
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The first study on transport proteins on a BLM setup was performed in
1974 by Drachev et al. [168]. Notably, this was before Neher and Sak-
mann recorded single ion channel currents for the first time in 1976 by the
patch-clamp technique [169]. Drachev et al. intended to observe activity
of the bacterial membrane transporters bacteriorhodopsin, H+-ATPase and
cytochrome oxidase by incorporating them into the BLM and then detect
ion flux between the two chambers. This approach, however, failed but the
authors realised that they could see currents when membrane sheets con-
taining the protein of interest were adsorbed to one side of the BLM. Based
on this observation the authors assumed that the observed currents are not
due to ions crossing the BLM but that capacitively coupled currents from
ion pumping into vesicles adsorbed to the BLM are detected.
At this point it is important to note that getting direct evidence of the
adsorption geometry of vesicles or membrane sheets on a planar BLM mem-
brane is challenging. Up to the present date, no images recorded from AFM
or SEM have been published. Knowing the adsorption geometry is impor-
tant for modeling an equivalent circuit to the system, which is required to
accurately interpret the measured currents. An key paper for establishing
a model circuit was published in 1979 by Bamberg et al. [170], who ad-
sorbed purple membranes containing bacteriorhodopsin and activated the
bacteriorhodopsin by illuminating with light. The authors observed that
when the BLM was non-permeable they obtained a light-induced transient
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Figure 2.7: BLM experiment with purple membranes. A: Activation by light induces
a short transient current that declines when the membranes are fully charged. B:
The BLM is made proton-permeable by the protonophore CCCP. In this case a con-
tinuous steady-state current is observed as the protein continues to pump protons.
Together this data is evidence for an adsorbed geometry ob the purple membranes
[170].
current that rapidly declines and after ca. 250 ms returned to baseline (fig.
2.7A). When the BLM was made permeable to protons, a large stationary
current remained after the initial transient current and, under constant illu-
mination, the stationary current was stable for at least 20 min (fig. 2.7B).
The interpretation of this data is that in the first case protons are trans-
ported into a compartment that builds up a positive potential inside and,
as a result, transport is stopped and the current declines. When the BLM
is made permeable to protons, protons can be constantly removed from the
compartment to the other side of the BLM. Therefore transport is main-
tained and a steady current is observed. These results were strong evidence
for the ”adsorbed configuration” and the authors described the system by
an equivalent circuit introduced by Herrmann and Rayfield in a precedent
study (fig. 2.8) [171]. In this circuit the parallel elements Cm and Gm rep-
resent the capacitance and conductance of the BLM. Because of the very
high resistance of a BLM Gm can assumed to be zero. Similarly Cp and Gp
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Figure 2.8: Equivalent circuit for BLM experiments that can be used analogously
for the SURFE2R technique. The protein preparations are described by three ele-
ments in parallel: A capacitance Cp, a conductance Gp and a pump. The BLM is
represented by a capacitance (Cm) and a conductance (Gm) in parallel, where Gm
is usually approximated to be equal to zero. Short circuit conditions are assumed,
which implies that Vp is equal to -Vm.
are assigned to the capacitance and conductance of the purple membrane
sheets and Ip models the current due to light induced proton pumping of
bacteriorhodopsin. Note that Gm does not only represent the conductance
of the purple membrane bilayer but also accounts for possible leakage at the
edge of the membrane sheets that contact the BLM [170]. As mentioned,
having an equivalent circuit is important for the analysis of signals. From
the model circuit in fig. 2.8 it is possible to predict the signal I(t) that is
obtained from a given pump current Ip. This will help to understand the
information that is contained in the observed current. An expression for
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I(t) can be obtained by circuit analysis, which means solving a differential
equation describing the behaviour of the circuit. Such equation can be ob-
tained for instance by using Kirchoff’s first law (2.9) and summing up all
the currents through the node between the membrane sheets and the BLM
to zero (eq. 2.12).
Ip +GpVp + Cp
dVp
dt
− CmdVm
dt
= 0 (2.12)
Solving this equation yields a complex expression, which has been derived
in more detail elsewhere ([172]).
I(t) =
Cm
Cm + Cp
[Ip(t)− exp(−t/τI) 1
τI
∫ t
0
Ip(t
′)exp(t′/τI)dt′] (2.13)
τI represents the so called ”system time constant” and is given by:
τI =
Cm + Cp
Gp
(2.14)
Because the solution is complex, it is worth considering a hypothetical sce-
nario in the limit Gp → 0. In this scenario the circuit would reduce to
the one in section 2.1.4 and hence under these conditions ideal capacitive
coupling would occur. In this case the solution simplifies to:
I(t) =
Cm
Cm + Cp
Ip(t) (2.15)
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As would be expected under ideal capacitive coupling conditions the mea-
sured current is related to the pump current by a simple proportionality
constant that is dependent only on the capacitances of the BLM and the
adsorbed membranes. The complexity of the real solution is due to the fact
that the adsorbed membranes do not behave as an ideal capacitor and ions
will leak out through the resistance Gp during the measurement. An im-
portant point is that at short times (t → 0) the leak current through Gp
will not be significant because leakage is dependent on the voltage across
the resistance according to ohm’s law. At the start of the experiment, the
pump has not had time to establish a membrane potential and therefore
leakage will be negligible. This can be verified mathematically by inserting
t = 0 into eq. 2.13. This will again yield eq. 2.15 and therefore this shows
that the conditions of ideal capacitive coupling are always fulfilled at short
times [172].
This is of great importance experimentally, because it means that the am-
plitude of the peak current is directly proportional to the pump current and
therefore can be used to quantify activity of the pump. With this informa-
tion, it is thus possible to characterise a transport protein, e.g. identifying
its substrate and determine the KM by plotting the amplitudes of the peak
current against the substrate concentration. It shows as well the necessity
of a rapid solution exchange when adding substrate, as otherwise the peak
current would shift out of the range where ideal capacitive coupling applies.
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Technically, planar membrane based electrophysiology can be used not only
to determine the substrates of transport proteins and their corresponding
KM values, but also transport associated rate constants. The latter infor-
mation is contained in the pre-steady state currents that are obtained in
a concentration jump experiment: At the start of the experiment, when
turnover starts, no substrate is bound to the enzyme. The enzyme will
then bind the substrate and after a short equilibration period the concen-
tration of the enzyme-substrate complex remains constant. This is when the
steady-state is reached. The time it takes to reach the steady state depends
on the rate constants of processes preceding the rate limiting step, which
is substrate translocation. Extensive analysis of pre-steady state currents
have been performed for instance on bacteriorhodopsin [173] and Na+/K+-
ATPases [172, 174] on BLMs. Pre-steady state analysis was restricted to
enzymes that could be activated either directly or indirectly with light, be-
cause of the low mechanical stability of the BLM. In case of the ATPase,
”caged”-ATP was used as a substrate, that is chemically modified ATP, that
forms ATP when exposed to light.
The development of SSM based electrophysiology enabled a rapid activation
of transporters with arbitrary substrates and successful studies have been
performed for example on sugar and amino acid transporters [166, 175].
Nevertheless, these experiments require a very high standard of equipment
to provide the required time resolution. Time constants of pre-steady state
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currents are usually in the order of 10-20 ms. The SURFE2R N1 instrument
used in this project at best has a time resolution of 20-30 ms, which is often
too low for this kind of analysis.
In this final paragraph of this section, some practical aspects are discussed
that highlight the potential advantages of the SSM based electrophysiology
over the standard patch clamp technique, but also its downsides. A key
advantage of SSM based electrophysiology is that it can be applied to sys-
tems with small internal volumes like bacteria, organelles or proteoliposomes
which in most cases are impossible or, at the very least, extremely difficult
to investigate with patch clamp techniques. Besides this, the technique is
particularly useful for investigating transport proteins. Even though patch
clamp is a perfectly suitable technique to detect activity of transporters,
they can be more challenging to work with than ion channels. Because
transporters have a much lower turnover compared to the ion conductivity of
ion-channels, it is generally more challenging to get a decent signal-to-noise
ratio. In SSM based electrophysiology, the signal is enhanced by the large
number of transporters investigated at the same time. Geibel et al. have
compared the performance of the two techniques and found that currents
from the sodium/calcium exchanger NCX1 recorded on the SSM were about
10 times larger than in corresponding whole cell patch-clamp experiments
with a better signal-to-noise ratio. This makes the SURFE2R technique at
the very least a strong competitor to patch clamp methods, including au-
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tomated patch-clamp, when it comes to performing drug screens. This is
especially true when considering that the SURFE2R fulfils the conditions of
high robustness, automation and easy handling that are very useful for this
task.
When it comes to ion channels, the SURFE2R so far has found much less
application. A major disadvantage is that the membrane potential, which
drives transport through ion channels, cannot be fully controlled. To com-
pensate for the lack of a membrane potential, a gradient of the transported
ion has to be applied instead [167]. Furthermore, there is less of a problem
with the signal-to-noise ratio of ion channels in patch clamp experiment and
hence in this respect there is not much gain using the SURFE2R. Never-
theless, the other mentioned advantages for drug screening purposes remain
and therefore the SURFE2R remains a viable alternative to automated patch
clamp for these types of experiments.
2.5 Non electrophysiological transport assays
Even though electrophysiogical methods are the gold standard when it comes
to measuring activity of membrane transport proteins, there are alternative
methods that are frequently used in practice as well. These methods, in
general, are either based on detecting a change in fluorescence upon sub-
strate translocation or they use a radiolabeled substrate. Both principles
can be applied to study either ion channel or transporter activity and will
be briefly introduced in the following sections.
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2.5.1 Fluorescence transport assays
Fluorescence based assays are indirect methods to detect ion transport as
ionic currents are not recorded directly, but either membrane-potential de-
pendent or ion-concentration-dependent changes of fluorescence signals are
measured [176]. Fluorescence based methods find widespread application in
primary drug screens, where whole cells, overexpressing the target protein,
are loaded with a cell-permeable dye that detects ion influx when a hit binds
to the target. High-throughput versions of these assays makes them partic-
ularly useful for that purpose [176].
The principle of using fluorescent probes can be applied as well to measure
uptake of reconstituted protein into proteoliposomes. Depending on the
desired time resolution, uptake can be measured in a normal fluorometer
or, when high time resolution is required, on a stopped flow apparatus. A
high time resolution is often required when the goal is to obtain biophysi-
cal parameters, such as transport rate constants or Michaelis constants for
particular substrates. To obtain a KM , the initial rates of transport have to
be measured at different substrate concentrations where the highest concen-
tration has to yield the maximum rate of transport. With sufficient quality
of data, a rate constant for transport (kcat) can be calculated as well. One
condition that has to be met is that the fluorescent response is linear with
substrate concentration over a certain range, such that the change in flu-
orescence can be directly related to the change in substrate concentration
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inside the vesicles. An example is provided by Chao et al. for the Zn2+
transporter ZitB of the CDF family [177]. It has to be added though that
the turnover number obtained in this paper may still contain a large error
because the authors had to assume that all their protein was functionally
reconstituted.
Although fluorescence based methods are a very useful tool to study trans-
membrane transport of proteins, there are some drawbacks in their appli-
cation, one of these being the requirement for a dye. Finding a suitable
dye for a specific assay is not always an easy task. Sometimes it is hard to
find a dye with a high enough selectivity for the substrate. Although highly
selective dyes exist for sensing sodium, potassium or calcium ions, the same
cannot necessarily said for transition metals. In particular there appears to
be no dye selective for manganese. Other potential issues regarding dyes
could be related to substrate affinity, absorption and emission wavelength
and pH dependency.
2.5.2 Radioactivity assays
Radioactivity based assays are frequently used for measuring substrate up-
take as they have the advantage over fluorescence based approach that they
provide a direct measurement of transport and importantly, any arbitrary
substrate can be made detectable by labeling it with an isotope. Assays can
be performed with whole cells or proteoliposomes by simply adding radioac-
tive substrate to the bath solution and then incubation to allow uptake to
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Technique Advantages Disadvantages
Patch clamp high time resolution
single channel recordings
control of membrane potential
low throughput
not applicable for bacteria/organelles
SSM-based
electrophysiology
very sensitive
optimal for transporters
medium throughput
no control of membrane potential
not optimal for ion channels
Fluorescence
transport assays
Slow and fast transport
detectable
low sensitivity
requires dye
Radioactivity
assays
Any substrate can be labelled availability of substrates
low time resolution
safety precautions
Table 2.1: An overview of different techniques and assays to measure membrane
transport. Advantages and disadvantages are lited that are generally associated with
the respective technique.
be completed. After isolating the cells/proteoliposomes from the bath by
either filtration or ultracentrifugation, radioactivity of the sample will be
indicative of protein activity. A drawback is that often radioactive sub-
strates are not commercially available and their synthesis can be laborious
and expensive. The assay is also not suitable if the substrate for a certain
transporter are not known yet. A low signal-to-noise ratio might be another
issue, in particular when dealing with transition metal ions. These will bind
unspecifically to lipid headgroups and therefore lead to a high background.
Similarly it might be hard to distinguish ions that are transported from ions
that are competitive binders and do not get transported. Finally, the assay
requires safety precautions to be met, which can be circumstantial. A gen-
eral overview of the techniques discussed in this chapter is found in table
2.1 together with their advantages and disadvantages.
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Materials and methods
3.1 Materials and suppliers
Common lab chemicals such as buffers, media components, salts and sol-
vents were purchase either from Sigma (Aldrich) or Melford unless specified
otherwise in the chemicals list. Water used in this study was of nanopure
grade (resistivity > 18.2 MΩcm−1) and was prepared using a Milli-Q system
(Millipore).
Lipids & detergents
E. coli polar lipid extract: Avanti polar lipids
1,2-diphytanoyl-sn-glycero-3-phosphocholine: Avanti Polar lipids
n-Dodecyl β-D-maltoside: Anatrace (Maumee Ohio, USA)
2,2-Dioctylpropane-1,3-bis-β-D-maltoside: Anatrace (Maumee Ohio, USA)
n-Octyl-β-D-glucopyranoside: Melford
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(Transition) metal salts
Manganese(II) chloride tetrahydrate, 99.99 % trace metal basis: Sigma
Aldrich
Manganese(II) sulfate monohydrate, ReagentPlusr, > 99 %: Sigma Aldrich
Manganese(II) gluconic acid, purity not verified: Sigma Aldrich
Iron(II) chloride tetrahydrate, puriss., p. a. > 99 %: Sigma Aldrich
Cobalt(II) chloride hexahydrate, BioReagent: Sigma Aldrich
Nickel(II) chloride hexahydrate, 99.9999 %: Acros Organics
Copper(II) chloride dihydrate, Reagent, 99 %: Acros Organics
Zinc(II) chloride, Reagent, > 98 %: Sigma Aldrich
Magnesium chloride, pure: Acros Organics
Calcium chloride dihydrate, BioReagentsr: Fisher
Cell culture
Cell culture flasks: TC treated Cellstarr flasks, greiner bio-one
Trypsin-EDTA: Life technologies
ZeocinTM: InvivoGen
Blasticidine: Sigma
Tetracycline: Sigma
Dyes and ionophores
Carbonyl cyanide m-chlorophenyl hydrazone (CCCP): Fluka
Nigericin: SLS
Valinomycin: Sigma
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2-Mercaptopyridine N-oxide sodium (pyrithione): Sigma
Calcium ionophore A23187 (calimycin): Sigma Aldrich
Trisodium 8-hydroxypyrene-1,3,6-trisulfonate (HPTS): Fluka
Calcein: Sigma
Calcium green-1, hexapotassium salt: Fisher Scientific
FluozinTM-1, tripotassium salt: Fisher Scientific
Fluo-3, pentaammonium salt: Fisher Scientific
SDS-PAGE Gel & Western Blot
PageRulerTM (unstained protein ladder; 10-250 K): Thermo Scientific
PageRulerTM Plus (prestained protein ladder; 10-200 K): Thermo Scientific
PierceTM 1-Step Ultra TMB Blotting Solution: Thermo Scientific
3.2 Media and Media components
SB media [no salt]
Component Quantity in 200 mL Concentration
Tryptone 6.4 g 3.2 % (w/v)
Yeast Extract 4 g 2 % (w/v)
20xNPSC
Component Quantity (in 500 mL) Concentration
H2O 450 mL -
Na2HPO4 35.5 g 0.5 M
KH2PO4 34 g 0.5 M
Na2SO4 7.1 g 0.1 M
NH4Cl 26.75 g 1 M
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50x5052
Component Quantity (in 200 mL) Concentration
Glycerol 50 g 0.5 % (w/v)
H2O 146 mL -
Glucose 5 g 0.05 % (w/v)
α-lactose 20 g 0.2 % (w/v)
SB-5052 medium for autoinduction
Component Quantity (in 400 mL) Concentration
SB [no salt] 372 mL -
1 M MgSO4 0.4 mL 1 mM
50x5052 8 mL 1 %
20xNPSC 20 mL 1 x
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3.3 Culture of HEK293 cells
TRPM2 was expressed from a stable, tetracycline-inducible, human embry-
onic kidney (HEK293) cell-line. The cell line was been established in work
prior to this thesis [178]. In the expression construct, TRPM2 carries a
FLAG tag at the N-terminus. Cells were grown in Dulbecco’s modified Ea-
gle Medium F12 (DMEM-F12) that was enriched with 10 % of fetal bovine
serum along with penicillin (50 units/mL) and streptomycin (0.5 mg/mL).
Growth conditions were 37 °C and 5 % CO2. Splitting of flasks was per-
formed when cells reached approximately 70 % confluence. The general
split ratio was 1:5. To detach cells from the surface, the bottom of the
flasks was rinsed briefly with trypsin-EDTA (1 mL, Life Technologies). Ex-
cess trypsin-EDTA was removed and flasks incubated for 2 min at 37 °C.
After each split selection antibiotics blasticidin (5 µg/mL) and zeocin (400
µg/mL) were added to the flasks. Expression of TRPM2 was induced by
tetracycline (1 µg/mL) 24 h prior to harvest. To harvest cells medium was
removed and exchanged for ice-cold PBS/EDTA (137 mM NaCl; 2.7 mM
KCl; 10 mM Na2HPO4; 1.8 mM KH2PO4; 1 mM EDTA). After 15 min
incubation cells were resuspended with a pipette. Suspended cells were con-
centrated by centrifugation (850 x g , 10 min, 4 °C). This step was repeated
3 times where each time the supernatant was replaced by fresh PBS/EDTA.
From 15 T175 flasks typically a yield of ca. 3 mL of packed cell volume
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(PCV) was obtained.
3.4 Isolation of membrane extracts
3.4.1 Isolation of plasma membranes
The membrane samples were kept at 4 °C for the whole procedure, including
the centrifugation steps. Ultra centrifugation steps were carried out using an
SW40 rotor (Beckman Coulter) on a Beckman ultra centrifuge (OptimaTM
L-90K or OptimaTM L-80). The PCV was first resuspended in homogeni-
sation buffer (25 mM HEPES, pH 7.4; 250 mM sucrose; 1 mM DTT; 0.5
mM PMSF; 1 mM EDTA; ”Complete” [Roche, Cat. No. 1836145])in a
ratio of 1:1 v/v. Breaking of cells was performed by 5-10 passes through a
ball-bearing homogeniser (isobiotec). To purify plasma membranes a pro-
tocol was followed that has been designed for membrane preparations for
SURFE2R experiments [179]. The homogenate was centrifuged for 10 min
at 6000 x g to pellet the nuclei, mitochondrial membranes and cell debris.
The supernatant of that step was centrifuged at 100,000 x g for 30 min to
pellet the residual membranes. The pellet was resuspended and the sucrose
concentration was adjusted to 54 % by adding an appropriate amount of 70
% sucrose solution in homogenisation buffer. The pellet was then overlaid
with sucrose solutions of three different concentrations (44 %; 31 %; 9 %).
The gradient was run for 1.5 h at 100,000 x g . The bands at the 9/31 and
31/44 interface were collected and diluted ca. 5x with resting buffer (25 mM
HEPES, pH 7.4; 2 mM MgCl2). Fractions were pooled at 100,000 x g for
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OptiPrep
medium
volume (µL)
Gradient
dilution buffer
volume (µL)
Final
volume
(µL)
OptiPrep final
concentration (%
w/v)
567 1434 2000 17
666 1334 2000 20
383 617 1000 23
900 1100 2000 27
500 500 1000 30
Table 3.1: Table of Opti-Prep density gradient medium steps
30 min. Pellets were resuspended in resting buffer and protein concentra-
tion was determined by a BCA assay. 10 % glycerol and 1 mM DTT were
added to the buffer and samples were aliquoted (10 - 20 µg total protein per
aliquot) and frozen in liquid N2. Membranes were stored at -80 °C.
3.4.2 Purification of lysosomes
To isolate lysosomes the same protocol was applied as described in the pre-
vious section up to and with the homogenisation step. From then on the
procedure was different and was based on a protocol reported by Zhao et al.
[180]. Centrifugation of the homogenate was done at lower speed (800 x g)
to remove only nuclei and cell debris. The supernatant was directly loaded
onto an OptiPrep gradient. The constitution of this gradient is shown in
table 3.1. The gradient dilution referred to in table 3.1 has the following
composition: 25 mM HEPES (pH 7.4), 250 mM sucrose, 2 mM EDTA. Be-
fore the sample was loaded OptiPrepTM density gradient medium (60 %
w/v iodixanol; sigma) was added to a concentration of 15 % w/v iodixanol.
The gradient was run for 3 h at 100,000 x g . The top band containing lyso-
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somes was collected, diluted 5x with resting buffer (25 mM HEPES, pH 7.4;
2 mM MgCl2) and pelleted (100,000 x g ; 30 min.) BCA assay, aliquoting
and freezing was done in the same way as for plasma membranes.
3.5 BCA assay
BSA standards used for calibration ranged between 0.2 and 1.0 µg. Samples
and standards were incubated with BCA reagent (50:1 mixture of A: 1.0 %
sodium bicinchonic acid; 2.0 % Na2CO3; 0.16 % NaK tartrate; 0.4 % NaOH,
0.95 % NaHCO3 and B: 4 % CuSO4) for 30 min at 37 °C. Absorptions were
measured in a plate reader at 562 nm.
3.6 SDS PAGE
Resolving gels: 40 % Acrylamide (3.475 mL); 2 % Bis-acrylamide (0.36 mL);
1.5 M Tris, pH 8.8 (2.81 mL); 10 % SDS (0.1 mL); milliQ (4.267 mL); am-
monium persulphate (45 µL); tetramethylethylenediamine (24 µL). Stacking
gels: 40 % Acrylamide (0.77 mL); 2 % Bis-acrylamide (0.39 mL); 1.5 M Tris,
pH 6.8 (0.75 mL); 10 % SDS (0.05 mL); milliQ (3.2 mL); ammonium per-
sulphate (30 µL); tetramethylethylenediamine (9 µL). Gels with the compo-
sition indicated above were run as described previously [181]. Samples were
mixed with loading buffer (Final conc.: 62.5 mM Tris-HCl, pH 6.8; 2.5 %
SDS; 0.00125 % Bromophenolblue; 1.25 % β-mercaptoethanol; 10 % glyc-
erol)and were prepared by warming at 40 °c for 1 h or alternatively boiling
at 90 °C for 5 min. After taking the gel out of the chamber it was stained
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with coomassie brilliant blue R-250 as reported elsewhere [182].
3.7 Western Blot
To perform western blotting a SDS PAGE gel was run as described in the
previous section. After completion of the electrophoresis the gel was soaked
in transfer buffer (47.9 mM Tris; 38.6 mM Glycine; 10 % w/v methanol) for
15 min. That gel together with a nitrocellulose membrane were sandwiched
between two sheets of filter paper on each side and put into a transfer cham-
ber. The membrane and filter papers have been wetted in transfer buffer
prior to use. A current of 50 mA was applied for 42 min to transfer proteins
from the gel to the membrane. Binding sides of the membrane were blocked
overnight with 3 % bovine serum albumin in TBS-T (50 mM Tris, pH 7.4;
150 mM NaCl; 0.05 % Tween20). The membrane was washed twice for 5 min
in TBS-T before incubating with HRP-conjugated anti-FLAG monoclonal
antibody (1:1000 in TBS-T) for 1 h. Antibody was washed off 6x with TBS-
T for 5 min. Bound antibody was visualised by wetting the membrane with
a 1:1 mixture of a luminol enhancer solution and a stable peroxide solution
from a kit (SuperSignal® West Pico; Thermo Scientific). The blot was then
imaged in a dark box designed for this purpose (G:BOX; Syngene).
The western blot staining procedure was slightly different when blotting for
MntH2. For transfer a Trans-Blotr TurboTM Transfer System (BioRad)
was used, following the standard procedure for 1 mini gel (25 V const.; 30
min). Transfer buffer, transfer stacks and nitrocellulose membranes were
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used from the Trans-Blotr TurboTM Transfer Kit (BioRad). After transfer,
membranes were blocked as above, before incubating with Anti-His6-HRP
conjugated antibody (1:5000) for 1 h. The membrane was washed 3x in
blocking buffer (5 min. each) followed by staining with Ultra TMB Blotting
Solution (PierceTM ).
3.8 Transformation of competent cells
For transformation of competent cells 1 µL of plasmid DNA was added to 50
µL of competent cells on ice. After an incubation time of 50 min on ice cells
were heat shocked at 42 °C for 60 s followed by another 2 min incubation
on ice. Cells were then diluted 1:10 with LB medium and incubated in an
orbital incubator (37 °C; 230 rpm) for 50 min. Cells were spun down at
16,200 g for 2 min and 200 µL of the supernatant was removed. The pellet
was resuspended in the remaining supernatant and spread on a LB-agar
plate containing the appropriate antibiotic that was incubated overnight at
37 °C.
3.9 Purification of plasmids
Following a transformation (section 3.8 into omnimax cells, single colonies
were selected from the plates and cells transferred into 5 mL LB medium
including antibiotics. After incubation overnight in an orbital incubator (37
°C; 230 rpm) plasmids were purified using the ChargeSwitchr-Pro Plasmid
MiniPrep kit (invitrogen).
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3.10 Overexpression of metal transporters
Overexpression of all metal transporters was performed in SB-autoinduction
medium. All media in the process contained 100 µg/mL carbenicillin as the
selection antibiotic. BL21*(DE3) cells harbouring the plasmid pRARE2
were transformed as described in section 3.8. Cells from single colonies
were transferred into 5 mL of LB medium in a 50 mL Falcon tube and
incubated overnight in an orbital shaking incubator (37 °C; 230 rpm). SB-
autoinduction medium (500 mL) was prepared in baﬄed flasks (2 L) and
each of the flasks was inoculated with a single LB starting culture (5 mL).
Flasks were incubated (37 °C; 230 rpm) for 22 - 24 h to complete overex-
pression of protein.
3.11 Expression in the fermentor
For a fermentor growth an agar plate with bacterial colonies transfected with
the pBT294CVH plasmid (3.8 were provided to the fermentation facility
together with the dry components for 30 L SB-autoinduction medium. All
further steps were then carried out by Dr David Sharples. The fermentation
system in use was an Applikon fermentor (ADI075/ADI 1010, 40 L Bio Pilot
System) which has a Steam In Place (SIP) system with a working volume
of 30 L of medium.
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3.12 Overexpression of HRV-3C protease
Overexpression of HRV-3C protease followed mainly the same procedure
as applied for metal transporters. Competent BL21*(DE3) cells without
the plasmid pRARE2 were transfected with the plasmid pET28-His-HRV-
3C. Overexpression was performed in SB-autoinduction medium and was
performed at 30 °C. The selection antibiotic was kanamycin (25 µg/mL).
3.13 Isolation of bacterial inner membranes
3.13.1 Large scale expression
Cultures from autoinduction were spun down in a high-speed centrifuge
(Sorvall Evolution RC) for 15 min at 7,000 x g using a SLC-6000 (Sorvall)
rotor. The supernatant was removed and cells were resuspended in lysis
buffer (100 mM HEPES, pH 7.0; 150 mM NaCl). From this step the cells
were constantly kept at 4 °C throughout the whole procedure. To the resus-
pended cells PMSF (0.5 mM) was added not more than 30 min before the
lysis step. Cells were then homogenised using a cell-homogeniser (IKArT18
basic, ULTRA-TURRAXr) and lysed by passing them twice through the
cell disruptor (CONSTANT SYSTEMS LTD) at 30 kpsi. Unbroken cells
were removed by centrifugation at 12,000 x g for 30 min. Membranes were
harvested by centrifugation at 100000 x g for 60 min and resuspended in
lysis buffer. The membranes were washed twice by resuspension in lysis
buffer and centrifugation, then snap frozen in liquid nitrogen and stored at
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-80 °C.
3.13.2 Small scale expression
If expression of protein was performed only in a small culture (50 mL),
the protocol for isolating spheroplasts was different from when protein was
expressed in a 4 L culture. This protocol is based on water lysis and adapted
from a method by Kaback [183]. 50 mL culture from overnight growth were
spun down in a JLA16.250 rotor on a Sorvall highspeed centrifuge (6500 x g
; 8 min; 10 °C). The pellet was resuspended in 10 mL 0.2 M Tris-HCl, pH8.
This was followed by shaking the cells for 20 min in an orbital incubator
(250 rpm; 25 °C). After shaking, 4.85 mL of a sucrose containing buffer
(1 M sucrose; 1 mM EDTA; 0.2 M Tris-HCl, pH 8.0) was added to the
cells, followed by brief vortexing. Precisely 1.5 min after adding the sucrose
buffer, 65 µL of lysozyme (10 mg/mL) resuspended in the sucrose buffer was
added on top, which was followed again by briefly vortexing the mixture.
The lysozyme was allowed to act for 30 seconds (timed) before 9.6 mL of
nanopure water was added. The final suspension was shaken in the orbital
shaker (20 min; 25 °C) for another 20 min to allow spheroplast formation.
Inner membranes were pelleted by centrifugation (25’000 x g ; 20 min; 4
°C) followed by resuspension in 15 mL of nanopure water and incubation
for 30 min at room temperature. The membranes were collected as in the
previous step and washed in sodium phosphate buffer (pH 7.2) containing
1 mM mercaptoethanol. This step was repeated twice, before membranes
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were frozen in liquid nitrogen and stored at -80 °C.
3.14 IMAC purification of MntH2
For purification, membranes were solubilised in solubilisation buffer (25 mM
HEPES, pH 8.0; 300 mM NaCl; 5 % glycerol; 1.5 % DDM, 10 mM Imidazole)
at a concentration of 3 mg/mL total membrane protein and incubated on a
roller mixer at 4 °C for 2 h. The sample was centrifuged at 100,000 x g for
1 h to remove insoluble material. Purification was performed on an AKTA
(A¨ktaTM pure; GE Healthcare Bio-Sciences AB) using a Ni-NTA column
(His Trap HP, 5 mL). The flowrate was kept at 0.5 mL/min throughout the
experiment. The column was equilibrated with 5 column volumes (CV) of
equilibration buffer (25 mM HEPES, pH 7.0; 300 mM NaCl; 5 % glycerol;
0.05 % DDM, 10 mM imidazole). After loading the sample the column was
washed with 10 CV of wash buffer containing 80 mM imidazole. To elute
the protein the imidazole concentration was then increased gradually up to
400 mM (16 CV). Fractions containing pure protein, as confirmed by SDS-
PAGE, were pooled and imidazole was dialysed out against dialysis buffer
(25 mM MES, pH 6.0; 150 mM NaCl; 5 % glycerol; 0.05 % DDM)(1:500
V/V sample/buffer) for 2 days with 2 changes of buffer.
3.15 IMAC purification of HRV-3C protease
The PBS buffer used in this protocol had the following composition: 10g/L
NaCl; 0.25 g/L KCl; 1.8 g/L Na2HPO4; 0.3 g/L KH2PO4.
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Cells were centrifuged using an SLC-6000 rotor on a Sorvall centrifuge (15
min, 7000 x g , 4 °C). The pellet was resuspended in 2 mL of disruption
buffer (PBS, pH 7.4; 0.5 mM EDTA) per g of cells using a cell homogeniser
(IKArT18 basic, ULTRA-TURRAXr). The cells were lysed by two pas-
sages through the cell disruptor (CONSTANT SYSTEMS LTD) at 30 kpsi.
Cell debris was removed by centrifugation on a JA25.50 rotor on a Sorvall
centrifuge (27’000 x g ; 15 min; 4 °C). The supernatant was diluted in PBS
buffer (pH 8.0) containing Triton X-100, imidazole and DTT. The concen-
tration of these compounds were previously determined such that the final
concentrations in the sample were 0.1 % Triton X-100, 7.5 mM imidazole
and 1 mM DTT. Before loading onto the IMAC column, the sample was
filtered through a stericup filter (0.45 µm). IMAC chromatography was
performed on the A¨kta on a Ni-NTA column (His-trap HP, 5 mL) that was
pre-equilibrated with 5 CV of equilibration buffer (PBS, pH 8.0; 1 mM DTT;
7.5 mM imidazole). After the sample was loaded, the column was washed
with another 20 CV of equilibration buffer followed by a wash of 5 CV with
extra wash buffer (PBS, pH 8.0; 1 mM DTT; 200 mM NaCl; 30 mM im-
idazole). Following this step the buffer was changed to extra wash buffer
without NaCl and the protein eluted in a gradient from 30 mM to 250 mM
imidazole over 15 CV. Fractions from the A¨kta containing HRV-3C were
pooled and dialysed overnight in dialysis buffer (50 mM HEPES, pH 7.5;
200 mM NaCl; 1 mM EDTA; 10 % glycerol). For storage the protein was
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concentrated to 5 mg/mL and glycerol was added to a final concentration
of 50 % glycerol.
3.16 Size exclusion chromatrography
After HisTrap purification of MntH2 the protein eluates were pooled and
concentrated to a volume of 1 mL or less using 30 kDa concentrators (vi-
vaspin). Size exclusion chromatography (SEC) was then performed on a
superdex 200 pg column using the AKTA at a flowrate of 0.5 mL/min.
The exact buffer composition used for SEC varied between experiments and
details can be found in chapter 7.
3.17 Reconstitution
3.17.1 Reconstitution of MntH2 using OGP
E. coli polar lipid extract (Avanti) from chloroform stock were dried un-
der nitrogen flow and residual solvent was removed by desiccation under
vacuum for 2 h. Lipids were hydrated with reconstitution buffer (25 mM
HEPES/NaOH, pH 7.0; 150 mM NaCl) to result in a cloudy, but homoge-
neous suspension (5 mg/mL lipid concentration). Lipids were dissolved by
adding OGP from 0.25 M aqueous stock up to a final concentration of 55
mM OGP. MntH2 from -80 °C (concentration of 1.3-1.8 mg/mL) was added
to give the desired ratio of protein/lipid w/w (typically 1:10) and sample
was incubated for 15 min on ice. All the following incubation steps were
performed on ice. In the next step biobeads were added to a concentration
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of 0.07 g/mL protein-lipid-detergent suspension followed by incubation for
30 min. Reconstitution was completed by another three subsequent steps
of biobead addition: Addition of 0.07 g/mL biobeads and incubation for 60
min. Addition of 0.14 g/mL biobeads and incubation for 60 min. Addition
of 0.14 g/mL biobeads and incubation for 120 min. Finally the supernatant
was collected and aliquots were frozen in liquid nitrogen and stored at -80
°C.
3.17.2 Reconstitution of MntH2 using DDM
Reconstitution of MntH2 was performed based on the protocol by Geertsma
et al. [184] optimised for MntH2. E. coli polar lipid extract (Avanti) from
chloroform stock were dried under nitrogen flow and residual solvent was re-
moved by desiccation under vacuum for 2 h. Dried lipids were resuspended
in reconstitution buffer (10 mM HEPES, pH 7.0; 150 mM NaCl) to a concen-
tration of 5 mg/mL. Lipids were extruded by at least 11 passages through a
200 nm track-edged polycarbonate membrane filter. The lipid concentration
was adjusted to 4 mg/mL and DDM was added to a final concentration of 1
%. Some reconstitutions have been carried out using less DDM (0.2 / 0.5 %
) but these samples did not perform as well in electrometric measurements.
Protein was added to a concentration of 1:10 protein/lipid (w/w) and in-
cubated for 15 min on ice. Detergent was removed by stepwise addition of
biobeads as described elsewhere [184].
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3.18 CPM assay
7-Diethylamino-3-(4’-Maleimidylphenyl)-4-Methylcoumarin (CPM) from 5
mg/mL stock (DMSO) was diluted 1:50 in aliquots of each assay buffer (100
µL) to make CPM working stock solutions. Aliquots were vortexed and
equilibrated for 10 min at 20 °C. In 0.3 mL PCR tubes 50 µL reactions were
set up first by diluting protein into assay buffer to yield a final concentration
of 0.05 mg/mL protein. CPM from the corresponding working stock solution
was then added to the reaction as well to a 10th of the total reaction volume.
Reactions were vortexed and left on ice for 10 min before the samples were
run through a temperature ramping program on a PCR machine (Strata-
gene Mx3005P, Agilent Technologies). The temperature ramping program
equilibrated samples for 3 min at 25 °C and then increasing temperature in
70 cyles of 15 s at 1 °C per cycle.
3.19 SEC-MALS
SEC-MALS runs were performed by Dr Maren Thomsen. Protein samples
of 10-30 g of purified protein (1-3 mg/mL) were subjected to analytical size
exclusion chromatography using a Schimadzu UFLC HPLC system. The
eluting samples were analysed with the coupled Wyatt Optilab rEX UV ab-
sorbance and refractive index, and Wyatt miniDAWN TREOS multi angle
laser light scattering detectors. Molecular mass, as well as protein and de-
tergent contents were calculated with Wyatt ASTRA software. MntH2 was
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run on a Superdex 200 10/300 column (GE Healthcare) pre-equilibrated with
running buffer (for details see section 5.5) for 16 hrs at room temperature. A
control run with carbonic anhydrase was performed on the pre-equilibrated
column before the experimental runs. This step allowed to factor and cor-
rect for the time delay of the sample between each detector, when aligning
the traces.
3.20 Mass Spectrometry
Mass spectrometry experiments were performed at the mass spectrometry
facility of the faculty of biological sciences at the University of Leeds. Sam-
ples of MntH2 protein were provided in concentrations of 0.4 mg/mL (Peak1
from IMAC) and 0.3 mg/mL (Peak2 from IMAC) in SEC running buffer (25
mM MES, pH 6.0; 150 mM NaCl; 0.05 % NMDG).
3.21 SURFE2R experiments
3.21.1 Sensor preparation
Sensors were prepared according to the manufacturer’s protocol [179] with
slight modifications. Sensors were incubated with 0.1 mM 1-ODT solution
in 50 % IPA for 15 min. Thiol was rinsed away with IPA three times and
the sensor was dried under a nitrogen flow. It was left to dry for 15 - 30 min
to allow residual IPA to evaporate. 3 µL of SensorPrep B (7.5 mg/mL 1,2-
diphytanoyl-phosphatidylcholine in decane) was added to the sensor followed
immediately by 50 µL of non-activating buffer B (25 mM HEPES/NaOH,
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pH 7.0; 150 mM NaCl; 2 mM MgCl2). This was incubated for 30 - 60
min at 4 °C. From this step on the sensor preparation protocol differed
slighly, depending on whether the sample was constituted of proteolipsomes
(MntH2), eukaryotic membranes (TRPM2) or bacterial inner membranes
(NupC, metal transporters).
MntH2
MntH2 proteoliposomes were thawed from frozen stock, diluted 1:50 in non-
activating buffer B and sonicated with 10 pulses (UPH50, Dr. Hielscher
GmBH, tip-size = 1 mm, Amplitude = 0.5, cycle = 0.2). The buffer was
removed from the sensor and replaced by 100 µL of the proteoliposome
sample. Sensor preparation was completed by centrifugation of the sensors
(800 g; 45 min; 4 °C).
Eukaryotic membranes
All buffer was removed from the sensor and replaced by buffer C (25 mM
HEPES/NMG, pH 7.4; 100 mM NMGCl; 2 mM MgCl2), where membrane
samples have been suspended in by pipetting up and down 30 times. Typi-
cally the amount of sample was such that 10 µg of total protein was added
to the sensor. Adsorption of membrane fragments was assisted by centrifu-
gation of the sensors (800 g; 45 min; 4 °C).
Bacterial inner membranes
Spheroplasts containing transport protein were mixed with 200 nm vesicles
from E. coli polar lipids prepared as described in section 3.17.2 in a ratio of
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1:9 lipid/total protein (w/w) and treated with 100 pulses of tip-sonication
(UPH50, Dr. Hielscher GmBH, tip-size = 1 mm, Amplitude = 0.5, cycle
= 0.2). 2 µg of total protein (5 µL of mixed proteoliposome suspension
) was then added to a sensor that was preloaded with 100 µL buffer B
(composition varied depending on protein; details are specified in chapter
6)). Centrifugation of sensors was performed as above (800 g; 45 min; 4 °C).
3.21.2 Experiments with TRPM2
For experiments with TRPM2 on the SURFE2R a protocol with two solution
exchanges and three buffers A, B and C was used. The exact composition of
buffers varied (see chapter 4, table 4.1) but some rules are generally applied:
1. The base components for all buffers were 25 mM HEPES, pH 7.4 and 2
mM MgCl2. Depending on whether KCl or NaCl were added to the base
buffer, the buffer pH would be adjusted accordingly by KOH or NaOH.
Buffer C and B are identical except that NaCl and KCl concentrations are
exchanged (eg. if buffer C contains 140 mM KCl, buffer B would contain 140
mM NaCl instead). Buffer A is identical to buffer B, but it contains varying
concentrations of the activating compound(s) (Ca2+ and/or ADPR). The
flow rate was kept at 200 µL/s during measurements.
3.21.3 Experiments with MntH2
Experiments on the SURFE2R N1 instrument at were performed at room
temperature. Typically a three phase solution exchange protocol was used:
(1) Non activating buffer B (1 second), (2) activating buffer A (= buffer
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B + 100 µM of transition metal salt)(1 second), (3) non activating buffer
B (1 second). The flow rate was set to 250 µL/s. Each measurement was
repeated at least four times and sensors were used for up to three days.
Experiments with his-tagged MntH2 were performed from in total three
different expressions. An additional expression was performed to get his-tag
cleaved MntH2.
3.22 Fluorescence based assays
3.22.1 Tryptophan fluorescence
Tryptophan fluorescence assays were performed on a fluorimeter (Photon
Technology International) at 20 °C with an excitation wavelength of 280
nm. The protein concentration (BSA and MntH2) was 0.2 mg/mL in assay
buffer (10 mM MHC, pH 8.0; 150 mM NaCl; 2 mM MgCl2; 0.05 % DDM)
and measurements were performed in a 400 µL quartz cuvette. Transition
metal ion salts were added from freshly prepared stock solutions in assay
buffer as appropriate. Before each measurement a waiting time of at least 2
min was included to allow equilibration of the metal ions with the sample.
3.22.2 Assay of H+ cotransport using the pH sensitive dye
HPTS
Vesicles for proton transport assays were prepared using the OGP recon-
stitution protocol (section 3.17.1) with some modifications. E. coli polar
lipids were resuspended in reconstitution buffer (5 mM MOPS, pH 7.0; 150
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mM KCl; 1 mM HPTS) and dissolved by adding OGP to a concentration
of 55 mM. Protein was added to a protein/lipid ratio of 1:70 w/w followed
by extensive dialysis (3 days with 2 changes of buffer) against reconstitu-
tion buffer. In the first dialysis step 1 mM HPTS was still added to the
buffer but was left out in the following steps. For assays proteoliposomes
were typically diluted 1:10 in reconstitution buffer to a concentration of 0.5
mg/mL lipid. To record changes in fluorescence, the emission at 510 nm
was detected using two different excitation wavelengths of 400 and 448 nm
on a fluorimeter (Photon Technology International). To get data points and
confidence the ratio between the signal from the two excitation wavelenghts
was calculated and monitored for 3x30 s with 30 s break in between for each
data point measured. To create pH jumps in the outside buffer 1 µL of 0.5
M HCl or KOH was added to the cuvette. The control ionophore nigericin
was added to a concentration of 0.1 µM from 0.1 mM aqueous stock.
3.22.3 Fluorescence transport assay with the transition metal
sensitive dye calcein
To prepare proteoliposomes for calcein fluorescence based transition metal
uptake assay a reconstitution was performed according to section 3.17.2 with
a MOPS reconstitution buffer (5 mM MOPS, pH 7.0; 150 mM KCl; 250 µM
calcein). Dialysis was performed in reconstitution buffer without calcein for
36 h with two changes of buffer. Liposomes were diluted 1:100 (0.04 mg/mL
lipid concentration) and dye quenching was monitored at 515 nm with an
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excitation wavelenght of 490 nm on a fluorimeter in a quartz cuvette. All
buffers were filtered (PES; 0.22 µm) before the experiment.
3.22.4 Stopped-flow
Proteoliposomes for stopped flow experiments were performed as described
in the previous section, but instead of removing the calcein by dialysis, the
dye was washed out in ultracentrifugation steps: After the incubation with
biobeads, the samples were diluted 1:60 and centrifuged in a Ti45 rotor
(43’000 rpm; 1h 30 min; 4 °C). The supernatant was removed and the pellet
washed once, by repeating the previous step. For experiments the proteoli-
posomes were diluted in reconstitution buffer to a final concentration of 0.2
mg/mL. Experiments were performed on a stopped-flow apparatus (SX20;
Applied Photophysics) that has a dead time of ca. 1 ms. The excitation
wavelength was set to 492 nm using a monochromator (bandpass = 4.65
nm/mm) and emission wavelengths were filtered by a high pass filter (515
nm; Applied Photophysics) with a transition of 50 % at 515 nm and > 0.001
% at 492 nm. Fluorescence was detected by a fluorescence photomultiplier
(Type R6095; Applied Photophysics) with a detection range of 300-650 nm.
The temperature of the water bath was set to 20 °C. For measurements,
proteoliposomes and solutions of manganese chloride in reconstitution buffer
were prepared in separate syringes and mixed in a ratio of 1:1 in the reaction
cell. Care was taken that buffers in both cells were exactly identical and
were filtered (PES; 0.22 µm) before the experiment. Usually, the manganese
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chloride concentration was 200 µM in the syringe to give a final concentra-
tion of 100 µM in the cell. To determine Fmax by performing experiments
with calimycin (0.5 µg/mL) added to the manganese chloride solution.
3.23 Crystallisation trials
Crystallisation trials were set with protein purified by IMAC and SEC as
described in sections 3.14,3.16. The protein was concentrated in 30 kDa
spin-concentrators (vivaspin) up to varying concentrations between 3 and 7
mg/mL. The exact concentrations for each trial and are specified in chapter
7. Trials were set up on MRC 96-well 3-drop plates with help of a crystalli-
sation robot (NT8). As well solutions three different commercially available
screens (MemGold, MemGold2, MemSys/MemStart; Molecular Dimensions
Ltd) were used that are designed specifically for the crystallisation of mem-
brane proteins. In each well one of the drops corresponded to protein from
one of the two peaks obtained from the IMAC purification step. Normally
protein was mixed in a 1:1 ratio with well solution (0.2 µL total drop vol-
ume) but optionally the third drop was used to test a different ratio of 1.75:1
protein to well solution. Plates were stored either at 4 °C or at 20 °C and
were observed for at least one month for crystal growth.
3.24 Data analysis
For data analysis and figures the software package R was used throughout
this thesis [185].
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TRPM2
In this chapter the work is presented that has been performed on the human
TRPM2 channel. TRPM2 was studied to investigate its proposed role in
the cell death of pancreatic β-cells. An introduction to this was given in
section 1.3.2. The goal was to isolate plasma membrane- as well as lysosomal
extracts from TRPM2 overexpressing cells and use these extracts to perform
electrophysiological experiments with the SSM-based technique.
4.1 Expression and isolation of membrane extracts
This section provides a short version of protocols for TRPM2 overexpression
and isolation of lysosomes and plasma membranes. More detailed protocols
are described in chapter 3, sections 3.3-3.4.2. TRPM2 was expressed in
HEK293 cells that was grown in DMEM-F12 medium. Added antibiotics
were penicillin/streptomycin as well as the selection antibiotics zeocin and
blasticidin. Expression was induced by tetracycline one day before cells were
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harvested. Cells were collected by resuspension in ice cold PBS/EDTA and
washed three times. The usage of trypsin in this step was avoided in order
to prevent potential damage of TRPM2 by trypsin. Breaking up of cells
was performed using a ball-bearing homogeniser. To isolate membrane frag-
ments two different protocols were applied, depending on which organelles
were to be purified. Plasma membranes were obtained from a sucrose gra-
dient (9/31 interface; section 3.4.1) whereas lysosomes were purified in an
OptiPrep gradient (table 3.1. In OptiPrep gradients 2-3 bands were ob-
tained and lysosomes were isolated from the first band at low OptiPrep
density. The membrane fragments were harvested by ultra centrifugation
and resuspended in storage buffer (25 mM HEPES, pH 7.4; 2 mM MgCl2;
10% Glycerol; 1 mM DTT). Membranes were frozen in liquid N2 and stored
at -80 °C. Western blot analysis was performed to ensure that TRPM2 was
present in the samples (fig. 4.1). Lysosome and plasma membrane sam-
ples showed both a clear band at the correct molecular weight, confirming
TRPM2 expression and localisation in plasma membrane and/or lysosomal
fractions. The band at lower molecular weight indicates that some protein
has degraded during membrane purification.
It was hypothesised that this degradation takes place due to proteolytic
activity, that might be not inhibited by the ”complete” protease inhibitor
cocktail (see chapter 3, sections 3.4.1-3.4.2). Consequently, the protocol was
adjusted by adding the protease inhibitor pepstatin, which reversibly in-
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Figure 4.1: Western Blot of samples obtained from density gradients. From left
to right: Marker, 9/31 interface (sucrose), 31/44 interface (sucrose), 1st band
(OptiPrep, low density), 2nd band (OptiPrep, medium density). Plasma membranes
and lysosomes were isolated from the 9/31 and 1st band respectively.
hibits aspartyl proteases, to the homogenisation buffer and to the gradient
diluent. To track at which stage degradation occurs, samples of membrane
preparations were collected at different steps of the purification (whole cells,
homogenised cells, post nuclear supernatant). The western blot showed
clearly that degradation of the channel was prevented, as there is no low
molecular weight band (fig.4.2). It does seem likely therefore, that pep-
statin solved the problem of degradation by preventing proteolytic cleavage.
The control bands on the blot (fig. 4.2) are from membranes of HEK293
cells not induced with tetracycline. The blot confirms that these cells did
not express TRPM2.
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Figure 4.2: Western Blot of TRPM2. The lanes were loaded with samples from
different steps of an OptiPrep density gradient as indicated in the labels above the
lanes. The control shows the first OptiPrep band from a preparation with non-
induced HEK293 cells.
4.2 SURFE2R of TRPM2
When starting experiments with a new protein with the SURFE2R, there
are a few things that have to be optimized as for instance the amount of
total protein added to the sensor or the lenght of sensor incubation to name
only two [179]. This can be quite a challenging task, especially if, as in the
case of TRPM2, it is not completely clear what the exact conditions are,
that are needed to activate the channel. Even though there is no doubt
that ADPR is an activator of the channel, a wide range of EC50 values from
1 to 100 µM has been reported ([83, 84, 186]). Moreover, Ca2+ has been
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reported to influence the channel to some very different degrees. There is a
general consensus that Ca2+ facilitates channel activation but it is less clear
what concentration or whether intracellular, extracellular or both Ca2+ are
needed [186]. Problematic in that context is that it cannot be excluded
that Ca2+ alone is sufficient to activate TRPM2 [187]. This means that one
cannot simply add Ca2+ to all buffers used in SURFE2R experiments, be-
cause in this case TRPM2 might be permanently activated. The situation is
further complicated by the fact that the orientation of TRPM2 in the mem-
brane may matter a great deal for these measurements. The primary gating
molecule, ADPR, has its binding side on the intracellular side of TRPM2.
Hence, TRPM2 has the wrong orientation in plasma membrane for being
activated by this molecule. Fortunately, experiments could be performed
as well on TRPM2 in lysosomes, which has its intracellular side facing out-
wards.
Purified membrane samples were subjected to a number of different con-
ditions where parameters indicated above were varied by adjusting buffer
compositions used for the SURFE2R workflow. As described in chapter 2,
section 2.4, three different buffers (resting buffer C, non-activating buffer B
and activating buffer A) are used for the two-solution exchange protocol to
activate ion channels. A summary of the different buffer conditions tested
is shown in table 4.1. First some fixed components were set, which were
25 mM HEPES, pH 7.4 and 2 mM MgCl2 in all buffers. In addition the
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concentration ADPR in the activating buffer was set to be 100 µM ADPR.
Variable parameters included mostly the cationic species in buffer salts and
the Ca2+ concentration in different buffers. In the beginning KCl and NaCl
were used in concentrations of 100-140 mM to establish the cation gradient
necessary to perform experiments. For instance, 140 mM KCl in buffer C
would be compensated by 140 mM NaCl in buffers B and A or vice versa.
Later it was preferred to replace Na+ or K+ in buffer C by a bulky cation,
which could safely assumed to not leak out of membrane vesicles. Ca2+ was
generally added in a concentration of 1-100 µM to buffers B and A, but not
to buffer C. This was to exclude the possibility of TRPM2 being activated
already in buffer C by the presence of Ca2+. Nevertheless, some experiments
were conducted in which 1 mM Ca2+ was added to all three buffers to allow
time for Ca2+ to bind prior to the activation by ADPR. Finally, experiments
were performed with 200 nM calmodulin. In this experiment the buffer salts
were 100 mM NMGCl in buffer C and 100 mM NaCl in buffer B/A. Ca2+
was added in a concentration of 100 µM to buffers A and B. Despite all
this effort no signal from the TRPM2 channel on the SURFE2R could be
obtained. (fig. 4.3).
4.3 Discussion
In this chapter plasma and lysosomal membranes from HEK293 cells were
successfully purified and subjected to a number of different conditions to
monitor TRPM2 activity. Some optimisation was required until it was found
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Figure 4.3: SURFE2R measurement of TRPM2. The trace is representative for
all experiments with TRPM2. Samples from in total four biological replicates were
used. The basic buffer used in the experiment was 25 mM HEPES/NMG, pH 7.4
with 2 mM MgCl2. Buffer C contained in addition 100 mM NMG
+ and buffers A
and B 100 mM NaCl and 100 µM CaCl2. As the only buffer, A contained 100 µM
ADPR. The vertical dashed lines indicate the change from B to A and back.
that the addition of the protease inhibitor pepstatin during membrane pu-
rification is necessary to avoid channel degradation. This was important
because it could not be excluded that the degraded channel renderes mem-
branes leaky to cations which could dissipate the ion gradient in SURFE2R
experiments. Nevertheless, no ion transport could be detected with the
SURFE2R methodology. As discussed in the introduction (section 1.2.2)
TRPM2 can adopt an inactive state after repeated activation. It is thus
possible that TRPM2 was isolated in an inactive state, either a physiologi-
cal relevant inactive state or one due to experimental procedures that were
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C
resting buffer
B
non-activating buffer
A
activating buffer
1 100-140 mM NaCl 100-140 mM KCl
1-100 µM CaCl2
100-140 mM KCl
1-100 µM CaCl2
100 µM ADPR
2 100-140 mM KCl 100-140 mM NaCl
1-100 µM CaCl2
100-140 mM NaCl
1-100 µM CaCl2
100 µM ADPR
3 100 mM NMGCl 100 mM NaCl
1-100 µM CaCl2
100 mM NaCl
1-100 µM CaCl2
100 µM ADPR
4 100 mM NMGCl
1 mM CaCl2
100 mM NaCl
1 mM CaCl2
100 mM NaCl
1 mM CaCl2
100 µM ADPR
5 100 mM NMGCl
200 nM calmodulin
100 mM NaCl
200 nM calmodulin
100 µM CaCl2
100 mM NaCl
200 nM calmodulin
100 µM CaCl2
100 µM ADPR
Table 4.1: Buffer compositions for SURFE2R experiments on TRPM2. The table
shows the different salt- and activating components that were added to buffers A, B
and C. All experiments used the same basic buffer: 25 mM HEPES, pH 7.4; 2 mM
MgCl2.
followed. Alternatively, there is a chance that there are cellular factors re-
quired for TRPM2 activation that have not yet been identified [104]. The
lack of response would then be caused by the absence of these factors in
SURFE2R experiments.
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Expression & purification of
MntH2
A purification protocol for MntH2 has been established in preceding work
[108, 154]. Here, this protocol was developed further and this chapter will
discuss some adjustments that have been made. The purified protein was
characterised by several techniques addressing different properties of the
detergent solubilised protein. These included oligomeric state analysis by
SEC-MALS (sec. 5.5 and 5.6), molecular mass determination by mass spec-
trometry (sec. 5.6.1) and thermal stability analysis by the CPM-assay (sec.
5.7).
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5.1 Expression of MntH2
The plasmid for MntH2 overexpression, named pBPT0294-CVH, was de-
signed prior to this thesis [108, 154]. Overexpression is described in detail in
section 3.10 and was performed in SB-autoinduction medium (sec. 3.2). The
amount of growth culture could vary between expressions from 50 mL (small
scale) to 4 L (large scale) up to 30 L (fermentor). From a 4 L growth cul-
ture typically a yield of ca. 80 g cells was obtained. For a fermentor growth
an agar plate with bacterial colonies transformed with the pBPT0294-CVH
plasmid, were provided to the fermentation facility together with the dry
components for 30 L SB-autoinduction medium. The yield from a 30 L
fermentor growth was between 250 - 300 g cells per growth.
5.2 Extractions of inner membranes
For small sample sizes (∼1 g of cells) inner membranes were isolated fol-
lowing a protocol based on water lysis (section 3.13.2). This protocol uses
the osmotic shock from a high sucrose buffer to lyse cells and strip off their
outer membranes. More typically, inner membranes were purified from a
larger amount of cells, between 80 and 120 g. In this case a cell disruptor
was used for cell lysis (section 3.13.1). Expression of protein was confirmed
by western blotting (fig. 5.1).
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Figure 5.1: Western blot of bacterial inner membranes containing MntH2. The
construct, which has a tag with eight histidine residues on the C-terminus, was
stained using HRP conjugated anti-his6 antibody. Overexpression was performed
in E. coli BL21* (DE3) harbouring the plasmid pRARE2 using SB-autoinducting
medium.
5.3 IMAC purification
IMAC was performed using two slightly different protocols. The first pro-
tocol is similar to the published method [154], with the difference that a
linear imidazole gradient is applied to elute the his-tagged MntH2 from the
Ni-NTA column, rather than a step gradient. This protocol was applied to
improve the purity of MntH2 from the IMAC chromatography step. The
second protocol was designed to maximise the yield of MntH2. It is similar
to the first protocol but contains some minor changes. The most important
change was to increase the solubilisation time of MntH2 into DDM from 1 h
to 2 h. To minimise unspecific binding of proteins to the Ni-NTA column the
salt concentration in the buffer was raised from 150 mM to 300 mM NaCl.
Protein that was purified with the second protocol was purified further by
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size exclusion chromatography as described in the following section. Fig.
5.2a shows a purification of MntH2, following the first protocol and fig. 5.2b
is from a purification, where the second protocol has been applied.
There are clear differences between the two chromatograms. The most strik-
ing one is that when the second protocol is applied, protein does not elute in
only one, but in three peaks. By coomassie stain analysis of an SDS-PAGE
gel it was confirmed that all three peaks correspond to MntH2 (not shown).
Despite this, fractions from the three peaks were kept separately. Protein
yields were determined by BCA assays as described in section 3.5: Following
the original protocol (fig. 5.2a) yields of 4.0-4.6 mg MntH2 were obtained,
starting from ∼ 600 mg total protein in extracted inner membranes. Yields
from purifications following the second protocol (fig. 5.2b) mounted up to
19 mg (protein from the first two peaks combined), starting from ∼ 240 mg
total protein. The yields between the two protocols are not directly compa-
rable, because purifications were performed from different expressions.
For storage, samples were dialysed against dialysis buffer (25 mM MES, pH
6.0; 150 mM NaCl; 5 % glycerol; 0.05 % DDM) for 2 days with 2 changes of
buffer. Samples were concentrated to a concentration of 1-2 mg/mL followed
by freezing in liquid N2 and storage at -80 °C.
Fraction from IMAC purifications were subjected to coomassie stain and
western blot analysis of SDS-PAGE gels (fig. 5.3). Fig. 5.3 shows the bands
of the peak fraction from fig. 5.2a. The coomassie stained gel revealed that
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pH 8.0; 300 mM NaCl; 10 % glyc-
erol; 0.05 % DDM; 10 mM imidazole
(sample load). The purification was
started from ∼240 mg total protein.
Figure 5.2: IMAC purification of MntH2 was performed on a Ni-NTA column.
Blue: UV, green: Imidazole. The profiles are shown from the wash step (80 mM
imidazole), where most impurities come of. After this the imidazole concentration
is gradually raised in a shallow gradient. MntH2 is eluted in this gradient as a
single peak at ca. 210 mM imidazole in (a) or as three different peaks in (b).
Comparing the imidazole concentration at the onsets of the peaks, the second peak
in (b) corresponds to the peak in (a). After the shallow gradient the imidazole
concentration is raised to 1 M in a steep gradient, to wash off residual protein.
MntH2 is pure (≥80 %) but for a contaminant at low molecular weight. In
the Western blot it was confirmed that the purified protein is MntH2. It was
noted that the band of MntH2 showed up at considerably lower molecular
weight than its actual mass: The MntH2 construct has a total molecular
weight of 61.4 kDa but the protein is running at ca. 40 kDa. It is common
for membrane proteins to migrate at a lower than expected molecular weight
due to the fact that membrane proteins can retain partial folding in SDS
[188]. Results from mass spectrometry experiments showed that the protein
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Figure 5.3: Coomassie stained SDS-PAGE gel and western blot of MntH2 purified
by IMAC as in fig. 5.2a. The protein appears to be pure with the exception of
a small contaminant at 6.5 kDa. Blotting was performed using HRP-conjugated
anti-his6 antibody.
was intact (sec. 5.6.1)
5.4 Size exclusion chromatography
Size exclusion chromatography was performed exclusively on samples pu-
rified following the second purification protocol in IMAC chromatography
(fig. 5.2b). As mentioned, samples from the first two peaks were kept sep-
arately and from now on are named P1 and P2. The third peak was not
collected. Before loading onto the SEC column samples were concentrated
to a volume of ca. 1 mL. Along with purifying MntH2, SEC can be used
to exchange buffers and the running buffer was identical to MntH2 storage
buffer (25 mM MES, pH 6.0; 150 mM NaCl; 5 % glycerol; 0.05 % DDM).
P1 and P2 were both run on a superdex 200 pg column and they elute at
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the same volume (fig. 5.4). P2 has a larger shoulder than P1, which might
indicate that there are more aggregates in P2. This does not necessarily
mean that P2 is more prone to aggregate, because aggregation is correlated
to protein concentration, which is higher in P2 than in P1. MntH2 purified
by SEC was loaded on an SDS-PAGE gel which was stained with coomassie
brilliant blue (fig. 5.5). Both samples run at the same molecular weight of
ca. 40 kDa and no impurities are detected on the gel. The yields from this
purifications were ca. 3-3.8 mg protein for P2 and 1-1.5 mg for P1 (nan-
odrop), starting from 7-8 mL inner membrane samples with a total protein
concentration of ca. 30 mg/mL.
volume (mL)
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Figure 5.4: Size exclusion chromatography of P1 (dashed line) and P2 (straight
line) on a superdex 200 pg column. Within error, both samples elute at the same
volume. The chromatogram is representative for three independent experiments
from the same expression. Running buffer: 25 mM MES, pH 6.0; 150 mM NaCl;
5 % glycerol; 0.05 % DDM.
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Figure 5.5: Coomassie stained SDS-PAGE gel of samples P1 and P2 after purifi-
cation with SEC. From left to right: M; P1; P2. In neither sample impurities are
detectable on the gel. Both samples were run on the same gel.
5.5 SEC-MALS
SEC-MALS is a valuable tool for assessing the quality of a (membrane) pro-
tein sample, because not only does it confirm a proteins purity, but also
its homogeneity. For certain applications it is important to have a homo-
geneous sample, i.e. only one oligomeric state. Determining the oligomeric
state of a membrane protein is not an easy task. The main issue is related
to the circumstance that membrane proteins in solution are assembled in
detergent micelles. The amount of detergent associated with a protein is
generally not known and may vary considerably dependent on the specific
protein [189]. The SEC-MALS technique approaches the problem by using
size exclusion chromatography coupled to a combination of measurements
of the solution refractive index, the absorbance at 280 nm and light scatter-
ing. The three detection methods together provide sufficient information to
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calculate a weight averaged mass of the protein in the sample [190]. The pur-
pose of SEC (in SEC-MALS) is to physically separate the different species
in solution by their size. This is to ensure that only one species at a time is
in the measuring chamber, which allows determining the molecular mass of
the corresponding oligomeric state.
To get optimal data from SEC-MALS experiments it is required that micelles
containing protein are well separated from empty micelles on the column.
In SEC-MALS chromatograms, a micelle peak shows up because the con-
centration of micelles in the sample is always slightly different than in the
equilibration buffer [190]. This difference is detected by the very sensitive
measurements of refractive index and light scattering. Generally the best
columns to meet this requirement are the WTC columns (Wyatt Technol-
ogy), which have been specifically developed for SEC-MALS applications. It
was found, however, that MntH2 sticks to the WTC columns and therefore
SEC-MALS was performed on a superdex 200 10/300 column instead. The
results for samples P1 and P2 are shown in fig. 5.6. Both chromatograms
show a single, symmetrical peak in the UV, which indicates that the samples
are pure and homogeneous. Despite this, it was not possible from the data
to accurately calculate the molecular mass of MntH2. The analysis of the
peaks is shown in fig. 5.7. The calculated molecular masses were 39 ± 0.5
kDa for P1 and 47 ± 0.3 kDa for P2. This is significantly below the expected
mass of a monomer (61.4 kDa), which might be due to poor separation of
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(a) SEC-MALS run of P1 on a su-
perdex 200 10/300 column.
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(b) SEC-MALS run of P2 on a su-
perdex 200 10/300 column.
Figure 5.6: SEC-MALS chromatograms of samples P1 and P2 purified by SEC. In
the two chromatograms, the first peak represents the protein-detergent complex. In
the light scattering (LS) and refractive index (dRI) data a second peak is seen on
the right, which is overlapping with the first peak. This is the detergent peak. The
large peak in the dRI at an elution volume between 2.5 and 3.0 mL is due to minor
differences between the sample and running buffer.
the protein- from the micelle peak. Overlapping of the micelle peak with the
protein peak will lead to overestimation of the contribution of detergent in
the protein-detergent complex and consequently the mass contribution from
the protein will be underestimated. Regardless of this issue, the conclusion
is that in DDM the protein is monomeric.
5.6 Purification in DMNG
Decyl maltose neopentyl glycol (DMNG) is a detergent which has been re-
ported to have favorable properties for membrane protein stability [191]. In
previous work, MntH2 has been found stable in DMNG [108] Here, it was
examined whether purifying MntH2 in this detergent would be of advantage,
in particular with respect to membrane protein crystallisation. Purification
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Figure 5.7: Overlap of the peak region in fig. 5.6a and 5.6b. All data related to
P1 is shown in black, whereas data for P2 is shown in red. A plot of the molecular
weight vs elution volume is included (cross shaped points, which appear as a thick
line). This plot has to be flat throughout the peak volume for it to be a reliable
estimate of the molecular weight.
in DMNG was performed as described in the previous section, but starting
from the solubilisation of inner membranes, DDM was replaced by equivalent
amounts of DMNG in buffers. For IMAC purification the second protocol
was used (fig.5.2b), meaning that inner membranes were solubilised for two
hours. Similarly to the purification in DDM, the protein eluted in two major
peaks from the IMAC column (fig. 5.8). In line with previous purifications
in DDM, these two peaks were run separately on the SEC. Surprisingly, in
DMNG the elution volume between P1 and P2 was different and P2 eluted
earlier than P1 (fig. 5.9). The purification in DMNG has been performed
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only one single time and yields were 2.7 mg protein for P1 and 1.0 mg for
P2, starting from the same amount of total protein as in purifications with
DDM. The yield for P2 was low, because due to a technical problem sample
was lost during SEC. The chromatogram in fig. 5.9 shows that a small
volume (mL)
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Figure 5.8: IMAC purification of MntH2 in DMNG buffer. The experiment was
performed analogous to purifications in DDM (fig. 5.2b) where inner membranes
were solubilised for 2 h, but DDM was replaced by equivalent amounts of DMNG
in buffers. MntH2 was eluted in two peaks (P1 and P2) during the first imidazole
gradient, which were collected separately. Running buffer: 25 mM HEPES, pH 8.0;
300 mM NaCl; 10 % glycerol; 0.05 % DMNG.
fraction of P1 eluted at the same volume than P2 and vice versa. This in-
dicates that either P1 is in equilibrium with P2 or that the two peaks were
not completely separated after IMAC purification.
P1 and P2 from the purification in DMNG were run in a SEC-MALS ex-
periment (fig. 5.10). Compared to the previous run in DDM (fig. 5.6) the
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Figure 5.9: Size exclusion chromatography of P1 and P2 on in DMNG buffer. The
elution volumes differ for P1 (straight line) and P2 (dashed line) suggesting that
P2 forms larger entities than P1. Running buffer: 25 mM MES, pH 6.0; 150 mM
NaCl; 0.05 % DMNG.
micelle peak is better separated from the protein peak. DMNG micelles are
smaller in size than DDM micelles, which increases the difference in size
between the protein-detergent complex and empty micelles. Better peak
separation increases the accuracy of mathematical analysis to determine the
oligomeric states (fig. 5.11). In fig. 5.11, the calculated molecular protein
mass is constant over time, which is a clear improvement when compared
to fig. 5.7. Nevertheless, the calculated molecular weights did not match
exactly with the mass of MntH2 (61.4 kDa) or multiples thereof. Calculated
masses were 67.5 kDa ± 0.5 kDa for P1 and 152.7 kDa ± 1.1 kDa for P2.
This shows that P1 is monomeric. In case of P2 the interpretation is less
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(a) SEC-MALS run of P1 on a su-
perdex 200 10/300 column.
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(b) SEC-MALS run of P2 on a su-
perdex 200 10/300 column.
Figure 5.10: SEC-MALS of P1 and P2 in DMNG buffer (25 mM MES, pH 6.0;
150 mM NaCl; 0.05 % DMNG) on a superdex 200 pg column. The protein peak
is better separated from the micelle peak compared to previous runs in DDM buffer
(fig. 5.6).
obvious because the calculated average molecular mass is almost exactly 2.5
times the mass of an MntH2 monomer. One explanation is that purified
MntH2 is bound to a natural binding partner, which could be a low molec-
ular weight protein. An alternative explanation would be that MntH2 is
complexing metal ions. A protein metal complex could affect the extinction
coefficient of MntH2 at 280 nm, which would cause an error in the calcula-
tion of protein concentration.
As an side note, the SEC-MALS experiment in DMNG was performed two
days after the protein was purified by SEC. The fact that P1 and P2 showed
a different oligomeric state in this experiment therefore shows, that there is
no noticeable equilibration between the two forms.
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Figure 5.11: Overlap of the peak region from SEC-MALS runs of P1 and P2 in
DMNG buffer (25 mM MES, pH 6.0; 150 mM NaCl; 0.05 % DMNG). Analysis
of peaks yields an averaged molecular weight of 67.5 ± 0.5 kDa for P1 and 152.7
± 1.1 kDa for P2 (data shown in cross-shaped points). Compared to fig. 5.7 the
calculated molecular weight is constant over the whole section of both peaks, which
shows that the calculations were not influenced by an overlap of the micelle peak.
Nevertheless, the calculated masses do not match well with the mass of MntH2 (61.4
kDa) or multiples thereof.
5.6.1 Mass Spectrometry
In mass determination experiments of P1 and P2 in DMNG buffer by mass
spectrometry, the exact molecular mass of both forms was determined. The
experiments confirmed that P1 and P2 share the same mass of 61354 Da.
(fig. 5.12). This matches almost exactly with the mass of the full MntH2
expression construct, which is 61359 Da. The additional peaks in the spec-
trum at 62303 Da correspond to protein with one bound detergent molecule.
The experiments also conclusively show that the protein is pure and samples
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are not contaminated by some protein binding partner of MntH2.
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5.6.2 Overexpression and purification of HRV-3C protease
HRV-3C protease was purified to get his-tag cleaved MntH2. Overexpression
of HRV-3C protease is performed similarly to MntH2 with details specified
in section 3.12. Cell growth for overexpression was performed at a reduced
temperature of 30 °C because otherwise the majority of the protein ended
up in the insoluble fraction after cell disruption. HRV-3C was purified using
IMAC chromatography in a linear gradient of imidazole. Fractions from
the run were analysed using coomassie stain (fig. 5.13) and western blot
(not shown). Fractions containing the protein were pooled and subjected to
dialysis overnight. Before storage the protein is concentrated to 5 mg/mL
followed by addition of glycerol to a concentration of 50 %. Samples are
frozen in liquid N2 and stored at -80 °C. The yield was 119 mg of protein
for 4 L of growth culture as estimated by a BCA assay.
Figure 5.13: IMAC purification of HRV-3C protease. Samples were subjected
to SDS-PAGE and stained with instant blueTM . The amount of sample was 0.5
µL/lane for lane 1-5, 15 µL for lane 6 and 9 and 5 µL for lane 7-8. The first two
lanes were taken from the soluble and insoluble fractions after cell disruption.
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5.6.3 Cleavage of the MntH2 his-tag
Performance of MntH2 cleavage was tested at different ratios (w/w) of
MntH2:HRV-3C (1:2, 1:5, 1:10) and samples were left for cleavage for 6
and 24 h. This experiment was performed both at room temperature and
at 4 °C. Western blot analysis showed that under all conditions a high per-
centage of MntH2 was cleaved (fig. 5.14). To obtain larger amounts of
Figure 5.14: Western blot analysis of MntH2 cleavage by his-tagged HRV-3C pro-
tease. Cleavage was performed in different ratios of MntH2:protease, as labelled in
the figure, and reactions were stopped after 6 h or after 24 h. The band on the
very right shows the control where uncleaved MntH2 was added that has not been
subjected to protease. For each lane, the total amount of loaded MntH2 was 11 µg.
The results shown are from an experiment conducted at room temperature but the
outcome was not affected by when the experiment was performed at 4 °C. The blot
was stained with HRP-conjugated anti-his6 antibody.
cleaved MntH2, the protein was purified as described before using IMAC
chromatography (fig. 5.2b). After elution, MntH2 was concentrated to 1
mg/mL with a spin-concentrator (30 kDa) and incubated with HRV in a
ratio of 1:2 (w/w). was added in a ratio of 1:2. For cleavage the sample
was left in dialysis buffer (25 mM HEPES, pH 8.0; 300 mM NaCl; 10 mM
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imidazole; 10 % glycerol; 0.05 % DDM) for 6 - 24 h at 4 °C. After cleav-
age was complete, as confirmed by western blot analysis, a reverse IMAC
purification was performed. As MntH2 purification, the reverse purification
was performed on a Ni-NTA column using an imidazole gradient. Cleaved
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Figure 5.15: Reverse purification of His-tag cleaved MntH2. Cleaved MntH2 elutes
from the column right at the start (arrow). Even before that a large amount of a low
molecular weight protein is eluted, which likely is a degradation product of MntH2.
Of the two remaining peaks in the chromatogram the first one represents cleaved
MntH2 as well and the second one correspond to HRV-3C protease.
MntH2 elutes right at the start of the run, as without His-tag MntH2 has
no high affinity towards Ni2+. The cleaved MntH2 from this run is con-
taminated by a low molecular weight impurity as seen in coomassie stained
SDS-PAGE gels (fig. 5.16). The impurity elutes even before MntH2 but
complete separation cannot be achieved. It is possible that this contam-
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inant is a degradation product of MntH2. Two more peaks are observed
in the chromatogram at higher elution volumes. Analysis (western blot &
coomassie stain) of these peaks revealed that the first peak corresponds to
cleaved MntH2 as well (not shown). Probably this protein was uncleaved
when it was loaded onto the column, and was cleaved while on the column
by HRV-3C. It is unclear, however, why given this explanation, this protein
would elute at exactly this position in the chromatogram in such a sharp
peak. The third peak shows HRV-3C protease. The final yield was ca. 4
mg starting from inner membrane samples with ∼240 mg total protein.
The obtained yield was not optimal and could be potentially significantly
improved by amending the protocol. It was observed that there was signif-
icant aggregation of protein during the cleavage step in dialysis buffer. In
addition there are losses connected to each time the protein is purified with
IMAC. To limit these losses it one could try to cleave MntH2 directly when
it is bound to the column during IMAC purification.
5.7 CPM assay
The CPM assay is a relatively new method to assess the (thermal) stabil-
ity of (membrane)-proteins and an alternative to circular dichroism (CD)
spectroscopy [192]. It was performed here to test whether purified MntH2
is folded, but also to measure thermal melting curves of MntH2 in different
solutions and in the presence of transition metals. The assay makes use of
the dye 7-Diethylamino-3-(4’-Maleimidylphenyl)-4-Methylcoumarin (CPM),
126
5.7 CPM assay
Figure 5.16: Coomassie stained gel of cleaved MntH2 after reverse purification. The
low molecular weight contaminant at ca. 18 kDa probably represents a degradation
product of MntH2.
which reacts with cysteine residues. In solution this dye is non-fluorescent,
but after reaction with the thiol group of a cysteine, it starts emitting light
at 463 nm (excitation ∼387 nm). Cysteines, buried in the hydrophobic core
of the protein do not react with CPM. However, if the protein denatures, the
originally buried cysteine becomes exposed to the bulk solution and after
reacting with CPM, this will lead to an increase in fluorescence. Naturally,
this method requires for the protein to contain one or more buried cysteines.
In addition, cysteines on the surface of the protein will interfere with the
assay, as in that case CPM can react with folded protein. For MntH2, which
has only one cysteine in its sequence, tests showed that the assay works very
well.
In a first set of conditions the stability of MntH2 was tested at different pHs.
All buffers contained 30 mM MES, 30 mM HEPES, 30 mM CHES, 150 mM
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NaCl and 0.05 % DDM, which covered the whole range of pHs investigated
(6.0 - 9.0). Varying concentrations of glycerol (0 % and 5 %) and magne-
sium (0 mM, 2 mM, 10 mM) were also tested. The influence of these two
compound on protein stability was of interest because glycerol is added to
buffers during protein purification while magnesium, as will be shown later,
is required in SURFE2R experiments. The result of the assay is shown in
fig. 5.17. The figure shows the first derivatives of the melting curves, the
peaks of which correspond to the different melting temperatures. The assay
revealed that of the tested factors, the pH had the largest impact on MntH2
stability. Melting temperatures ranged from 57.9 - 59.6 °C at pH 6.0 to 42.1
- 45.6 °C at pH 9.0. MntH2 was previously found to be most stable at pH
5.5 in an assay using light scattering [193]. The presence of 5 % glycerol
has a minor stabilising effect at lower pH (pH 6.0 and 7.0) but no effect at
pH > 7.0. Finally, the presence of magnesium did not appear to influence
melting curves.
The dependence of MntH2 stability on salt (K+) concentration was also
determined because potassium was used in transport experiments with vali-
nomycin (chapter 6). Two of the conditions in this assay contained 2 mM
EDTA. This was done in case MntH2 remain bound to a metal during purifi-
cation. The results of the second assay are shown in fig. 5.18. It is revealed
that in all conditions the protein has a very similar stability. Neither the
salt concentration nor the presence of EDTA induces a shift of the melting
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Figure 5.17: CPM assay on MntH2. The buffer conditions varied in this assay
included pH (6.0, 7.0, 8.0, 9.0), glycerol (0 %, 5 %) and magnesium (0 mM, 5
mM, 10 mM). The base buffer was 30 mM MES, 30 mM HEPES, 30 mM CHES
and 150 mM NaCl. The figure shows the derivatives of the different melting curves
which have been smoothened in OriginPro using fast Fourier transformation. The
data shows that of the tested parameters, the pH had the largest impact. Curves
from conditions with the same pH have been drawn in two different, but similar,
colours as indicated in the figure legend. The darker of the two colours represent the
conditions where 5 % glycerol was present. The different magnesium concentrations
are indicated by the plot symbols of the data points. The assay was performed with
a concentration of 0.05 mg/mL protein.
point.
A third CPM assay was designed with the goal to optimise the buffer used
for reconstitution. Different detergents were added in a concentration of 1
%. It was examined if different concentrations of glycerol (5 % or 10 %) may
support protein stability during reconstitution. The base buffer for this ex-
periment was 20 mM MES/HEPES/CHES, pH 7.0 and 150 mM KCl. The
assay showed that OGP has an effect that is detrimental to MntH2 stability
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Figure 5.18: CPM assay on MntH2 with varied K+-salt concentrations. The buffer
was 5 mM MOPS at pH 7.0 and salt concentrations were as shown in the figure leg-
end. The figure shows the derivatives of the different melting curves smoothened by
fast Fourier transformation (OriginPro). The stability did not greatly vary between
the different conditions. Each dataset represents the average of three measurements
on the same plate. *In the EDTA sample the salt concentrations was 150 mM KCl.
(fig. 5.19). Stability is improved in Triton X-100 but clearly is highest in
DDM. Raising DDM from 0.05 % to 1 % does not influence thermostability
(compare fig. 5.19 to fig. 5.17). Glycerol does have some stabilising ef-
fect, but it is minor. Glycerol was therefore left out from the reconstitution
buffer.
In the final assay, it was investigated whether the presence of transition
metal ions (i.e. possible substrates) would have any effect on the stability
(fig. 5.20). If a metal substrate binds to its binding pocket, it is likely to
induce a shift in the melting point. In the assay two metal ions, Mn2+ and
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Figure 5.19: CPM assay on MntH2 using different detergents. All detergents were
used in a concentration of 1 % in base buffer (20 mM MES/HEPES/CHES, pH 7.0;
150 mM KCl). Glycerol concentrations were varied as specified in the right figure
legend. The melting temperature was clearly mostly affected by the nature of the
detergent. Including the variability in glycerol concentrations, melting temperatures
were 34.9 - 37.7 °C for OGP, 45.2 - 46.1 °C for Triton X-100 and 52.4 - 54.6
°C for DDM. For each set of conditions in different detergents, the highest melting
temperatures were found in the probes with 10 % glycerol.
Ni2+, were tested at low (1 µM) and high (100 µM) concentrations. This
was done at pH 6.0 as well as at pH 8.0, as binding might be affected by the
pH. The results show that neither metal appears to have a significant effect
on protein stability: Under all conditions tested, the melting point is stable
compared to the samples without metals, although at 100 µM Ni, pH 8.0,
there appears to be a second peak at higher temperature. This may indicate
that in this sample the protein is distributed between two states, but this
possibility has not been further investigated.
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Figure 5.20: CPM assay testing the effect of metal binding at pH 6.0 (black) and
pH 8.0 (red). At neither pH the addition of Mn2+ or Ni2+ at the given concentra-
tion significantly affected the melting temperature. An exception appears to be the
condition of 100µM Ni2+ at pH 8.0. The melting curve of this sample was 49.1 ±
0.5 °C compared to 45.7 ± 0.7 °C measured for the metal free condition. However,
in a successive assay this difference was not confirmed (see text). *For visual rea-
sons this data has been scaled down to match amplitudes with the data for the metal
free condition.
5.8 Tryptophan fluorescence
Due to their aromaticity, tryptophan residues are a natural fluorescent la-
bel in protein with an excitation wavelength of 280 nm. The fluorescence
intensity of tryptophan residues in proteins is strongly dependent on their
environment (polarity/solvent accessibility) in the protein. Conformational
changes of the protein, that alter the environment of a tryptophan residue
can therefore be detected as a change in the fluorescencent signal. This may
be a shift in the emission wavelength or a decrease/increase in fluorescence
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intensity. In MntH2 there is a tryptophan residue, W65, that is right next to
N64, which is part of the conserved metal binding pocket. Therefore it was
possible that metal binding to the protein could be detected via the fluo-
rescence of this tryptophan. However, no change in tryptophan fluorescence
was observed when Ni2+ or Mn2+ in concentrations of up to 100 µM were
added to MntH2. For Cu2+ this assay turned out to be not compatible,
because in experiments with bovine serum albumin (BSA) Cu2+ induced
strong non-specific fluorescence quenching at a concentration of 10 µM.
5.9 Discussion
Even though MntH2 has been purified before this work, the data presented
here shows some interesting new insights. Starting from IMAC chromatog-
raphy, when comparing the two purifications represented in fig. 5.2, a much
higher yield was obtained, when the solubilisation time of inner membranes
was increased. In the first purification a yield of 4-4.6 mg ( from ∼600 mg to-
tal protein) and in the second purification a total yield of 19 mg (from ∼240
mg total protein) was obtained. Even though the yields are not directly
comparable, because the purifications were from different expressions, this
strongly suggests that increasing the solubilisation time leads to improved
yields. It appeared that MntH2 obtained from protocol two was somewhat
less pure than when purified according to protocol one. These impurities,
however, can be removed by SEC, which yields highly pure protein as con-
firmed by SDS-PAGE, SEC-MALS and mass spectrometry.
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In IMAC purifications following protocol two, MntH2 eluted from the col-
umn in two or even three peaks (P1, P2 and P3). It was expected that these
peaks would represent different oligomeric states of MntH2. However, SEC-
MALS data (even though calculated molecular weights were not accurate)
clearly showed that protein from both peaks is monomeric when MntH2
was solubilised in DDM. That there is a difference between P1 and P2 only
shows when MntH2 is solubilised in DMNG, when SEC-MALS data show
that P2 is multimeric. Because mass spectrometry data show that P1 and
two P2 share the same molecular mass it remains unclear what distinguishes
the two forms. Possibly they represent two different states of the protein.
MntH2 was successfully cleaved from its his-tag using HRV-3C protease.
An excess ratio of 2:1 (w/w) protease was enough to cleave more than 80
% of MntH2 within 6 h. Protease was removed by reverse purification on
a Ni-NTA column. The final yield of 4 mg cleaved MntH2 was good, but
it could be further improved. A protocol, where MntH2 is cleaved directly
when bound to the Ni-NTA column, should lead to increased yields, because
it reduces the amount of required steps.
The CPM assay showed that purified MntH2 was folded and stable in a
wide range of conditions. Binding of metal ions to the protein could not be
observed, neither in the CPM nor in the tryptophan fluorescence assay. In
both cases this could be either because the assay is not sensitive enough or
because in detergent micelles the protein adopts a conformation that does
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not bind metals. The latter seems plausible, given that the SLC11 homo-
logue EcoDMT was crystallised in a structure that did not bind any metal
ions [123].
5.9.1 Conclusions
For future purifications of MntH2 I suggest to use the second purification
protocol using a combination of IMAC and SEC. This protocol yields highly
pure protein and the final yield of ca. 4-5 mg (P1 and P2 combined) from
250 mg total protein is very good for a membrane protein. Data from
mass spectrometry, SEC-MALS and CPM assays show that the protein is
intact, monodisperse and thermally stable under various conditions. These
are promising characteristics to perform functional and structural studies
on MntH2, which are presented in the following two chapters.
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Chapter 6
Biophysical characterisation
of Enterococcus faecalis
MntH2
This chapter deals with the biophysical characterisation of the transition
metal transporter Enterococcus faecalis MntH2. MntH2 is a homologue of
the SLC11 (Nramp) family and as such it is hypothesised to be a high-
affinity metal-uptake protein. This property makes it contribute to bacterial
virulence for reasons that have been explained in section 1.7. MntH2 was
chosen as a model protein, to demonstrate the applicability of the SURFE2R
technique to investigate transition metal transport. The procedure, that led
to the selection of MntH2, is presented in section 6.1 followed by an in depth
characterisation of metal transport by MntH2.
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6.1 Selecting a suitable transition metal transporter
To investigate if transition metal transporters can be biophysically charac-
terised with the SURFE2R, a protein had been found that would be suit-
able for that task. A library of proteins was available that has been created
by the Steve Baldwin group in Leeds as part of the MPSIL (Membrane
Protein Structure Initiative Leeds) project. From this library six transi-
tion metal transporters were chosen from three distinct families (table 6.1).
CDF (cation diffusion facilitator) transporters are a family of Me2+/H+ an-
tiporters with Zn2+ and other transition metal ions as substrates [177, 194].
ZIP (Zrt/Irt-like Protein) transporters are involved in uptake of Zn2+ and
Fe2+ [195, 196]. As mentioned, Nramp homologues (MntH2) are supposed
to be responsible for H+-coupled transition metal uptake with a broad sub-
strate specificity, but with Mn2+ being one of the main substrates [135, 147].
The expression protocol for all constructs has been established in previous
work [108, 197] and was performed as described in section 3.10. Because ex-
pression of the different constructs was performed on a small scale (50 mL),
inner membranes were purified by water lysis (section 3.13.2). All constructs
had a his-tag attached and expression was confirmed by Western blotting of
inner membrane samples (fig. 6.1). Five of the six proteins showed up as a
signal in the western blot. Three constructs showed acceptable expression
levels, migrated in SDS-PAGE as a single band and were chosen for further
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MPSIL code Family Organism
63A CDF (SLC30) Escherichia coli K12
67E CDF (SLC30) Corynebacterium diphtheriae
NCTC 13129
294CVH Nramp (SLC11) Enerococcus faecalis V853
295G Nramp (SLC11) Escherichia coli K12
414MBP ZIP (SLC39) Desulfovibrio vulgaris subsp.
vulgaris str. Hildenborough
600DAT ZIP (SLC39) Achromobacter xylosoxidans
Table 6.1: Table of the expression constructs of transition metal transporters ex-
amined. Enterococcus faecalis MntH2 is encoded by the combination 294CVH.
CDF: Cation Diffusion Facilitator family; Nramp: Natural resistance associated
macrophage protein family; ZIP: Zrt/Irt-like Protein family.
Figure 6.1: Western blot on inner membranes containing transition metal trans-
porters. All constructs were stained using HRP conjugated anti-his6 antibody. Over-
expression was performed in E. coli BL21* (DE3) harbouring the plasmid pRARE2
using autoinducing medium.
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study.
6.1.1 SURFE2R experiments using bacterial inner membranes
SURFE2R experiments were performed using bacterial inner membrane ex-
tracts containing the constructs 63A, 294CVH and 414MBP. The inner mem-
branes were not applied in pure form to the sensors, but instead a special sen-
sor preparation protocol was applied. Bacterial inner membranes extracts
containing transport protein, have not been tested successfully in the past
in SURFE2R experiments. The reason for this is unconfirmed, but might
be related to outer membrane fragments in the sample that may hinder the
adsorption of the inner membrane to the surface. The protocol applied here
dilutes inner membrane exctracts with ”pure” lipids and has been estab-
lished for the nucleoside transporter NupC [198]. When inner membrane
vesicles containing NupC were mixed with liposomes by tip-sonication, up-
take signals due to NupC could be observed in SURFE2R experiments. Here,
inner membranes containing transition metal transporters were treated as
described in section 3.21.1.
To screen for a signal, the transition metal ions Mn2+, Zn2+ and Co2+ were
tested as a substrate for the three transporters. The signal obtained with
63A and 414MBP was very small, or absent, but a signal was observed for the
construct 294CVH (fig. 6.2). Besides testing different substrates, the signal
was recorded at varying buffer pH and compared to signals from control
experiments, set up using samples from inner membranes of E. coli BL21*
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Figure 6.2: SURFE2R experiments on mixed inner membrane samples. The dif-
ference of the MntH2 sample to the control is significant, but the amplitude of ca.
150 pA is too low for biophysical characterisation using SURFE2R experiments.
bacteria (fig. 6.3). Importantly, the signal-to-noise was too low to conduct
experiments for biophysical characterisation. To improve signal amplitudes,
samples of purified MntH2 (294CVH) reconstituted in proteoliposomes were
tested.
6.2 Reconstitution of MntH2
As with expression and purification, a protocol for reconstitution of MntH2
has been described previously [154]. The original method starts by dissolv-
ing lipids to a micellar suspension by adding OGP in a sufficiently high
amount (see section 3.17.1 for details). The membrane protein in deter-
gent solution is added to that mixture and proteoliposomes are generated
by slowly removing the detergent by adding hydrophobic polystyrene beads
(bio-beads) that absorb the detergent.
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(a) Control with mixed inner mem-
branes from E. coli BL21*.
(b) Mixed inner membrane sample
with MntH2 (294CVH)
Figure 6.3: Peak amplitudes of SURFE2R experiments with varying conditions on
mixed inner membrane samples. Of the four repeats of each condition, the first two
were performed with 50 µM- and the other two with 100 µM substrate.
The protocol for MntH2 reconstitution was optimised during the course of
the project. Modifications were made after a protein stability assay (CPM
assay, section 5.7, fig. 5.19) showed that OGP destabilises MntH2 compared
to other detergents, such as Triton X-100 and DDM. To minimise potential
loss of protein, DDM was used as DDM is the detergent in which the protein
was most stable. Reconstitutions in DDM, or other detergents with a low
CMC, are slightly more complicated than reconstitutions in OGP, which
has a relatively high CMC. In a publication on the reconstitution of ABC-
transporters in Triton X-100, Geertsma et al. [184] give their suggestions of
general guidelines to establish a reconstitution protocol in a low CMC de-
tergent. These suggestions have been followed here. Unilamellar liposomes
are prepared by extrusion and saturated with detergent (or slightly oversat-
urated). An important parameter to determine is the right concentration of
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detergent to use. The saturating concentration is determined by titrating a
concentrated detergent solution to the proteoliposomes and monitoring the
OD540. The concentration at which the OD540 reaches its maximum should
be the saturating concentration. This experiment has been done here using
liposomes (200 nm) of E. coli ’polar’ lipids and titrating DDM in steps of
0.05 - 0.1 %. Contrary to expectations, the graph showed no maximum
and therefore no saturating concentration could be determined (fig. 6.4).
Because the titration experiment did not inform on a suitable DDM con-
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Figure 6.4: DDM titration of liposomes from E. coli polar lipids prepared by ex-
trusion (200 nm). After each titration step the sample was left to equilibrate for
at least 1 min. With increasing concentrations of DDM the OD at 540 nm steadily
decreased and no maximum was observed. Therefore a saturation radius could not
be determined.
centration to use, three reconstitutions were performed in parallel, using
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different DDM starting concentrations of 0.2 %, 0.5 % and 1 % DDM. To
determine which concentration works best, samples of the three reconstitu-
tions were tested in SURFE2R experiments. The reconstitution which has 1
% DDM, showed a significantly larger current than the other two samples.
Consequently, all reconstitutions were performed with 1 % DDM and re-
sults shown in this thesis have been obtained from proteoliposome samples
following the DDM reconstitution, unless specified otherwise.
6.3 SURFE2R experiments on MntH2
6.3.1 Background Signals
In experiments with the SURFE2R care has to be given to background sig-
nals due to solution exchanges on the sensor surface. The redistribution of
charges on the SSM leads to a capacitive current response. This solution
exchange artefact is usually not a great concern when uncharged substrates
are used that do not interact with the SSM. In contrast, the problem be-
comes more severe with transition metals, as these carry a twofold positive
charge and metals can interact with the polar phospholipid head groups of
the SSM. This may lead to serious background signals. A strategy to re-
duce these artefacts is to ”saturate” the SSM with Mg2+ ions. Mg2+ ions
can prevent transition metal ions from binding non specifically to the phos-
pholipids. To experimentally test the effect of Mg2+ ions, a control sensor
(liposomes from E. coli polar lipids) was prepared and the amplitude of the
solution exchange artefact of 1 mM Ca2+ was measured as a function of
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Mg2+ concentration in the buffer (fig. 6.5). Without any Mg2+, the am-
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Figure 6.5: Solution exchange artefact from Ca2+ ions in SURFE2R experiments.
The figure shows the amplitude of the solution exchange artefact of 1 mM Ca2+
on a control sensor with liposomes from E. coli polar lipid extract as a function of
Mg2+ concentration in the buffer. The components of the base buffer were 25 mM
Tris, pH 8.0 and 150 mM NaCl.
plitude of the artefacts was high with a maximum current of more than 1
nA. 2 mM Mg2+ already reduced the amplitude to almost 50 %. Adding
more Mg2+ further reduced the amplitude up to a concentration of 20 mM,
after which no further decrease was observed. However, sensors with > 10
mM Mg2+ appeared to have a shorter lifetime than sensors with only 2 mM
Mg2+, so it was decided to use 2 mM Mg2+ as the working concentration in
all buffers.
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6.3.2 The valinomycin control experiment
A problem concerning SURFE2R experiments is that the background varies
for each individual sensor and cannot always be accurately determined from
experiments with control liposomes. One way to determine background
would be to add an inhibitor to the sensor, completely stopping protein
activity. A second way to eliminate the protein specific signal was developed
here and comprises the use of valinomycin. When valinomycin is added to
a sensor containing K+ ions, the activity of the valinomycin transporting
K+ ions down the electrical potential gradient will cancel the electrometric
signal from the protein. This is shown in fig. 6.6 for the example of the
nucleoside/H+ symporter NupC. Cancellation of the electrometric signal
will occur if K+ transport activity is faster than transporter activity (e.g.
from NupC or MntH2). It was observed that 1 µM valinomycin in 150 mM
KCl is able to fully cancel transport signal in the order of 1 nA.
6.4 SURFE2R experiments with MntH2 proteoli-
posomes
Before activity of MntH2 in proteoliposomes was measured on the SURFE2R,
it was known that proteins of this family have been found to be most active
at pH 5.5-6.0 ([142], [199]). It was also known that the protein has been
reported to be most stable at pH 5.5 [193] and fluorescence experiments
measuring Zn2+ transport in stopped-flow experiments were obtained at pH
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Figure 6.6: Effect of valinomycin on NupC currents in SURFE2R experiments.
In buffer containing 150 mM KCl the presence of 1 µM valinomycin leads to al-
most complete inhibition of the NupC current, even though NupC does not trans-
port potassium (red trace). Evidently, any potential gradient built up from NupC
H+ symport is immediately dissipated by counter transport of K+ by valinomycin.
When KCl is replaced by NaCl in the buffer, the signal reappears, confirming that
valinomycin does not interfere otherwise with NupC activity.
6.8 [154]. Therefore it was surprising that when activity of MntH2 was
tested as a function of pH, highest activity was observed at pH ≥ 7.5. The
conditions under which the most ”robust” signal is obtained was at pH 8.0
with an activating buffer containing 100 µM Mn2+ (fig. 6.7). For prolonged
experiments it is not advisable to measure MntH2 currents at pH ≥ 8.0
because the stability of the protein decreases at high pH (fig. 5.17). PH
dependencies of the signal are shown in fig. 6.8a for uncleaved MntH2 and
in fig. 6.8b for MntH2 where the his-tag was cleaved (section 5.6.3). Both
pH profiles in fig. 6.8 look similar, indicating that the pH dependency of the
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signal is not influenced by the his-tag. Before each experiment at different
pH, the sensor was rinsed with 1 mL buffer, followed by a waiting time of
900 s. This was to make sure, that the buffer pH between in- and outside of
the proteoliposomes on the sensor surface was equilibrated before the start
of the experiment. The waiting time in between experiments at the same
pH was 300 s. The experimental sequence was performed in two directions,
that is from low to high pH and vice versa (fig. 6.8a). At pH 6.0 almost no
signal is seen and the amplitude increases with increasing pH.
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Figure 6.7: SURFE2R measurement of reconstituted MntH2 (LPR 1:10; uncleaved)
activated by 100 µM Mn2+ at pH 8.0. These conditions were used as a standard for
experiments with MntH2. Buffer: 10 mM MES/HEPES/CHES, pH 8.0; 140 mM
KCl; 2 mM MgCl2. A after two seconds results in a peak in the opposite direction
due to reverse transport of the substrate. The trace is representative for experiments
from three biological replicates.
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(a) PH profile for uncleaved MntH2.
The sample used in this experiment
was reconstituted in OGP. Buffer: 10
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(b) pH profile for his-tag cleaved
MntH2. Currents represented in this
figure were corrected for background,
as determined by valinomycin (6.3.2).
Buffer: 5 mM MES/HEPES/CHES;
150 mM KCl; 2 mM MgCl2.
Figure 6.8: pH dependency of Mn2+-currents for uncleaved and cleaved MntH2.
Both profiles look similar. In fig. 6.8a the experiment was performed in both direc-
tions (started at low pH and moving to high pH and vice versa) to eliminate the
possibility of a bias due to the sequence in which buffer pHs are changed. Errorbars
are representative of four measurements on the same sensor.
6.4.1 Experiment with different LPRs
Here, the effect of different lipid to protein ratios (LPRs) is tested. The
idea of the experiment is to prove that the observed signal is due to ion
transport: In case of transport the signal is expected to be broadened with
a decreasing LPR as at a low LPR, substrate uptake should be slower. This
leads to lower currents and an increased decay time of the signal. In prac-
tice, this has been shown to hold true for LacY, where proteoliposomes with
LPRs of 1:5 and 1:10 were used to demonstrate lactose transport [200]. For
electrogenic events other than transport (conformational change or electro-
genic substrate binding), the decay time is expected to be independent of
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the LPR.
MntH2 was reconstituted at LPRs of 1:5, 1:10 and 1:20. A BCA assay was
performed to confirm that the LPRs after reconstitution are as expected.
LPRs of 1:5, 1:11 and 1:20 were determined, assuming no lipids were lost
during reconstitution. In SURFE2R experiments all samples produced a
similar signal. Neither the amplitude, nor the decay time of the signal var-
ied greatly between sensors (fig. 6.9). This behaviour is atypical, because
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Figure 6.9: Mn2+-induced currents of MntH2 as a function of the LPR. His-tag
cleaved MntH2 was used for this experiment. The decay phase of the currents is not
influenced by the LPR, which would be expected if the signal represents transport.
As discussed in the text, the reason for this could be, that the signal may represent
only one single turnover. The highest amplitude is seen for the LPR 1:10, which
was used throughout this thesis. The control was performed with empty liposomes
that were prepared in the same reconstitution along with the proteoliposome samples.
Traces are representative for four measurements on the same chip. Buffer: 10 mM
HEPES, pH 8.0; 150 mM KCl; 2 mM MgCl2.
regardless of the origin of the signal, the amplitude should be higher at a
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high LPR (even though the amplitude is also dependent on the sensor cover-
age). Consequently, this result neither confirms nor disagree with substrate
transport. I hypothesise this behaviour is related to the very small space
available in the lumen of proteoliposomes: In proteoliposomes with a di-
ameter of 200 nm, a concentration of 100 µM Mn2+ corresponds to a total
number of only ca. 250 Mn2+ ions. In the same proteoliposome, with an
LPR of 1:20, the number of MntH2 is ca. 250 as well, estimated using a
surface area per lipid of 0.6 nm2. Therefore, even at the lowest LPR, one
turnover of each protein is enough to bring the Mn2+ concentrations to equi-
librium. Especially since a build up of an electrochemical gradient might
stop transport before the inside concentration reaches equilibrium with the
outside. In case of LacY experiments, a substrate concentration of 10 mM
has been applied, which allows for more turnovers of the protein before the
equilibrium is reached [200].
6.4.2 Substrate profile and KM of different metals
Of the first row transition metals, it was found that besides Mn2+, Co2+
and Zn2+ are substrates of MntH2. In addition, the toxic Cd2+ ion, of the
second row transition metals, was identified as a substrate. Other transi-
tion metal substrates that were tested, which included Fe2+, Ni2+ and Cu2+
did not show transport activity and neither did the earth-alkali metal ion
Ca2+. The summary of these results is shown in fig. 6.10 as a barplot: The
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bars represent the average of four measurements (technical repeats) using
100 µM substrate at pH 8.0. The experiments for the transported cations
(Mn2+, Co2+, Zn2+, Cd2+) have all been recorded on the same sensor. The
data of Fe2+ and Ca2+ has been added by normalisation to Mn2+ activity.
To determine the KM of substrates, the peak amplitude was measured as
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Figure 6.10: Relative peak currents obtained with 100 µM of different transition
metals. Currents of transported substrates (Zn(II), Mn(II), Co(II), Cd(II)) were all
recorded on the same sensor where each measurements was repeated four times. The
errorbars represent standard errors with a confidence intervall of 95 %. *Fe(II) and
Ca(II) currents were recorded on a different sensor and amplitudes were calculated
by normalisation to Mn(II) currents recorded on this sensor. Fe(II) currents were
recorded in the presence of 1 mM of ascorbic acid in order to prevent oxidation to
Fe(III).
a function of substrate concentration (fig. 6.11). This experiment was per-
formed for Mn2+, Co2+ and Zn2+, as well as for Ca2+ as a control, with
substrate concentrations varying between 0 and 200 µM. As an additional
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control, the same experiment was performed on a sensor with empty lipo-
somes (using Mn2+). The peak current showed very similar dependency for
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Figure 6.11: Peak currents plotted as a function of Mn2+, Co2+ and Zn2+ con-
centrations. As controls, the equivalent data obtained from measurements with a
cation that is not transported (Ca2+) is shown as well as a control of data with
Mn2+ currents obtained on a different sensor with empty liposomes devoid of pro-
tein. Data is shown as mean ± SEM of four measurements on the same chip. Data
is representative for one (Ca2+), two (Zn2+ and Co2+) or three (Mn2+) biological
replicates.
all transported cations on substrate concentration. This dependency did not
follow Michaelis-Menten-type behaviour, but was more linear. Because the
data does not plateau, it is not possible to mathematically determine a KM
for this data. Even so, a lower limit of a KappM of 50 µM can be estimated.
This is considerably higher than would be expected, because, as discussed,
the physiological concentrations of these transition metals are in the range of
nano- to low micromolar. There are different reasons why this could be the
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case and I propose that the lack of an electrochemical gradient in SURFE2R
experiments leads to an increase in the apparent KM . This possibility will
be discussed in more detail in the section about MntH2 cotransport (sec.
6.5). For Mn2+ the experiment was also repeated for cleaved MntH2 (see
appendix fig. A1a).
6.4.3 Inhibition experiments with non-transported metals
Given that some of the transition metal ions do not appear to be transported,
it was tested how the presence of these ions influences Mn2+ transport. Ex-
periments were performed where 100 µM of Cu2+, Ni2+ or Fe2+ were present
throughout the experiment while 100 µM Mn2+ was a constituent only of
activating buffer. The results showed that Ni2+ and Cu2+ strongly inhib-
ited Mn2+ uptake. In case of Ni2+ the inhibition was fully reversible, eg.
when Ni2+ was washed out of the system, Mn2+ uptake signals would re-
turn to previous amplitude. In contrast, when inhibition was performed
with Cu2+ the signal would recover only very slowly (incubation overnight)
and often the amplitude would remain lower (ca. 70 %) than before inhibi-
tion. Only when Cu2+ was washed out with 10 mM EDTA the signal would
recover close to its initial amplitude. This suggests that Cu2+ binds very
tightly and specifically to the protein, likely in the same site as Mn2+ (i. e.
competitive inhibition), although this was not experimentally verified. In
tryptophane fluorescence experiments, Cu2+ binding could not be confirmed
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due to its property of unspecific fluorescence quenching (section 5.8). Fe2+
did not cause a significant effect on the signal and therefore does not appear
to interact with the metal binding site of the protein.
In order to demonstrate that inhibition of MntH2 is not caused by interac-
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(a) Influence of 100 µM of non-
tranported metal ions on Mn2+ cur-
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(b) (Ir)-reversibility of Cu2+ inhi-
bition. After MntH2 was inhibited
with Cu2+, Mn2+ currents would not
return when no Cu2+ is added to
buffers in the following experiment.
Only after the sensor is washed with
10 mM EDTA, the amplitude would
come back. For this experiment un-
cleaved MntH2 was used.
Figure 6.12: Inhibition of MntH2 with non-transported transition metal ions. Data
in (a) and (b) is representative for two independent experiments on different sen-
sors. In addition (a) was repeated with his-tag cleaved MntH2 (fig. A1b).
tion of Ni2+ or Cu2+ with the his-tag, the previous experiment was repeated
with his-tagged cleaved MntH2. This data is shown in the appendix (fig.
A1b).
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6.5 MntH2 cotransport
6.5.1 Influence of Cation and Anion composition in buffers
In summary, the experiments so far have shown that MntH2 transports
Mn2+, Cd2+, Zn2+ and Co2+ and that it is inhibited by Ni2+ and Cu2+.
Next, it was attempted to get an understanding of the cotransport in MntH2.
Although it is generally believed that MntH proteins are proton symporters
[199, 201–204], there is only one publication so far that investigates of this
aspect with purified protein [123]. In order to exclude that other mono-
valent cations (Na+ or K+) are involved in cotransport, experiments were
carried out with buffers containing either 150 mM NaCl or 150 mM KCl,
respectively. Mn2+-induced currents were the same in both buffers which
confirmed that neither Na+ or K+ is the cosubstrate (fig. 6.13). As an
alternative, it was considered, if chloride ions are used as a cosubstrate.
This may seem unlikely, but it has been suggested in previous work that
anions might have a role in SLC11 cotransport [205]. This hypothesis came
from the observation that 55Fe2+ uptake into oocytes expressing DCT1 was
strongly reduced when chloride was replaced by gluconate in the medium.
Consequently, here experiment were conducted where chloride was replaced
by gluconate in all buffers. It turned out that indeed, in gluconate buffer
the signal was strongly suppressed (fig. 6.14). However, replacing chloride
by sulfate did not lead to any alteration of the signal. Because it seemed
155
Biophysical characterisation of Enterococcus faecalis MntH2
time (s)
cu
rr
e
n
t (n
A)
0 0.2 0.4 0.6 0.8 1
−
0.
2
0.
0
0.
2
0.
4
0.
6
K+−Buffer
Na+−Buffer 
Figure 6.13: MntH2 transport dependency on cationic buffer salt component. Mn2+
induced currents do not change when the salt component of the buffer is exchanged
from 150 mM KCl to 150 mM NaCl. The conclusion is that MntH2 transport is
neither K+ nor Na+ dependent. The data is representative for four measurements
on the same sensor.
unlikely that chloride and sulfate could be involved in the same transport
mechansim, the hypothesis that anions are involved in cotransport was re-
jected. There are other reasons why the signal could be suppressed in glu-
conate buffers. One of them is that gluconate at this high concentration
might complex the metal ions.
6.5.2 H+ cotransport
Experiments with pH gradient
Given the results from the experiments described in the previous section, H+
is still a likely cosubstrate in MntH2 transport. However, the difficulty in
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Figure 6.14: Impact of anions on Mn2+ currents. Salt components in buffers for
the different experiments were 1): 150 mM KCl, 2 mM MgCl2+, 100 µM MnCl2;
2): 150 mM NaGlu, 2 mM MgGlu2, 100 µM MnGlu2; 3): 30 mM K2SO4, 2 mM
MgSO4, 100 µM MnSO4. The buffer was 10 mM HEPES, pH 8.0. Mn
2+-currents
are suppressed in Glu−-buffer but are not affected in SO4-buffer. The data is rep-
resentative for four measurements each on two different sensors.
showing H+ cotransport is that it cannot simply be removed from buffers.
One experiment that can be done on the SURFE2R, is to generate a pH
gradient and study its effect on metal transport. This can be achieved
by adding a third buffer to the workflow and following a protocol similar
to the one applied for TRPM2 (section 4.2). A pH gradient in the same
direction should promote Me2+ transport, whereas a pH gradient opposite
to the transport direction should hamper it. A problem with establishing
a pH gradient in SURFE2R experiments is that buffers with different pHs
show very large signals upon solution exchange affecting the measurement.
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For this reason it difficult to create a gradient of more than 0.5 pH units.
Experiments were performed with buffers at pH 8.0 and 8.5. No difference
in amplitudes could be determined between experiments where the pH was
low on the inside or where it was low on the outside (fig. 6.15). Proton
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Figure 6.15: SURFE2R experiments on MntH2 making use of a pH gradient. If
MntH2 is a H+ symporter, a proton gradient in either direction should have an
influence on the magnitude of the currents. The results show that regardless of the
direction of the gradient the amplitude does not change. The black and grey trace
were recorded without pH gradient and can be barely seen, because they are almost
identical to the black and red trace. The experiment was repeated on two different
sensors.
symport could therefore not be confirmed in these types of experiments.
Experiments with the protonophore CCCP
A further method that allows observing proton (co)-transport in SURFE2R
experiments involves using a protonophore. In case of MntH2, if H+ is a co-
substrate, the electrometric currents will result from a combination of Mn2+
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and H+ transport. Adding a protonophore, like CCCP (carbonyl cyanide
m-chlorophenyl hydrazone), to the sensor changes the proton permeability
of the proteoliposomes, which should lead to an alteration of the signal.
To illustrate this effect, experiments were first performed with CCCP and
NupC. NupC is a bacterial nucleoside/proton-symporter for which proton
symport has previously been experimentally verified (Fig. 6.16B; [198]). In
case of NupC, the addition of CCCP clearly led to a decrease in amplitude
and importantly in width. This is expected as CCCP will dissipate any
proton gradient very soon after transport starts. The leak current will then
equalise the NupC pump current, which leads to a fast decrease in signal and
explains the narrowing of the peak. The amplitude of the peak current (at t
= 0), in theory, is not affected by the increased membrane conductivity. The
peak current is recorded immediately after the start of substrate transport
before an electrochemical potential gradient has built up and therefore leak-
ing is not yet significant [172, 206]. In practice, however, the peak current
will decrease due to the time required for solution exchange.
In contrast to NupC, no change was observed upon addition of CCCP to
MntH2 (fig. 6.16A). This result strongly suggests that there is no contribu-
tion from proton flux to the signal.
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(a) The presence of 3 µM CCCP in
buffers A and B did not alter MntH2
currents, suggesting that protons do
not contribute to the signal.
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(b) Control with NupC currents. To
test the effect of CCCP on proton
currents, the experiments were per-
formed under the same conditions
as in A with the Adenosine/H+
symporter NupC. The presence of
CCCP clearly leads to a a decrease
in amplitude and narrowing of the
proton-current, providing evidence
that under these experimental con-
ditions CCCP does increase proton-
permeability of the membranes.
Figure 6.16: Impact of the protonophore CCCP on SURFE2R signal from different
proteins. Data in (a) is representative for experiments on three different sensors.
The experiment in (b) was performed on a single chip.
6.6 Fluorescence Spectrometry
6.6.1 Proton transport assay using HPTS
Because in SURFE2R experiments no signs of H+ cotransport were detected,
proton transport was monitored with a different method. In a fluorescence
based method, the proton sensitive dye 8-Hydroxypyrene-1,3,6-trisulfonic
acid trisodium salt (HPTS) was encapsulated in proteoliposomes containing
MntH2. HPTS is a ratiometric dye: The emission is detected at 510 nm
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but the dye is excited at two different excitation maxima at 400 and 448
nm. The ratio in fluorescence intensity is sensitive to the pH of the solution.
This ratio was measured as a functions of pH to get a calibration curve. The
calibration curve was measured with 0.5 µM of HPTS in assay buffer (5 mM
MOPS; 150 mM KCl) with pH varying between 6.0 and 8.0. The ratio is
not linear with pH but is following a Boltzmann equation (eq.6.1).
y =
A1 −A2
1 + ex−x0/dx
+A2 (6.1)
The Boltzmann equation yields four parameters (A1, A2, x0 and dx) and
adequately fits the calibration data (fig. 6.17).
When measuring proton transport into proteoliposomes, it has to be made
certain that the proteoliposomes are sufficiently tight. This is important for
transported protons not leaking back on a shorter time scale than is rele-
vant for the measurement. A protocol to make proton tight liposomes has
been introduced by Tsai and Miller [207]. The main finding of these authors
was that a lipid composition of 3:1 POPE/POPG showed a much higher
resistance to proton leaks than other lipid compositions, including E. coli
polar lipid extract. In addition, the authors noticed that proton leakage was
strongly dependent on the protein content in the vesicles: Proteoliposomes
with a protein content higher than 15 µg protein/mg lipid, proton leakage
became much more significant.
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Figure 6.17: HPTS fluorescence in solution as a function of pH. The ratio of
fluorescence intensities at 510 nm from excitation at 448 and 440 nm was measured
at five different pH in assay buffer (5 mM MOPS, pH 7.0; 150 mM KCl) with a
concentration of 500 nM HPTS. The calibration curve is obtained by fitting the data
to a Boltzmann equation.
However, when test experiments with liposomes were reproduced in this
thesis, liposomes prepared from E. coli polar lipids were observed to be less
leaky than those prepared from POPE/POPG. Hence, the natural E. coli
polar lipids were preferred to the synthetic lipid combination.
The experiment was performed at pH 7.0 and pH 8.0 using a low buffer
strength, in order to make sure that transported protons would have an ef-
fect on the pH. After adding Mn2+ at different concentrations, a control was
performed by adding HCl followed by the H+/K+ exchanger nigericin (fig.
6.18A). This was to reassure that the proteoliposomes under investigation
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are sufficiently resistant to proton leaking.
The results shown in fig. 6.18 have been recorded at pH 7.0. The con-
condition
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Figure 6.18: Examination of MntH2 proton cotransport in fluorescence assays using
the proton sensitive dye HPTS. A: Experiment at pH 7.0. Addition of up to 1 mM
Mn2+ did not lead to a decrease of the pH inside the liposomes. The addition of
HCl (0.5 µM) followed by the K+/H+ exchanger nigericin (0.1 µM) served as a
control to show that proteoliposomes were sufficiently tight to protons to perform
the assay. Points are the average from data recorded for 3x30 s with 30 s break in
between. Buffer: 5 mM MOPS, pH 7.0; 150 mM KCl.
clusion was the same as for experiments performed at pH 8.0: The data
shows no indication of H+ symport. This confirmed the results from the
SURFE2R experiments. Consequently, it is proposed that MntH2 works as
a uniporter and does not require a cosubstrate for transport: The driving
force for metal transport is provided by the electrochemical gradient only,
where the twofold positive charge of the metal ions will cause them to be
strongly attracted towards the negative potential inside the bacteria. When
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evaluating equation (1.2), assuming a membrane potential of -70 mV and a
concentration gradient of 100x more substrate inside, the free energy is still
negative by ca. 2.1 kJ. This shows that at least from a thermodynamic point
of view MntH2 could transport its substrate even against a large concentra-
tion gradient. This is especially the case when considering that inside the
cell, the largest part of the Mn2+ is likely to be bound by proteins or small
ligands and therefore removed from the equilibrium of MntH2 transport.
In line with the above considerations, the focus was on finding a method
that could establish the importance of the electrical potential on MntH2
transport. For this purpose two techniques could be considered: One possi-
bility was to use the SURFE2R and perform experiments similar to the ones
described in section 6.5.2 with the difference of using an electrical- instead
of a pH gradient. The electrical gradient can be established by the use of
valinomycin. It will be mentioned in the discussion to this chapter that
these experiments failed due to technical problems. The second possibility
was to perform fluorescence based measurements using a metal sensitive dye.
The results from these experiments will be presented in the following two
sections of this chapter.
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6.7 Fluorescence assays of MntH2 metal ion trans-
port
To assay metal ion transport in MntH2 it was required to decide on a suit-
able dye first. The dye calcein was chosen, because it is sensitive to a variety
of different metal ions, including Mn2+, Ni2+ and Co2+. Calcein had the
additional advantages that it is stable at room temperature and notably has
been employed in functional studies on the two SLC11 homologous proteins
of which the structure has been solved [122, 123]. A drawback of calcein
is that it is not sensitive at pH 8.0, where the highest activity was seen
in SURFE2R experiments. As a consequence, the pH of the assay buffer
was chosen to be 7.0. The sensitivity of calcein towards different metals
was tested first in solution of the assay buffer (5 mM MOPS, pH 7.0; 150
mM KCl). The results confirmed the metal sensitivity of calcein, where the
response towards Ni2+ ions is greater than for Mn2+ ions at the same con-
centration (fig. 6.19). Co2+, Ca2+ and Cu2+ have been tested as well. The
sensitivity of the former two metals was similar to that of Mn2+, whereas
Cu2+ completely quenched calcein fluorescence already at a concentration
of 10 µM (data not shown).
The next step was to show that control vesicles devoid of protein do not
allow transition metals to leak in. This test was performed with Mn2+,
Ni2+, Ca2+ and Cu2+ (6.20). As expected, the liposomes were clearly im-
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Figure 6.19: Quenching of calcein dye in solution as a function of metal ion con-
centration. A: Quenching in response to Mn2+. B: Quenching in response to Ni2+.
The comparison shows that the dye is more sensitive to Ni2+ than to Mn2+. Buffer:
5 mM MOPS, pH 7.0; 150 mM KCl.
permeable towards Mn2+, Ni2+ and Ca2+, but not to Cu2+. The latter was
quenching calcein fluorescence already at a concentration of 10 µM, indicat-
ing that Cu2+ could not be used in these studies. To determine the maximal
fluorescence response of the calcein loaded vesicles, the Me2+/H+ exchanger
calimycin was added. After addition of 0.5 µg/mL calimycin, the fluores-
cence drops as the metal ions equilibrate with the inside of the liposomes.
It was noted that the performance of the calimycin varies between metals
and is less effective for Ni2+-transport (fig. 6.20).
Time dependent metal ion uptake into MntH2 proteoliposomes are shown
in fig. 6.21. The time resolution in these experiments was between ca. 10 -
20 s (the time required to take out the cuvette from the instrument, inject
the sample and put the cuvette back in). Each of the tested metals was
added at a concentration of 100 µM to proteoliposomes with an LPR of
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Figure 6.20: Quenching of calcein dye inside lipsomes by different metal ions.
When metal ions are added at a concentration of 100 µM to liposomes, that have
calcein encapsulated, the fluorescence is greatly affected. The exception is Cu2+,
which almost completely quenches calcein fluorescence already at a concentration of
10 µM. When the Me2+/H+ exchanger calimycin (0.5 µg/mL) is added (asterisk
symbols), calcein fluorescence drops indicating metal induced quenching.
1:50. An exception to this was the experiment with Zn2+, which does not
quench calcein fluorescence. The method to detect whether Zn2+ interacts
with the protein is by investigating how the presence of Zn2+ affects uptake
of Mn2+. The procedure for this was adapted from Ehrnstorfer et al. [122]
and accordingly 1 mM of Zn2+ was added to the sample at the start of the
experiment. In the experiment calcein fluorescence was quenched upon ad-
dition of either Mn2+ or Ni2+. While the former was expected as it confirms
Mn2+ transport, the latter was more of a surprise, given that in SURFE2R
experiments, Ni2+ inhibited Mn2+ induced currents. An explanation for
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this can be found by closer inspection of the results in fig. 6.21. It can
be seen that Ni2+ uptake occurs at a much slower rate than Mn2+ uptake.
In SURFE2R experiments the peak amplitude is proportional to the speed
of uptake, which can be the reason why Ni2+ transport does not show up
as a current, but instead acts as a competitive inhibitor. The effect would
be similar to that of Zn2+ in the fluorescence experiment. The presence of
Zn2+ interferes with Mn2+ uptake, demonstrating that Zn2+ interacts with
MntH2, even though from the fluorescence data alone it cannot be concluded
whether Zn2+ is transported or is an inhibitor. The last cation used in this
assay was Ca2+. As expected, Ca2+ is not transported.
The calcein assay was repeated to test the concentration dependent re-
sponse of Mn2+ and Ni2+. The dose dependent initial velocity of the flu-
orescence quenching can be used to determine the Michaelis constant of
transport, as described in section 2.5.1. Because of the low time resolution
of the assay, proteoliposomes were prepared at different LPRs (1:70, 1:90,
1:110). Ni2+ uptake, which was expected to be slow, was measured at the
highest LPR of 1:70 (fig. 6.22A). Because calcein fluorescence is sensitive
to Ni2+, the response was measured starting from a low concentration of 1
µM up to 100 µM. For Mn2+, a faster uptake was expected, and therefore
measurements were performed with the LPR 1:110 proteoliposomes. Mn2+
uptake was measured at concentrations between 10 and 200 µM (fig. 6.22B).
In both experiments a clear dose-dependence of the calcein quenching was
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Figure 6.21: Time dependent measurement of metal ion uptake into proteolipo-
somes with encapsulated calcein dye. The first vertical dashed line represents the
addition of 100 µM of the corresponding metal ion (colours indicated in figure leg-
end). In the special case of Zn2+, at this point 100 µM Mn2+ is added, because
calcein is insensitive to Zn2+. Instead Zn2+ is present in an excess concentration
of 1 mM in the background during the whole experiment. Addition of 100 µM Ni2+
or 100 µM Mn2+ leads to quenching of calcein fluorescence indicating metal ion
uptake. The presence of excess Zn2+ interferes with Mn2+ uptake, which suggests
that Zn2+ is either transported, or is an inhibitor of MntH2. Ca2+ is not trans-
ported. The second dashed line represents the addition of calimycin (slightly delayed
for Ca2+), which is to determine the maximal quenching to be observed.
observed. To determine the initial velocities vi, the data from the first 20 s
of metal uptake were fitted to a straight line. The slope of that line was used
as the estimate for the quantity vi. From these quantities a KM value of 14
µM was obtained for Ni2+ uptake by using the Michaelis Menten equation
(eq. 1.5, fig. 6.22C). For Mn2+ not enough data was available to perform
such a fit. Initial velocities plateaued already at 50µM Mn2+ which would
suggest a KM << 50 µM.
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To get a better time resolution it was decided to repeat the experiments on
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(a) Ni2+-uptake measured by quench-
ing of calcein dye.
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(c) Michaelis fit of Ni2+ uptake.
Figure 6.22: Concentration dependent quenching of calcein in metal uptake assays.
Calcein dye was incapsulated into proteoliposomes with MntH2 at LPRs of 1:70 (a)
and 1:110 (b). Arrows in (a) and (b) indicate addition of metal (t ∼ 250 s) and
calimycin (t ∼ 750 s). The initial velocities vi were obtained by a linear fit to the
first 20 s of data recorded after Ni2+ addition. vi at 200 µM Ni
2+ was assumed
to be the maximum velocity vmax. (c): Michaelis Menten fit (eq. 1.5) of the data
extracted from (a). The estimated KM value from this fit was 14 µM. Experiments
in (a) and (b) were performed just once.
a stopped flow apparatus.
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6.8 Fluorescence transport assays using the stopped
flow
Fluorescence transport assays on the stopped flow apparatus work in prin-
ciple the same as the assay described in the previous section. The difference
is that this approach yields a much higher time resolution which is in the
order of ca. 1 ms for the apparatus used here. Measuring at such low time
resolution has some practical consequences. An important one to consider
is, that integration times to accumulate fluorescent signal are much shorter
in stopped flow experiments lowering fluorescence intensity and increasing
noise.
Before measuring metal uptake by MntH2, it had to be evaluated what the
maximal response of the system (Fmax) would be, to make sure that the
assay had a high enough sensitivity. To determine Fmax, calimycin induced
Mn2+ uptake into control liposomes was measured. It turned out, that when
liposomes were prepared according to the same protocol as they have been
for the experiments on the fluorimeter, there was almost no response seen in
stopped flow experiments. To resolve this issue, the protocol was changed
in the step to remove the external dye: Instead of using dialysis, dilution of
residual dye in the bulk was achieved in steps that included ultracentrifu-
gation. By this change the protocol is accelerated by ca. one day. This
appeared to make a big difference as now calcein quenching could be clearly
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observed in control experiments. MntH2 proteoliposomes were prepared in
LPRs of 1:30, 1:70 and 1:110 together with control liposomes. However,
neither sample containing MntH2 showed any uptake of Mn2+ in these ex-
periments (fig. 6.23). Only when Mn2+ was added together with calimycin,
fluorescence quenching was observed, which occurred to a similar degree as
in control liposomes.
Naturally, it was tested whether the samples used in the stopped flow exper-
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Figure 6.23: Transport assay with incapsulated calcein vesicles on the stopped flow.
One syringe was loaded with 200 µM Mn2+ in assay buffer (5 mM MOPS, pH 7.0;
150 mM KCl) either without (black) or with 1 µg/mL calimycin (red). The other
syringe was loaded with (proteo)liposomes in a concentration of 0.2 mg/mL lipid.
Samples of the two syringes were mixed in a ratio of 1:1 in the mixing chamber.
Fluorescence excitation was performed at 492 nm and for detection a long pass
filter with a cut-off wavelength of 515 nm was used. Mn2+ induced quenching of
was observed neither if the sample was liposomes (control) or proteoliposomes (data
shown for LPR 1:30) in the absence of calimycin. Only in the presence of calimycin,
mixing of samples with Mn2+ led to a strong quenching of calcein fluorescence. This
confirms that the assay is sensitive enough for Mn2+ uptake to be detected, but it
is not observed for MntH2. This experiment has not been repeated.
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iments would show a signal on the fluorimeter. If for some reason transport
was very slow, compared to previous experiments, it might be unnoticeable
on a short time scale. These control experiments, however, confirmed the
negative result. These negative results were confirmed when the experiment
was repeated a second time, which means that the data presented in section
6.7 could not be reproduced. It was not possible within the time frame of
this project to figure out where the problem lies but potential reasons for
this will be discussed in section 6.9.
6.9 Discussion
The results presented in this chapter demonstrate that the SURFE2R tech-
nique is applicable to investigate the transition metal transporter MntH2.
Currents measured with this technique may correspond to any electrogenic
process that is related to transport activity (substrate binding, conforma-
tional change and transport) but in case of MntH2 the signals were assigned
to substrate transport. The alternatives were excluded for the following
reasons: MntH2 currents do not represent electrogenic substrate binding,
because currents are inhibited by Ni2+ and Cu2+, two ions that on their
own do not give rise to a signal. Inhibition of Ni2+ and Cu2+ has to be com-
petitive: Structures of ScaDMT including different transition metal ions
show that Ni2+ and Cu2+ bind to the same conserved binding pocket as
Mn2+ [122]. If binding to the substrate pocket was electrogenic these ions
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would also evoke currents in SURFE2R experiments with MntH2. It has also
been excluded that binding of ions to the his-tag contributes to the signal.
Even though most experiments were performed with his-tagged MntH2, key
experiments were repeated with his-tag cleaved protein and the obtained
results were qualitatively the same. It is possible that MntH2 signals are
caused by a conformational change, but it does not seem plausible: A confor-
mational change is normally followed by substrate transport and is unlikely
to be observed on its own. Therefore MntH2 currents are resulting from
substrate transport. This conclusion is reached even though an attempt to
show transport directly, by comparing proteoliposomes with varying LPRs,
did not yield the expected result. A possible explanation for this is that
substrate turnover stops rapidly due to the build up of the electrochemical
gradient, as discussed in section 6.4.1.
The data obtained in SURFE2R experiments shows that MntH2 is a Mn2+
transporter as has been proposed for members of the MntH family. Apart
from Mn2+, MntH2 is able to transport Cd2+ as well as Zn2+ and Co2+
albeit at a slower rate. Ni2+ is transported, but at such a low rate that no
signal is observed in SURFE2R experiments. This broad substrate speci-
ficity is consistent previous studies on homologous proteins which found
that members of the family transport a wide range of transition metal ions
[122, 141]. Our findings are slighly different from the ones of Richer et al.
[151], who have examined metal sensitivity of E. coli overexpressing MntH2.
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We observe Mn2+ but not Fe2+ transport while their study suggests it is the
other way round. The problem of whole cell studies is that overexpression
will always have side effects on the bacteria that are beyond control. For
instance, one issue that these authors had was that MntH2 turned out to be
cytotoxic when overexpressed in E. coli. Considering that Mn2+ is not as
cytotoxic as other transition metals it might be that Mn2+ toxicity might
have been masked under the MntH2-overexpression induced toxicity.
There is as well contradiction between our results and the study of Abrantes
et al. [152], where they have shown that expression of MntH2 is downreg-
ulated in the presence of Mn2+ and Cu2+ and upregulated by excess Zn2+
or Fe2+. It has been suggested that transcription of the mntH2 gene is
coupled with transcription of the next gene upstream the sequence [153].
This gene (uspA), encodes a member of the universal stress protein family
(UspA) [208]. Proteins of this family have been studied in E. coli where
it has been found that they are overexpressed under a number of different
stress conditions [208]. It seems plausible that this protein is overexpressed
in the presence of excess Fe2+ or Zn2+. It remains unclear though, why
MntH2 is downregulated in the presence of Cu2+.
Interestingly, the trend that we see for the interaction of MntH2 with tran-
sition metals aligns with the well-known Irving Williams Series. This series
predicts the stability of high-spin octahedral complexes of first row transi-
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tion metal ions as follows:
Mn2+ < Fe2+ < Co2+ < Ni2+ << Cu2+ > Zn2+
It is generally assumed that this trend applies for metal binding sites in pro-
teins [209]. Mn2+ has the lowest affinity and is transported most efficiently,
binding only weakly and is therefore released the fastest. Co2+ binds more
strongly and is transported less efficiently. Very strong binding metals like
Ni2+ and Cu2+ bind so tightly that they might not dissociate from the bind-
ing site at all and therefore block transport. An exception to this trend is
Fe2+, which does not appear to strongly interact with the protein.
The transport kinetics suggest KM values that are high compared to physi-
ologically relevant metal concentrations. This is contrary to the belief that
MntH2 functions to efficiently scavenging trace elements from its surround-
ings. The most likely explanation for this is that the absence of a proton
electrochemical gradient (∆µH+) influences the kinetic parameters of the
protein. The LacY transporter is a well studied example where the ab-
sence of a membrane potential causes a marked increase in apparent KM :
In membrane vesicles KappM increased more than a 100 fold in the absence
of ∆µH+ [210]. Later qualitatively similar results have been obtained with
LacY reconstituted in proteoliposomes [211] and in particular increased KM
values have been obtained as well when reconstituted LacY was probed in
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SSM-electrophysiological experiments [200].
Complementary to SURFE2R experiments, fluorescence based transport as-
says using the metal sensitive dye calcein were performed to observe metal
uptake in MntH2. This experiments showed uptake for Mn2+ and Ni2+.
Ni2+ uptake was very slow, which fits well with the observation in SURFE2R
experiments, that Ni2+ inhibits Mn2+ currents. Despite this, there is a
caveat to these results as later they could not be reproduced. Because this
issue could not be reproduced within the time frame of this project, it was
not possible to perform experiments investigating the effect of a membrane
potential. It is hard to determine why the results of the fluorescence assay
are not as reproducible as the experiments on the SURFE2R. A reason could
be that problems were caused by the ultracentrifugation step, that was in-
troduced to optimise experiments for the stopped-flow.
Apart from the question which substrates are transported by MntH2 stud-
ies are presented to elucidate the cosubstrate of this putative symporter.
Na+ or K+ are ruled out as substrates in line with published propositions
that MntH proteins are proton symporters [199, 201–204]. However, in ex-
periments which were designed to observe proton co-transport, no evidence
could be found that H+ is involved in the turnover cycle. This has led to
the hypothesis that MntH2 is a uniporter and transport is driven solely
by the electical potential gradient. Because there are many studies that
have observed proton symport in SLC11 tranporters, it should be discussed
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here whether this hypothesis can realistically be true. First, it is impor-
tant to recall that although SLC11 proteins are widely considered proton
symporters it has been recognised already in early studies that proton co-
transport does not follow a strict stoichiometric ratio, but depends on the
external conditions [142, 212]. These observations have led to the model
that was introduced in section 1.6, fig. 1.13. In this very complicated model
DMT1 is a Me2+/H+-symporter but sometimes may work as a H+ or Me2+
uniporter. Here, an alternative model is proposed that is less complicated.
In this model DMT1 is a uniporter for Me2+, but leaky to protons. This is
not a new proposition as the phenomenon of ”leak currents” or ”mechanistic
slips” in SLC11 proteins is well known and has been discussed in a review
[213]. The decisive point in the proposal made here is that when DMT1 is
transporting its substrates, it must become more leaky to H+. This could
be the case if for instance due to conformational changes in the protein some
pathways open up, where H+ can slip through. If this suggestion is right,
this would imply that when investigating proton flux in SLC11 transporters,
it is hard to distinguish between coupled and uncoupled proton co-transport.
This is the case in particular in studies conducted with whole cells which
includes most of the ones mentioned above. An exception is the study by
Courville et al. [203] where in addition to experiments with whole cells,
uptake measurements have been conducted on activated E. coli membrane
vesicles. In these experiments the authors have investigated the influence of
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the different components of the electrochemical gradient (the electrical po-
tential ∆Ψ and the pH gradient ∆pH) on E. coli MntH uptake of 109Cd2+.
In activated membrane vesicles ∆pH or ∆Ψ can be selectively deleted (in
presence of potassium salt) by adding either nigericin (deletion of ∆pH) or
valinomycin (deletion of ∆Ψ). Based on their results of these experiments
the authors claim to have found evidence that MntH forward transport is
proton dependent. However, we cannot follow how the authors came to
that conclusion as in our view their results suggest that the opposite is the
case: They found that in the presence of nigericin 109Cd2+ transport was
increased, while it was abrogated by valinomycin. This implies that MntH
transport does not rely on ∆pH but rather on ∆Ψ and hence this data sup-
ports the theory that protons are not required as a cosubstrate. We can
only speculate that the authors came to a different conclusion because they
found that when no external potassium was present MntH transport was
abrogated by the protonophore CCCP. However, CCCP will dissipate ∆pH
and ∆Ψ and hence this finding does not prove that transport is H+ depen-
dent and is perfectly consistent with the idea that these proteins might be
uniporters.
Another important study has been mentioned in section 1.6.2 and was re-
leased recently together with the crystal structure of EcoDMT [123]. In
that study, the authors characterised (co)-transport of EcoDMT in fluores-
cence experiments, similar to the ones performed in this thesis. Calcein was
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incapsulated in proteoliposomes to measure metal uptake as described in
section 6.7. To monitor H+ co-transport the authors used the dye 9-amino-
6-chloro-2-methoxyacridine (ACMA) instead of HPTS. Metal and proton
transport was monitored under conditions with and without membrane po-
tential. Interestingly, metal transport was observed under both conditions,
but proton transport was observed only in the presence of a membrane po-
tential. In case proton transport was strictly coupled to metal uptake, one
would expect to see co-transport as well in the absence of a membrane po-
tential. The observations made are in line with the hypothesis that binding
or transport of metal renders the protein leaky to H+ which in the presence
of a membrane potential would lead to proton flow, but not in its absence.
The authors also made a mutant of EcoDMT (H236A), where they replaced
a histidine, which is hypothesised to have a role in proton transport, with an
alanine. The mutant still showed metal uptake, albeit at a lower rate, but
no proton transport was detectable. This could indicate that, as the authors
suggest, H236 has a role of proton-coupling in the transport mechanism. At
the same time, considering that the H236A mutant is still able to transport
Mn2+, this shows that metal transport in principle can work without proton
coupling.
In order to strengthen the hypothesis that MntH2 is a uniporter, it was
attempted here to measure substrate uptake of MntH2 under the influence
of an electrical potential. In SURFE2R experiments, an electrical gradient
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can be established using a two-solution-exchange protocol in the presence of
valinomycin. These experiments failed because of technical issues: A large
artefact was seen where the exchange between non-activating and activating
buffer occurs, which made it impossible to measure protein activity in this
set up. The origin of this artefact is unknown. The influence of a membrane
potential could have been tested in fluorescence experiments using calcein.
The problem was that when it was attempted to optimise these experiments
to be performed on a stopped-flow apparatus, they did not work and there
was no time left to fix this issue.
6.9.1 Conclusions
The results presented in this chapter show that MntH2 transports a range
of substrates including Mn2+, Cd2+,Co2+ and Zn2+. Ni2+ and Cu2+ are
not transported and in fact inhibit manganese uptake. MntH2 cotransport
could not be observed, neither in SURFE2R experiments making use of the
protonophore CCCP, nor in fluorescence based assay using the pH sensitive
dye HPTS. These results strongly suggest that MntH2 is a uniporter, even
though there may not be sufficient proof. In any case this topic deserves
more investigation because inspection of data from literature shows that the
matter of co-transport in SLC11 is far less clear that it is generally assumed.
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Chapter 7
Crystallisation trials
7.1 Membrane protein crystallisation
Even though crystal structures have been solved of two SLC11 homologues,
solving the structure of MntH2 would still be of great importance to under-
stand how this protein transports its substrates. A full transport mechanism
of SLC11 can not yet be established using the available structures. More-
over, it is uncertain how physiologically relevant the structures are, that
have been published. In the structure of EcoDMT [123], no substrate was
bound when the protein was co-crystallised with transition metal ions. This
was in spite of the structure showing an outward open state. ScaDMT was
crystallised in complex with a nanobody, which stapled the protein together
in a dimer, which likely is not its native state [122]. Therefore it is evident
that to get a more complete picture of transition metal transport, more
structures are needed and MntH2 is an interesting candidate to get these.
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If the two forms in which MntH2 is purified (P1 and P2; chapter 5) reflect
different states of the protein (a possibility which has to be considered),
crystal structures of P1 and P2 could be very helpful to establish a model
of a transport cycle.
For crystallisation of membrane proteins (proteins in general) to succeed
it is important to start crystallisation trials from a highly pure and ho-
mogeneous sample [214]. To achieve the required degree of purity, protein
obtained from IMAC chromatography was purified further by using size ex-
clusion chromatography (SEC; chapter 5). SEC has the advantage that not
only are impurities eliminated from the sample, but it also removes aggre-
gates and separates different multimers. This is especially important for
crystallisation because, as mentioned, the quality of the preparation does
not only depend on its purity, but also on its homogeneity.
Crystallisation trials for membrane proteins can be set up, in principle, in
the same way as for soluble proteins. There are commercial screens avail-
able which have been designed especially for crystallisation of membrane
proteins. These screens are based on findings about which buffer conditions
have been successfully used in the past to obtain crystals from membrane
proteins. For instance, screen conditions often contain PEG400, or other
short-length PEGs, as these compounds work well as a precipitant [215].
There is also a different approach to crystallise membrane proteins, which is
called the ”lipidic cubic phase” crystallisation. With this method, membrane
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proteins are crystallised in a lipidic rather than in a detergent environment.
But even though there are certainly merits to this approach, this technique
has not been applied here and will not be further discussed.
Attempts to crystallise MntH2 have been undertaken previously [108]. These
trials also made use of commercial screens for membrane proteins and some
crystals were obtained, even though they did not diffract. The approach
taken here was to try and reproduce these hits first, and afterwards working
on ways to optimise crystallisation conditions.
7.2 Crystallisation trials in DDM
MntH2 for crystallisation trials was purified by IMAC, followed by SEC as
described in sections 5.3 - 5.4. After purification, the samples were imme-
diately prepared for trials in order to minimise protein aggregation. The
samples P1 and P2, which originated from the two different peaks in the
chromatogram of IMAC purification (fig. 5.2b), were treated separately.
Proteins were concentrated using a spin-concentrator (30 kDa; vivaspin) up
to concentrations of 3.8 mg/mL (P1) and 8.4 mg/mL (P2) as confirmed by
a BCA assay. The trials were set up using the commercial screens MemGold
[216], MemGold2 [217] and MemSys/MemStart [214]. Each of these screens
correspond to 96 different conditions. Plates were set up with the help of a
crystallisation robot (NT8), where protein was mixed in a ratio of 1:1 with
well solution to a total drop size of 0.2 µL. For all screens three drop 96-well
plates were used where one drop per well was for P1 and another one for P2.
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All plates were stored at 4 °C and trials were run for 34 days. In three of
the conditions, crystals were formed which had the form of thin needles (fig.
7.1A, B and C). Because these needles are very hard to pick, only the ones
shown in fig. 7.1B were shot at the synchotron. No diffraction was obtained,
which confirms that at least these crystals are from protein. Interestingly,
in conditions where needles were obtained, they showed up only in one of
the drops. In two cases needles appeared in drop 2 (P2) and in one case in
drop 1 (P1). In each case the second drop corresponding to the same well
either remained clear or some minor precipitation was seen.
A fourth condition, that might be of interest is represented in fig. 7.1D. The
heavy precipitation, which leads to very dense protein aggregation in some
spots, could serve as a starting point for an optimisation trial.
7.3 Crystallisation trials in DMNG
For membrane protein crystallisation, DDM is not the most optimal deter-
gent, partly because of its relatively long chain length. An alternative to
DDM are the maltose neopentyl glycol based detergents, which have been
shown to have favorable properties for membrane protein stability and crys-
tallisation [191]. In the precedent thesis on MntH2 the protein has been
found stable in these detergents and it was proposed that especially DMNG
(fig. 7.2) would be a promising candidate for crystallisation because of its
short chain length [108, 218].
Purification of MntH2 in DMNG was performed analogously to purification
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Figure 7.1: Crystallisation trials on MntH2 in DDM buffer. Trials were set up
in 96-well plates at 4 °C using the commercial screens MemGold, MemGold2 and
MemSys/MemStart. Crystals in the shape of thin needles were obtained in three
different drops, from P1 (3.8 mg/mL; A) and P2 (8.4 mg/mL; B and C). Well
solutions were A: 0.2 M (NH4)2SO4; 0.02 M NaCl; 0.02 M Na Acet, pH 4.0; 33
% v/v PEG 200, B: 0.2 M CaCl2; 0.1 M MES, pH 5.0; 20 % v/v PEG MME 350,
C: 0.2 M Ca Acet; 0.1 M HEPES, pH 7.0; 24 % v/v PEG 400. The precipitate in
D is from P1 (3.8 mg/mL) and conditions were 0.01 M KCl; 0.02 M Tris, pH 7.0;
0.1 M K Acet; 44 % PEG 3K.
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Figure 7.2: Structure of detergents used for crystallisation trials.
in DDM and is described in section 5.6. The following steps were performed
immediately after purified protein was obtained. The protein was concen-
trated (spin-concentrator; 30 kDa) to concentrations of 6.5 mg/mL (P2) and
3.2 mg/mL (P1) as determined by nanodrop measurements. The first three
plates were set up using the same three screens as before: MemGold, Mem-
Gold2 and MemSys/MemStart. These plates had the following load: Drops
one and three were from P1, mixed in a ratio of 1:1 and 1.75:1 respectively
and the final drop volume was 0.2 and 0.275 µL. Drop two was P2 mixed in
a ratio of 1.75:1 to a drop volume of 0.275 µL. After these plates were left
for storage at 4 °C, the remaining protein was concentrated further before
setting up the next trials: P2 was concentrated up to 5.4 mg/mL protein
concentration and P1 to 6.7 mg/mL as confirmed again on a nanodrop. Us-
ing this higher concentrated protein sample, two more crystallisation plates
were set up, using the MemGold and MemGold2 screen. In these screens
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drop one and three were loaded as before with P1, but in drop two, P2 was
now mixed in a 1:1 ratio with well solution. Both plates were stored at 20
°C.
Of all five screens in total, there was one interesting result in particular. In
one of the conditions at 4 °C, crystals appeared only 45 min after the plate
was put into storage (fig. 7.3). This happened in drop 1 and drop 2, but
not in drop 3. The appearance of these crystals suggested, that they might
well be from membrane protein. However, the crystals remained stable for
only eight more hours and were gone after one day. An issue with this
condition was that when setting up the plate, the solution from this well
has been mixed accidentally with a neighbouring well solution in a ratio of
1:1. This combination led to formation of salt crystals in the well solution,
which appeared as well in the drops. These crystals were eventually shot
at the synchotron where it was confirmed that they were salt crystals, but
this does not change the fact that some of the crystals seen initially, looked
promising.
7.4 Discussion
Two series of trials have been set up for MntH2 and the results appear
quite promising. In a first series MntH2 it was attempted to reproduce crys-
tallisation trials that have been performed in previous work, where some
(non-diffracting) crystals were obtained [108]. In contrast to the preceding
trials, MntH2 was separated into samples P1 and P2, a distinction that was
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Figure 7.3: Crystallisation trials on MntH2 in DMNG buffer (25 mM MES, pH
6.0; 150 mM NaCl; 0.05 % DMNG). Trials were set up in 96-well plates at both
at 4 and at 20 °C using the commercial screens MemGold, MemGold2 and Mem-
Sys/MemStart as indicated in text. In the condition shown, already 45 min after
starting the trial crystals appeared, that had the look to be from membrane protein.
After only one day the crystals had redissolved and the remaining crystals were
confirmed to be salt. Crystals appeared in drop one (1:1 P1 (3.2 mg/mL):buffer)
and drop 2 (1.75:1 P2 (6.5 mg/mL):buffer). Well solution was a 1:1 mixture of 11
% PEG 600; 0.35 M LiSO4; 0.1 M Na Acet, pH 4.5 and 38 % PEG 400; 0.2 M Ca
Acet; 0.1 M Na Acet.
found only, because MntH2 was eluted in a linear gradient in IMAC purifi-
cation. In addition, MntH2 was screened with MemGold2, a complement
to the MemGold screen incorporating more recent advances in membrane
protein crystallography [217].
The result of this screen was that needle shaped crystals were obtained in
three different conditions, albeit these were not identical to the conditions
identified previously. Crystals from one condition (fig. 7.1) were shot at the
synchotron, but no diffraction pattern was obtained.
Trials in DMNG led to one potentially interesting hit, where crystals were
obtained that had the shape of small rods, which is an indication that they
are membrane protein crystals. Unfortunately these crystals redissolved and
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could not be investigated at the synchotron. If these crystals could be re-
produced, they could be harvested in time and stored in liquid N2.
In general terms MntH2 appears to have some properties that are quite
favourable for crystallisation. It does have a high thermal stability, it does
not have a strong tendency to aggregate and importantly, the yields are
comparably very high for a membrane protein.
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Chapter 8
Conclusions
In this thesis the SURFE2R technique has been applied for two very dif-
ferent proteins: The human TRPM2 non-selective Ca2+ channel and the
bacterial transition metal transporter Enterococcus faecalis MntH2. What
these systems have in common is that they are both very challenging to
characterise, for different reasons that have been explained in the text. As
a result, not everything that has been tried to achieve has worked out in
the end. Despite considerable effort it was not possible to monitor the ac-
tivity of the TRPM2 channel in SURFE2R experiments. The reasons for
this remain unknown, but there is always a risk when taking a protein out
of its native environment, that it will not behave well and may loose its
functionality. It may also have to be conceded, that the SURFE2R has not
been designed primarily to investigate ion channels and therefore TRPM2
was not a straightforward target.
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In contrast to experiments with TRPM2, characterisation with the SURFE2R
worked well for the transition metal transporter MntH2. Metal substrates
and inhibitors of the protein were identified and a pH profile for activity was
established. For these types of experiments the SURFE2R has shown to be
invaluable because it would have been much harder to get the same data
with other techniques. The fluorescence based assay with calcein, also ap-
plied in this thesis, is much more time consuming and requires more protein.
Also, the assay cannot be performed at arbitrary pH because calcein has a
low sensitivity at pH > 8.0. The most unexpected result from SURFE2R ex-
periments on MntH2 was that currents were unaffected by the protonophore
CCCP, suggesting that MntH2 transport is not proton coupled. It has been
proposed here that MntH2 may be a uniporter and arguments supporting
this hypothesis were presented in chapter 6.
8.1 Future research
Future research on MntH2 would include experiments on the stopped flow.
These would allow to obtain kinetic data of MntH2 transport under condi-
tions with and without membrane potential. In the most ideal case these
experiments would be conducted with his-tag cleaved protein, where pro-
tein from the two peaks in the IMAC step is treated separately. It might
be worth to repeat some experiments on the SURFE2R with protein from
both peaks to see if there is any difference in functional behaviour. It would
be interesting to compare the data obtained in this thesis with data from
8.1 Future research
a different SLC11 homologues, e.g. EcoDMT. In particular the experiment
with CCCP should be repeated to confirm the finding made with MntH2
that metal transport in SLC11 can work without co-transport of protons.
Crystallisation trials for MntH2 should be continued because there is still a
demand for more structural information on SLC11 homologues. Optimisa-
tion trials could be set up around the crystallisation conditions that have
been found in this project or in previous work. Another path that may
be pursued is to try and obtain a structure with the LCP crystallisation
technique.
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(b) Inhibition of Mn2+-induced cur-
rents by Ni2+ and Cu2+ for his-tag
cleaved MntH2. Because of the high
background of the sensor, a control
experiment was performed with vali-
nomycin.
Figure A1: Control experiments on SURFE2R with his-tag cleaved MntH2. Quali-
tatively the data is not different from data recorded with uncleaved protein.
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